Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,OR[95%CI],P_value
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",A1BG,Alpha-1B-glycoprotein,6589,178,4.76 [1.96-11.59],0.0005787731414674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AAMDC,Mth938 domain-containing protein,6393,171,0.82 [0.61-1.10],0.1816822321429471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AARSD1,Alanyl-tRNA editing protein Aarsd1,7543,206,0.72 [0.57-0.91],0.0058978502581246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABCA2,ATP-binding cassette sub-family A member 2,6354,169,1.05 [0.69-1.60],0.8284059214264754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABHD14B,Protein ABHD14B,7482,207,0.87 [0.70-1.09],0.2363806595719432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABL1,Tyrosine-protein kinase ABL1,7543,206,0.92 [0.75-1.11],0.3722064628172574
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABO,Histo-blood group ABO system transferase,6592,177,0.99 [0.90-1.10],0.90445961954971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ABRAXAS2,BRISC complex subunit Abraxas 2,6354,169,0.88 [0.70-1.12],0.2976682925075138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",7437,205,1.01 [0.86-1.19],0.8691758097631423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",6448,175,1.03 [0.84-1.27],0.7726814324484494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",6580,177,1.05 [0.89-1.24],0.545372451267125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACAN,Aggrecan core protein,7486,206,1.60 [1.01-2.53],0.0454305531983454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE,Angiotensin-converting enzyme,6592,177,1.08 [0.64-1.80],0.7793213414236635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACE2,Angiotensin-converting enzyme 2,7455,202,0.79 [0.62-1.02],0.0744251213119273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACHE,Acetylcholinesterase,6435,173,0.51 [0.32-0.80],0.0037839738800684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOT13,Acyl-coenzyme A thioesterase 13,6553,176,0.99 [0.87-1.13],0.908049321238124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,7572,207,0.94 [0.73-1.21],0.6164593192850614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP1,Low molecular weight phosphotyrosine protein phosphatase,6368,169,0.75 [0.53-1.07],0.1121084963478628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP5,Tartrate-resistant acid phosphatase type 5,7626,210,1.03 [0.71-1.50],0.8804370285369585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACP6,Lysophosphatidic acid phosphatase type 6,7647,207,0.97 [0.81-1.16],0.7451996581788659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRBP,Acrosin-binding protein,6554,173,0.96 [0.66-1.39],0.8282657375941624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACRV1,Acrosomal protein SP-10,6368,169,0.81 [0.70-0.94],0.0047141547283159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACSL1,Long-chain-fatty-acid--CoA ligase 1,6354,169,1.03 [0.67-1.57],0.9058463462178936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTA2,"Actin, aortic smooth muscle",7455,202,1.32 [1.03-1.70],0.0299518550300304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN2,Alpha-actinin-2,6354,169,0.78 [0.60-1.02],0.0699052380985924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACTN4,Alpha-actinin-4,7455,203,1.04 [0.72-1.50],0.8528511089173066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACVRL1,Serine/threonine-protein kinase receptor R3,7488,206,1.37 [0.87-2.15],0.1781117068873309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY1,Aminoacylase-1,7572,207,0.90 [0.73-1.11],0.3249978368864672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,6354,169,1.10 [0.84-1.44],0.4869914949097773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ACYP1,Acylphosphatase-1,6417,173,0.89 [0.71-1.12],0.3296775683813548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA,Adenosine deaminase,7660,209,0.85 [0.60-1.21],0.3598112807256161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADA2,Adenosine deaminase 2,7554,203,1.10 [0.83-1.45],0.5021814519298015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,6368,169,1.60 [1.09-2.34],0.0154738956419247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,7455,202,1.45 [0.97-2.17],0.0679858174723572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,7503,207,1.32 [0.93-1.85],0.1156149901199997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,7660,209,1.35 [0.93-1.95],0.1142318980131374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,7629,209,1.06 [0.69-1.64],0.786760541376821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,6553,176,1.14 [0.71-1.83],0.597805744437329
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,6368,169,1.00 [0.63-1.60],0.9882662128340562
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,7681,210,1.33 [0.79-2.24],0.282250491341847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,7543,206,1.32 [0.97-1.79],0.0740146782114255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,7455,202,1.12 [0.80-1.57],0.5022715829100746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,6368,169,1.19 [0.79-1.80],0.4040332851989376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,7608,208,1.05 [0.80-1.38],0.7149765014267777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL2,ADAMTS-like protein 2,6573,174,0.93 [0.60-1.42],0.7250024338694474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL4,ADAMTS-like protein 4,6393,171,1.91 [1.02-3.58],0.0425582444076027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADAMTSL5,ADAMTS-like protein 5,6580,177,0.91 [0.63-1.31],0.6055978383710319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,7437,205,0.78 [0.49-1.24],0.2854409787275551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADD1,Alpha-adducin,6435,173,0.80 [0.65-0.98],0.0329959479305792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRB3,Adhesion G protein-coupled receptor B3,7488,206,1.03 [0.71-1.49],0.8806441385487502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRD1,Adhesion G-protein coupled receptor D1,6435,173,0.84 [0.57-1.22],0.3558380744963302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE1,Adhesion G protein-coupled receptor E1,6553,176,1.29 [1.00-1.67],0.048110244044605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE2,Adhesion G protein-coupled receptor E2,7605,207,1.55 [1.03-2.36],0.0378521248087793
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRE5,Adhesion G protein-coupled receptor E5,7649,209,1.18 [0.81-1.73],0.3947209492876538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRF5,Adhesion G protein-coupled receptor F5,6580,177,0.80 [0.45-1.39],0.4248852671788207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG1,Adhesion G-protein coupled receptor G1,7543,206,0.97 [0.85-1.11],0.6493090147964172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRG2,Adhesion G-protein coupled receptor G2,7572,207,1.85 [1.17-2.94],0.0087579866164001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADGRV1,Adhesion G-protein coupled receptor V1,6400,169,0.92 [0.74-1.16],0.496740289333429
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH1B,All-trans-retinol dehydrogenase,6435,173,0.88 [0.71-1.08],0.226382247213794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,7455,202,1.07 [0.91-1.25],0.4141919382683473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADIPOQ,Adiponectin,6589,178,1.12 [0.91-1.38],0.2762026283991144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADM,Pro-adrenomedullin,7659,207,1.27 [0.79-2.04],0.3256430075120151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ADRA2A,Alpha-2A adrenergic receptor,6354,169,1.16 [0.96-1.40],0.1188907612138948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFAP1,Actin filament-associated protein 1,6435,173,1.11 [0.93-1.32],0.2611381421337354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFM,Afamin,6589,178,2.07 [1.02-4.19],0.0432783440595579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AFP,Alpha-fetoprotein,7475,205,1.08 [0.89-1.31],0.4479315203702499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGBL2,Cytosolic carboxypeptidase 2,6400,169,1.00 [0.85-1.17],0.9546727343606064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGER,Advanced glycosylation end product-specific receptor,7562,207,1.43 [1.07-1.91],0.0164962896726649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR2,Anterior gradient protein 2 homolog,7366,201,1.04 [0.91-1.19],0.5402769628807707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGR3,Anterior gradient protein 3,7423,205,1.09 [0.88-1.34],0.4350698851387402
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRN,Agrin,7605,207,1.33 [0.95-1.86],0.0967549067452989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGRP,Agouti-related protein,7660,209,1.15 [0.90-1.47],0.2514393501848762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGT,Angiotensinogen,6592,177,0.88 [0.44-1.75],0.7145935249463746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AGXT,Serine--pyruvate aminotransferase,7572,207,0.98 [0.82-1.16],0.774505815549677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHCY,Adenosylhomocysteinase,7572,207,0.86 [0.71-1.04],0.1131813731233635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK,Neuroblast differentiation-associated protein AHNAK,6393,171,1.06 [0.65-1.71],0.8239448593264215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHNAK2,Protein AHNAK2,6393,171,1.12 [0.71-1.77],0.6153972244300445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,6554,173,1.01 [0.81-1.27],0.8972350391637183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSG,Alpha-2-HS-glycoprotein,6592,177,1.02 [0.60-1.74],0.942816361331515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AHSP,Alpha-hemoglobin-stabilizing protein,7571,208,0.81 [0.70-0.94],0.0067766619297047
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIDA,"Axin interactor, dorsalization-associated protein",6413,172,0.97 [0.81-1.15],0.7103727421541755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1,Allograft inflammatory factor 1,7437,205,0.93 [0.73-1.19],0.5558044572727896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIF1L,Allograft inflammatory factor 1-like,6393,171,0.77 [0.55-1.07],0.1135527584298066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AIFM1,"Apoptosis-inducing factor 1, mitochondrial",7534,206,0.98 [0.87-1.10],0.7518571433615231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK1,Adenylate kinase isoenzyme 1,7572,207,0.83 [0.68-1.02],0.0715614328139613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AK2,"Adenylate kinase 2, mitochondrial",6567,172,1.02 [0.89-1.18],0.7436346512730747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKAP12,A-kinase anchor protein 12,6435,173,1.48 [0.75-2.92],0.2623733811011732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B1,Aldo-keto reductase family 1 member B1,7437,205,0.98 [0.82-1.17],0.8384665569510356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1B10,Aldo-keto reductase family 1 member B10,6413,172,1.07 [0.85-1.35],0.5509159730610885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR1C4,Aldo-keto reductase family 1 member C4,7455,202,0.89 [0.68-1.17],0.4085060235280258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKR7L,Aflatoxin B1 aldehyde reductase member 4,6368,169,1.02 [0.81-1.28],0.8729552812402879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT1S1,Proline-rich AKT1 substrate 1,7422,204,0.89 [0.73-1.07],0.2126853342214917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT2,RAC-beta serine/threonine-protein kinase,6571,175,0.97 [0.86-1.08],0.5491054214083756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AKT3,RAC-gamma serine/threonine-protein kinase,7410,204,0.95 [0.76-1.19],0.6651529406481791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALCAM,CD166 antigen,7681,210,2.34 [1.29-4.25],0.0050232953864088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH1A1,Retinal dehydrogenase 1,7592,208,0.71 [0.55-0.92],0.0081918498338149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH2,"Aldehyde dehydrogenase, mitochondrial",6554,173,0.95 [0.71-1.29],0.7572173995387346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",7555,209,0.95 [0.79-1.14],0.5781112964823765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",6571,175,0.95 [0.69-1.31],0.744108434564375
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALMS1,Alstrom syndrome protein 1,6448,175,0.86 [0.60-1.25],0.4287144140193296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPI,Intestinal-type alkaline phosphatase,6368,169,1.02 [0.91-1.15],0.6932051851062472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ALPP,"Alkaline phosphatase, placental type",7543,206,1.00 [0.88-1.12],0.940906414988484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBN,Ameloblastin,7455,203,1.05 [0.68-1.64],0.8196629377551241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMBP,Protein AMBP,7648,207,2.52 [1.41-4.49],0.0017323373254589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,6573,174,1.78 [0.99-3.19],0.0531740503361346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMFR,E3 ubiquitin-protein ligase AMFR,7422,204,1.20 [1.00-1.44],0.0454122489697654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO1,Amphoterin-induced protein 1,6413,172,0.94 [0.69-1.29],0.712784901636397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMIGO2,Amphoterin-induced protein 2,7543,206,1.55 [0.93-2.59],0.0938105637032587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMN,Protein amnionless,7455,203,1.02 [0.78-1.34],0.8664745060788247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOT,Angiomotin,6435,173,1.24 [0.84-1.83],0.2772310359054082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMOTL2,Angiomotin-like protein 2,6527,172,0.91 [0.66-1.26],0.5638386019873416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMPD3,AMP deaminase 3,6567,172,0.78 [0.64-0.96],0.020296647190114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,6166,170,0.91 [0.67-1.24],0.5453668089855834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2A,Pancreatic alpha-amylase,7303,199,1.09 [0.84-1.41],0.5141303005175772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AMY2B,Alpha-amylase 2B,7073,193,1.09 [0.84-1.41],0.51164207814103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANG,Angiogenin,7578,204,1.35 [0.94-1.94],0.1020614196514179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT1,Angiopoietin-1,7544,206,0.97 [0.83-1.12],0.6601815546936647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPT2,Angiopoietin-2,7659,207,1.08 [0.79-1.48],0.630809761799723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL1,Angiopoietin-related protein 1,7465,203,1.13 [0.73-1.75],0.5807349660670035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL2,Angiopoietin-related protein 2,7579,206,1.33 [0.97-1.83],0.07235655821717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL3,Angiopoietin-related protein 3,7598,204,1.52 [1.06-2.18],0.0215463716108813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL4,Angiopoietin-related protein 4,7598,207,0.86 [0.65-1.13],0.283313686630934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANGPTL7,Angiopoietin-related protein 7,7659,207,0.92 [0.65-1.30],0.6420071001116396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANK2,Ankyrin-2,6354,169,1.03 [0.83-1.27],0.7831399033255364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,6368,169,0.95 [0.78-1.15],0.5907427632697559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRA2,Ankyrin repeat family A protein 2,6350,168,1.15 [0.88-1.49],0.3032230575730704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANKRD54,Ankyrin repeat domain-containing protein 54,7437,205,1.02 [0.82-1.27],0.854855835528183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,6393,171,1.11 [0.78-1.57],0.5633345449352808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANPEP,Aminopeptidase N,7612,207,1.25 [0.80-1.96],0.322357709283666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA1,Annexin A1,6406,173,0.91 [0.63-1.32],0.624893674623054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA10,Annexin A10,7422,204,1.04 [0.90-1.20],0.6203936394700768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA11,Annexin A11,7559,208,0.97 [0.80-1.17],0.7444477660291866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA2,Annexin A2,6292,170,0.81 [0.65-1.02],0.0705556074779781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA3,Annexin A3,7629,209,1.00 [0.84-1.20],0.9665095927334744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA4,Annexin A4,7544,207,0.99 [0.83-1.18],0.8985171522149789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ANXA5,Annexin A5,7394,204,1.13 [0.76-1.70],0.5424235527549155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC1,Amiloride-sensitive amine oxidase [copper-containing],7455,203,1.01 [0.81-1.28],0.9077544922343266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AOC3,Membrane primary amine oxidase,7623,207,1.18 [0.79-1.78],0.4251366402070493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP1G2,AP-1 complex subunit gamma-like 2,6554,173,0.91 [0.75-1.10],0.3244728187028842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP2B1,AP-2 complex subunit beta,6413,172,0.97 [0.71-1.32],0.8285051499103261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3B1,AP-3 complex subunit beta-1,6553,176,0.91 [0.75-1.11],0.3377282816955225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AP3S2,AP-3 complex subunit sigma-2,6567,172,0.96 [0.71-1.31],0.8150008631300744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,7543,206,1.06 [0.80-1.39],0.6968164145142584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APCS,Serum amyloid P-component,6519,176,1.28 [0.82-2.02],0.280072302062755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,7632,206,1.01 [0.82-1.25],0.9062249409361864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APLP1,Amyloid-like protein 1,7572,207,1.01 [0.79-1.29],0.9302541960489058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA1,Apolipoprotein A-I,6589,178,0.74 [0.42-1.33],0.3174295720847853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA2,Apolipoprotein A-II,6592,177,1.06 [0.79-1.42],0.6854799251273065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOA4,Apolipoprotein A-IV,6589,178,1.39 [0.93-2.08],0.1090848958775823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOB,Apolipoprotein B-100,6592,177,1.18 [0.62-2.25],0.6176204527233625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOBR,Apolipoprotein B receptor,6393,171,1.03 [0.72-1.47],0.8633154457057155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOC1,Apolipoprotein C-I,6579,178,0.94 [0.64-1.38],0.7510874970940138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOD,Apolipoprotein D,6311,173,0.70 [0.46-1.08],0.1088137187560711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOE,Apolipoprotein E,6589,178,1.03 [0.83-1.28],0.7561157143468376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOF,Apolipoprotein F,6592,177,0.91 [0.52-1.62],0.7561955598653846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOH,Beta-2-glycoprotein 1,7592,208,1.35 [0.97-1.87],0.0753584511172314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOL1,Apolipoprotein L1,6592,177,1.07 [0.81-1.41],0.6496055568233301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APOM,Apolipoprotein M,7611,206,1.59 [1.04-2.43],0.0337064659523569
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APP,Amyloid-beta precursor protein,7584,208,0.98 [0.82-1.19],0.8736915136027519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APPL2,DCC-interacting protein 13-beta,6435,173,0.99 [0.87-1.13],0.8770117231742992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",APRT,Adenine phosphoribosyltransferase,7482,207,0.89 [0.69-1.16],0.400648472502501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARAF,Serine/threonine-protein kinase A-Raf,6448,175,1.00 [0.81-1.24],0.9885075665695092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AREG,Amphiregulin,7543,206,1.01 [0.75-1.37],0.9429439728697576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARF6,ADP-ribosylation factor 6,6553,176,0.99 [0.86-1.13],0.8711914722875491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARFIP1,Arfaptin-1,6571,175,0.95 [0.76-1.18],0.6253614938856265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG1,Arginase-1,7539,205,0.90 [0.70-1.14],0.371570043231711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARG2,"Arginase-2, mitochondrial",6554,173,1.19 [0.87-1.63],0.2694639745056422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP1,Rho GTPase-activating protein 1,7437,205,0.71 [0.54-0.93],0.0131383131096069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP25,Rho GTPase-activating protein 25,7437,205,1.03 [0.84-1.27],0.7548659196342598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP30,Rho GTPase-activating protein 30,6448,175,0.94 [0.65-1.36],0.734836557344349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP45,Rho GTPase-activating protein 45,6435,173,0.99 [0.83-1.19],0.943512394920096
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGAP5,Rho GTPase-activating protein 5,6350,168,0.81 [0.65-1.02],0.0676649838009606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF1,Rho guanine nucleotide exchange factor 1,6567,172,0.93 [0.79-1.10],0.4185527950377559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF10,Rho guanine nucleotide exchange factor 10,6571,175,0.96 [0.82-1.12],0.5811492513621228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF12,Rho guanine nucleotide exchange factor 12,7573,209,0.92 [0.81-1.04],0.1618742868364067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARHGEF5,Rho guanine nucleotide exchange factor 5,6400,169,1.22 [1.01-1.46],0.034701251546664
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID3A,AT-rich interactive domain-containing protein 3A,6400,169,1.16 [0.82-1.65],0.4079112838471036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARID4B,AT-rich interactive domain-containing protein 4B,7422,204,1.15 [0.86-1.53],0.3385338790719108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL13B,ADP-ribosylation factor-like protein 13B,6354,169,1.19 [0.97-1.46],0.0890078789339931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,6354,169,1.00 [0.68-1.46],0.9995350967143845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARMCX2,Armadillo repeat-containing X-linked protein 2,6400,169,1.14 [0.92-1.42],0.2395039237844105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNT,Aryl hydrocarbon receptor nuclear translocator,7455,203,0.80 [0.55-1.17],0.2512170711895466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,6354,169,1.06 [0.81-1.39],0.6724848648462463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSA,Arylsulfatase A,7592,208,1.08 [0.82-1.42],0.5833702483811015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARSB,Arylsulfatase B,7543,206,1.14 [0.91-1.42],0.2478435695945852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART3,Ecto-ADP-ribosyltransferase 3,7623,207,0.93 [0.67-1.30],0.6774622193194111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ART5,Ecto-ADP-ribosyltransferase 5,6400,169,1.13 [0.92-1.40],0.2393624352607579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ARTN,Artemin,7455,203,1.15 [0.90-1.47],0.2556999938800528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH1,Acid ceramidase,6513,173,1.28 [0.95-1.73],0.0995053890358318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASAH2,Neutral ceramidase,7503,207,1.00 [0.79-1.26],0.9845087872995668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR1,Asialoglycoprotein receptor 1,7503,207,1.37 [0.93-2.03],0.1119050245315251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASGR2,Asialoglycoprotein receptor 2,6592,177,1.80 [1.08-2.98],0.0233912203510251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPN,Asporin,6580,177,0.91 [0.53-1.56],0.7385182000443056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASPSCR1,Tether containing UBX domain for GLUT4,6571,175,0.85 [0.68-1.07],0.1633098545481327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASRGL1,Isoaspartyl peptidase/L-asparaginase,6393,171,0.95 [0.82-1.11],0.5349530946736782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ASS1,Argininosuccinate synthase,6354,169,0.89 [0.72-1.09],0.2568747747687372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF2,Cyclic AMP-dependent transcription factor ATF-2,7422,204,1.07 [0.90-1.27],0.4210737306307848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATF4,Cyclic AMP-dependent transcription factor ATF-4,6350,168,0.89 [0.56-1.41],0.6199014541459846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG16L1,Autophagy-related protein 16-1,6553,176,0.92 [0.78-1.10],0.3785803890249097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATG4A,Cysteine protease ATG4A,7437,205,0.74 [0.59-0.93],0.0089455217346837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATOX1,Copper transport protein ATOX1,7608,208,0.97 [0.81-1.16],0.7148824225665348
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,6354,169,1.02 [0.74-1.41],0.8868373336568255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,6354,169,1.25 [0.81-1.92],0.3181479667235486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,6354,169,0.87 [0.58-1.32],0.5231872565975949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP1B4,Protein ATP1B4,6350,168,0.93 [0.64-1.34],0.6861827980637174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP2B4,Plasma membrane calcium-transporting ATPase 4,6354,169,1.00 [0.79-1.27],0.997682793744696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5F1D,"ATP synthase subunit delta, mitochondrial",6354,169,1.10 [0.85-1.42],0.4821023072741058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5IF1,"ATPase inhibitor, mitochondrial",7605,207,1.02 [0.91-1.14],0.7909790133798583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP5PO,"ATP synthase subunit O, mitochondrial",7422,204,1.22 [0.96-1.54],0.0988274106020694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6AP2,Renin receptor,7437,205,1.15 [0.86-1.55],0.341925819650937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1D,V-type proton ATPase subunit D,7543,206,1.37 [0.93-2.01],0.109907554041846
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1F,V-type proton ATPase subunit F,7412,204,0.92 [0.76-1.12],0.4253048849745201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G1,V-type proton ATPase subunit G 1,6393,171,0.96 [0.78-1.19],0.725327399907093
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATP6V1G2,V-type proton ATPase subunit G 2,6354,169,1.03 [0.88-1.21],0.6972076266615232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRAID,All-trans retinoic acid-induced differentiation factor,6553,176,1.35 [0.91-1.99],0.1348429094906396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATRN,"Attractin, Isoform 2",6589,178,2.25 [0.94-5.38],0.0687049069172596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN10,Ataxin-10,7422,204,0.89 [0.75-1.06],0.1896639307375723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2,Ataxin-2,6400,169,1.06 [0.92-1.21],0.4256116881195347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN2L,Ataxin-2-like protein,6571,175,0.81 [0.58-1.13],0.2086127858366151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ATXN3,Ataxin-3,6567,172,0.79 [0.62-1.00],0.0494413537179738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXIN1,Axin-1,7573,209,0.93 [0.81-1.06],0.2579776264598927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AXL,Tyrosine-protein kinase receptor UFO,7623,207,2.05 [1.32-3.18],0.001317362991341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZI2,5-azacytidine-induced protein 2,6571,175,1.06 [0.82-1.37],0.667913227092295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",AZU1,Azurocidin,7354,202,1.06 [0.90-1.24],0.4944744922313276
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B2M,Beta-2-microglobulin,6589,178,1.27 [0.87-1.86],0.2220103483042552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,6354,169,1.52 [0.79-2.94],0.2106044821068071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",6393,171,0.76 [0.51-1.13],0.1801020166933981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GALT1,"Beta-1,4-galactosyltransferase 1",7605,207,1.66 [1.08-2.56],0.0206351463232155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",B4GAT1,"Beta-1,4-glucuronyltransferase 1",7592,208,1.37 [0.82-2.28],0.2235318814107108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BABAM1,BRISC and BRCA1-A complex member 1,6368,169,0.66 [0.38-1.17],0.1589666625201971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BACH1,Transcription regulator protein BACH1,7573,209,0.91 [0.77-1.09],0.3094478087716533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG3,BAG family molecular chaperone regulator 3,7488,206,1.18 [0.86-1.63],0.3113307837296022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG4,BAG family molecular chaperone regulator 4,6368,169,0.87 [0.63-1.21],0.4175015991310858
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAG6,Large proline-rich protein BAG6,7455,202,0.78 [0.55-1.12],0.1792132796324299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,7437,205,0.96 [0.78-1.17],0.6796375934386598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAMBI,BMP and activin membrane-bound inhibitor homolog,7437,205,1.90 [1.29-2.78],0.0010450474152009
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BANK1,B-cell scaffold protein with ankyrin repeats,7573,209,0.92 [0.82-1.03],0.1329199087049235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAP18,Chromatin complexes subunit BAP18,6567,172,1.03 [0.83-1.27],0.7987236237936983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BATF,Basic leucine zipper transcriptional factor ATF-like,6413,172,0.99 [0.83-1.18],0.8967572850275038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BAX,Apoptosis regulator BAX,7410,204,1.05 [0.91-1.21],0.5050754333127856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAM,Basal cell adhesion molecule,7592,208,1.11 [0.67-1.84],0.6709812801570105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAN,Brevican core protein,7503,207,0.90 [0.63-1.27],0.5380736682060351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",6580,177,0.82 [0.50-1.35],0.4415389998457686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",6400,169,0.98 [0.74-1.30],0.8858494936738334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCHE,Cholinesterase,6465,176,1.17 [0.67-2.03],0.5841776047442997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,6553,176,1.01 [0.77-1.33],0.9232767584278818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L1,Bcl-2-like protein 1,6567,172,0.99 [0.85-1.15],0.8587604056539505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",7573,209,0.85 [0.63-1.13],0.2650285800874626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL2L15,Bcl-2-like protein 15,6368,169,0.99 [0.76-1.29],0.9573200540134652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7A,B-cell CLL/lymphoma 7 protein family member A,6350,168,1.05 [0.83-1.33],0.684741385986797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCL7B,B-cell CLL/lymphoma 7 protein family member B,6554,173,1.12 [0.84-1.48],0.4370366514933558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BCR,Breakpoint cluster region protein,7573,209,0.94 [0.82-1.07],0.3383966226130069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BDNF,Brain-derived neurotrophic factor,6573,174,0.99 [0.83-1.18],0.8945403630806386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BECN1,Beclin-1,6393,171,0.86 [0.66-1.12],0.2638086819693849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BEX3,Protein BEX3,6350,168,0.87 [0.60-1.25],0.4414468055313648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGLAP,Osteocalcin,6573,174,1.14 [0.96-1.35],0.1410211279575821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BGN,Biglycan,7426,205,1.04 [0.93-1.15],0.5191832442856992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHLHE40,Class E basic helix-loop-helix protein 40,6400,169,1.10 [0.90-1.34],0.3729715406637599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,6354,169,1.71 [0.99-2.97],0.0548507130233879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BID,BH3-interacting domain death agonist,7573,209,1.09 [0.91-1.30],0.3658782798683786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIN2,Bridging integrator 2,7592,208,0.98 [0.85-1.13],0.7785762234565314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BIRC2,Baculoviral IAP repeat-containing protein 2,7437,205,0.90 [0.73-1.10],0.3081994769609899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLMH,Bleomycin hydrolase,7681,210,0.77 [0.51-1.17],0.2190995163874957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLNK,B-cell linker protein,6368,169,1.41 [1.00-1.99],0.0529606969191956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,6400,169,1.03 [0.84-1.25],0.7806212678526432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,6567,172,1.04 [0.72-1.49],0.850475770765913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BLVRB,Flavin reductase,7592,208,0.80 [0.66-0.97],0.0262820311497706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP10,Bone morphogenetic protein 10,6435,173,1.59 [0.96-2.64],0.0695401362983278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP4,Bone morphogenetic protein 4,7488,206,0.84 [0.64-1.11],0.2148648851866467
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMP6,Bone morphogenetic protein 6,7445,202,0.83 [0.60-1.15],0.2632217747732328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BMPER,BMP-binding endothelial regulator protein,6435,173,1.34 [0.74-2.43],0.3307798257138787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,6580,177,1.32 [0.89-1.96],0.1691897166381092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,6368,169,0.79 [0.54-1.14],0.2078598785580722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOC,Brother of CDO,7455,202,1.39 [0.81-2.38],0.2371767679472315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA1,BolA-like protein 1,6400,169,1.00 [0.76-1.33],0.974153480631267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BOLA2_BOLA2B,BolA-like protein 2,6393,171,0.72 [0.54-0.95],0.0219910163607427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFA2,BPI fold-containing family A member 2,6179,167,0.93 [0.81-1.08],0.3369469857432342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB1,BPI fold-containing family B member 1,7580,205,1.01 [0.83-1.22],0.9454120616291204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BPIFB2,BPI fold-containing family B member 2,6565,176,1.29 [1.04-1.60],0.0209335595542694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRAP,BRCA1-associated protein,6495,175,0.95 [0.83-1.08],0.4284294977520911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD1,Bromodomain-containing protein 1,6448,175,1.18 [0.74-1.88],0.4867854282062069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD2,Bromodomain-containing protein 2,6400,169,1.16 [0.79-1.71],0.449381485693718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRD3,Bromodomain-containing protein 3,6354,169,0.91 [0.65-1.25],0.5499551902183212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRDT,Bromodomain testis-specific protein,6354,169,0.94 [0.63-1.41],0.773153640355942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRK1,Protein BRICK1,7422,204,1.35 [1.03-1.76],0.0307314444912338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRME1,Break repair meiotic recombinase recruitment factor 1,6400,169,1.48 [1.11-1.97],0.0082610748402921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BRSK2,Serine/threonine-protein kinase BRSK2,6571,175,1.25 [0.85-1.84],0.2524552655229933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSG,Basigin,7648,209,0.96 [0.53-1.73],0.8906899591224792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BSND,Barttin,6350,168,0.82 [0.50-1.32],0.4088450886427975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,7641,209,1.26 [0.93-1.72],0.1345949930435192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BST2,Bone marrow stromal antigen 2,7641,209,1.08 [0.84-1.39],0.5408664894567492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTC,Probetacellulin,7437,205,0.94 [0.79-1.12],0.4932134617020518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTD,Biotinidase,6589,178,0.95 [0.47-1.92],0.8843126235793279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTLA,B- and T-lymphocyte attenuator,6350,168,0.97 [0.82-1.16],0.7656919071830923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN1A1,Butyrophilin subfamily 1 member A1,6539,173,1.28 [0.94-1.75],0.1197595841832643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN2A1,Butyrophilin subfamily 2 member A1,7605,207,1.74 [1.13-2.67],0.0110904236377145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTN3A2,Butyrophilin subfamily 3 member A2,7573,209,1.06 [0.76-1.46],0.7409915525415443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",BTNL10,Butyrophilin-like protein 10,6350,168,0.97 [0.67-1.40],0.8648285494710798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C19orf12,Protein C19orf12,7422,204,1.01 [0.83-1.23],0.9047995694977896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1GALT1C1,C1GALT1-specific chaperone 1,6354,169,1.10 [0.70-1.72],0.6763989902289639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QA,Complement C1q subcomponent subunit A,7624,208,0.79 [0.45-1.38],0.4049446836457823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",6571,175,0.94 [0.75-1.18],0.6059656376683306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QL2,Complement C1q-like protein 2,6368,169,1.04 [0.73-1.49],0.8363208391554341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,7623,207,1.13 [0.86-1.50],0.3788958214570178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,6435,173,0.85 [0.56-1.27],0.4242349308269899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,6571,175,1.31 [0.88-1.93],0.182380866194148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,6424,172,0.95 [0.70-1.28],0.7157560242108477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1R,Complement C1r subcomponent,6589,178,1.92 [0.94-3.91],0.0732786043360427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1RL,Complement C1r subcomponent-like protein,6570,178,3.31 [1.54-7.09],0.0021268666637231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C1S,Complement C1s subcomponent,6589,178,2.69 [1.46-4.95],0.0015213251378514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2,Complement C2,7611,206,2.96 [1.55-5.64],0.0009882486961724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2CD2L,Phospholipid transfer protein C2CD2L,7412,204,1.39 [1.09-1.79],0.0090362136530653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C2orf69,UPF0565 protein C2orf69,6413,172,0.94 [0.72-1.23],0.6685334684652025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C3,Complement C3,6230,167,1.07 [0.77-1.48],0.6932996619408018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C4BPB,C4b-binding protein beta chain,7608,208,1.63 [1.20-2.23],0.0019496528428073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C5,Complement C5,6589,178,1.49 [0.56-3.97],0.4297551310170223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7,Complement component C7,6419,172,0.89 [0.56-1.39],0.5968898739077881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C7orf50,Uncharacterized protein C7orf50,6567,172,1.28 [0.76-2.16],0.3476841453002963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C8B,Complement component C8 beta chain,6589,178,1.38 [0.86-2.23],0.1822929287579191
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9,Complement component C9,6592,177,0.96 [0.74-1.24],0.7654668236158075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",C9orf40,Uncharacterized protein C9orf40,6553,176,0.82 [0.68-0.98],0.0326189341014262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA1,Carbonic anhydrase 1,7442,202,0.72 [0.58-0.90],0.0036040795767327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA11,Carbonic anhydrase-related protein 11,7437,205,1.09 [0.73-1.62],0.6789377956218805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA12,Carbonic anhydrase 12,7543,206,1.47 [1.03-2.11],0.0345492102264934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA13,Carbonic anhydrase 13,7479,204,0.97 [0.86-1.09],0.5749765520734025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA14,Carbonic anhydrase 14,7659,207,0.96 [0.68-1.34],0.7979093337709829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA2,Carbonic anhydrase 2,7563,208,0.78 [0.64-0.94],0.0077361786278428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA3,Carbonic anhydrase 3,7673,210,0.73 [0.58-0.90],0.0041072563598798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA4,Carbonic anhydrase 4,7681,210,1.02 [0.63-1.67],0.9285354168438328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA5A,"Carbonic anhydrase 5A, mitochondrial",7455,202,0.97 [0.84-1.12],0.6598428493075511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA6,Carbonic anhydrase 6,7572,208,0.75 [0.61-0.91],0.0035951086782288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA7,Carbonic anhydrase 7,6448,175,0.95 [0.61-1.49],0.8380159614903855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA8,Carbonic anhydrase-related protein,6368,169,0.92 [0.49-1.71],0.780312427948599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CA9,Carbonic anhydrase 9,7659,207,1.06 [0.83-1.36],0.6344795281773052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CABP2,Calcium-binding protein 2,6413,172,1.12 [0.91-1.39],0.2811905996682674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,6400,169,0.91 [0.56-1.47],0.694897423938545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,6354,169,1.04 [0.80-1.34],0.7861021073777911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,6400,169,1.17 [0.93-1.47],0.1841694215999061
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,6571,175,0.95 [0.79-1.13],0.5548445809784002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CACYBP,Calcyclin-binding protein,6425,173,1.01 [0.87-1.17],0.8812849090884514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CADPS,Calcium-dependent secretion activator 1,6413,172,1.43 [1.07-1.92],0.0152756029327924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB1,Calbindin,7543,206,1.15 [0.88-1.51],0.2970720553178281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALB2,Calretinin,7422,204,1.44 [0.96-2.14],0.0750539237020345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCA,Calcitonin,7493,207,0.91 [0.76-1.10],0.3466737332929136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCB,Calcitonin gene-related peptide 2,6567,172,1.05 [0.74-1.50],0.7667462638056732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,7634,207,0.91 [0.81-1.03],0.1505825138156006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,6393,171,0.95 [0.77-1.16],0.5891452509121232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CALY,Neuron-specific vesicular protein calcyon,6354,169,1.17 [0.82-1.66],0.3861423753791098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,7437,205,0.95 [0.71-1.27],0.7343949303015103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMLG,Guided entry of tail-anchored proteins factor CAMLG,6413,172,1.03 [0.78-1.36],0.8107073126154662
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,6571,175,0.95 [0.82-1.09],0.4461437676451356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CANT1,Soluble calcium-activated nucleotidase 1,7545,206,2.06 [1.12-3.78],0.0198898779932404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPG,Macrophage-capping protein,7533,203,1.18 [0.95-1.46],0.1284228176788048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPN3,Calpain-3,6554,173,1.06 [0.71-1.59],0.7792664014563755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAPS,Calcyphosin,6567,172,0.99 [0.85-1.14],0.8778526404609341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CARHSP1,Calcium-regulated heat-stable protein 1,7422,204,0.70 [0.54-0.91],0.0069775602963217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASC3,Protein CASC3,6413,172,1.00 [0.70-1.43],0.9956628489450232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP1,Caspase-1,7422,204,1.23 [1.05-1.44],0.0105560905572167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP10,Caspase-10,7422,204,1.00 [0.84-1.19],0.99836596477475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP2,Caspase-2,7573,209,0.91 [0.76-1.10],0.332257112606704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP3,Caspase-3,7681,210,0.94 [0.82-1.08],0.3872725980309797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP4,Caspase-4,6448,175,0.93 [0.85-1.03],0.1663806042933543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP7,Caspase-7,6567,172,1.01 [0.85-1.21],0.9103833948819822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP8,Caspase-8,7636,207,0.92 [0.75-1.13],0.4219508119055652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASP9,Caspase-9,6368,169,0.86 [0.67-1.11],0.2383617283476854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CASQ2,Calsequestrin-2,6354,169,1.06 [0.79-1.42],0.6890704467778355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CAT,Catalase,6498,176,0.72 [0.54-0.96],0.0244194223402713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLIF,Cobalamin binding intrinsic factor,7561,206,1.05 [0.90-1.22],0.5283442460326209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN1,Cerebellin-1,6400,169,1.03 [0.88-1.21],0.67726223701737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBLN4,Cerebellin-4,7659,207,1.29 [0.91-1.83],0.1539794457022917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBS,Cystathionine beta-synthase,6393,171,1.14 [0.86-1.51],0.3558587583171876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CBX2,Chromobox protein homolog 2,6354,169,0.95 [0.63-1.41],0.7837047917051954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CC2D1A,Coiled-coil and C2 domain-containing protein 1A,7503,207,0.87 [0.72-1.04],0.1166672672307656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCAR2,Cell cycle and apoptosis regulator protein 2,6567,172,1.22 [0.99-1.51],0.0612512261815509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC134,Coiled-coil domain-containing protein 134,6554,173,1.09 [0.80-1.48],0.5895259637143618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC28A,Coiled-coil domain-containing protein 28A,6413,172,1.03 [0.63-1.70],0.9005696623439021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC50,Coiled-coil domain-containing protein 50,6571,175,0.88 [0.71-1.09],0.2347975208694676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCDC80,Coiled-coil domain-containing protein 80,7572,207,1.10 [0.79-1.52],0.5798616165511956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCER2,Coiled-coil domain-containing glutamate-rich protein 2,6393,171,1.01 [0.79-1.28],0.9634866166348546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL11,Eotaxin,7660,209,1.23 [0.88-1.71],0.2271012602301909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL13,C-C motif chemokine 13,7652,209,0.92 [0.77-1.10],0.3784994057142561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL14,C-C motif chemokine 14,7578,204,1.71 [1.32-2.22],5.113526388529831e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL15,C-C motif chemokine 15,7681,210,1.18 [0.90-1.54],0.2382035696492753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL16,C-C motif chemokine 16,7681,210,1.07 [0.84-1.35],0.6022872626528541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL17,C-C motif chemokine 17,7564,207,1.13 [0.99-1.28],0.0807093478122775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL18,C-C motif chemokine 18,7488,201,1.18 [1.00-1.38],0.0473229082274526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL19,C-C motif chemokine 19,7641,209,1.03 [0.93-1.13],0.5849439155068774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL2,C-C motif chemokine 2,7488,206,1.01 [0.79-1.28],0.94981901052147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL20,C-C motif chemokine 20,7660,209,1.06 [0.93-1.21],0.388872320923066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL21,C-C motif chemokine 21,7605,207,1.24 [0.92-1.67],0.1544807822983778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL22,C-C motif chemokine 22,7506,207,1.35 [1.08-1.69],0.0089227820667788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL23,C-C motif chemokine 23,7605,207,1.38 [1.02-1.85],0.033921176464377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL24,C-C motif chemokine 24,7598,207,1.08 [0.93-1.26],0.2986667615026154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL25,C-C motif chemokine 25,7660,209,1.14 [0.89-1.47],0.3023110657569486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL26,C-C motif chemokine 26,7573,209,1.08 [0.96-1.22],0.1929665835944275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL27,C-C motif chemokine 27,7572,207,0.97 [0.79-1.19],0.7513002365703642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL28,C-C motif chemokine 28,7543,209,1.20 [0.99-1.47],0.0665757771695149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,7573,209,1.18 [0.98-1.42],0.0861386242696632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL4,C-C motif chemokine 4,7585,207,0.87 [0.70-1.08],0.2150433635018701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL5,C-C motif chemokine 5,7623,207,1.08 [0.95-1.22],0.2261004690949576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL7,C-C motif chemokine 7,7573,209,1.07 [0.87-1.32],0.5251653369372515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCL8,C-C motif chemokine 8,7648,207,1.00 [0.82-1.23],0.9779890101804032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN1,CCN family member 1,7532,206,1.05 [0.88-1.25],0.5730897804794298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN2,CCN family member 2,7575,206,0.89 [0.71-1.12],0.3165011328655368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN3,CCN family member 3,7668,210,1.99 [1.45-2.73],2.231531368066802e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN4,CCN family member 4,7659,207,1.20 [0.88-1.65],0.2462376434639552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCN5,CCN family member 5,7592,208,0.84 [0.61-1.17],0.3124690524281679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCND2,G1/S-specific cyclin-D2,6448,175,1.02 [0.68-1.54],0.9169041921266504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCNE1,G1/S-specific cyclin-E1,6368,169,0.88 [0.72-1.09],0.2418112065525672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCS,Copper chaperone for superoxide dismutase,7503,207,0.84 [0.64-1.10],0.2008605637435241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CCT5,T-complex protein 1 subunit epsilon,7437,205,0.84 [0.63-1.13],0.2466225987320222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD101,Immunoglobulin superfamily member 2,6553,176,1.07 [0.77-1.48],0.6978878325432856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD109,CD109 antigen,7592,208,1.05 [0.72-1.52],0.8156207778794056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD14,Monocyte differentiation antigen CD14,7452,202,1.61 [1.20-2.17],0.0014894631396938
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD160,CD160 antigen,7660,209,1.33 [1.04-1.70],0.0248679170854169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD163,Scavenger receptor cysteine-rich type 1 protein M130,7623,207,1.40 [1.06-1.84],0.0184727823250816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164,Sialomucin core protein 24,7592,208,1.37 [0.94-2.00],0.1017130503975636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD164L2,CD164 sialomucin-like 2 protein,6413,172,1.05 [0.70-1.57],0.8060864288659124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD177,CD177 antigen,7575,208,1.02 [0.93-1.12],0.6397640439438117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD1C,T-cell surface glycoprotein CD1c,7608,208,2.43 [1.46-4.05],0.0006449196352834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2,T-cell surface antigen CD2,6354,169,1.06 [0.75-1.52],0.7266379590358104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200,OX-2 membrane glycoprotein,7573,209,1.10 [0.69-1.74],0.6980539518632958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD200R1,Cell surface glycoprotein CD200 receptor 1,7551,209,1.56 [1.12-2.18],0.0085223995545319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD207,C-type lectin domain family 4 member K,7403,203,1.26 [0.92-1.74],0.1476851636691217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD209,CD209 antigen,7611,207,0.87 [0.63-1.21],0.4200519373608369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,7660,209,1.28 [0.97-1.69],0.0833931538109229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD226,CD226 antigen,6368,169,1.30 [0.91-1.85],0.1525232083606373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD244,Natural killer cell receptor 2B4,7660,209,1.63 [1.07-2.49],0.0243565347194647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD248,Endosialin,6573,174,0.84 [0.59-1.21],0.358884127964401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,7608,208,1.22 [0.91-1.62],0.1790274143406701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD274,Programmed cell death 1 ligand 1,7503,207,1.19 [0.83-1.70],0.3392332412288437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD276,CD276 antigen,7573,207,1.32 [0.94-1.87],0.1099721230887752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,7437,205,1.42 [1.05-1.92],0.0243374051967145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD2AP,CD2-associated protein,7572,207,0.88 [0.72-1.08],0.2326642195194456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300A,CMRF35-like molecule 8,6435,173,1.20 [0.75-1.91],0.4562826316877197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300C,CMRF35-like molecule 6,7641,209,1.27 [0.90-1.78],0.1743175612032387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300E,CMRF35-like molecule 2,7635,206,1.38 [1.04-1.82],0.0243956745447282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LF,CMRF35-like molecule 1,7659,207,1.42 [1.13-1.77],0.0022465117465278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD300LG,CMRF35-like molecule 9,7592,208,1.10 [0.80-1.52],0.5651220827265413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD302,CD302 antigen,7543,206,1.46 [1.01-2.12],0.0460449385187964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD33,Myeloid cell surface antigen CD33,7608,208,1.15 [0.98-1.36],0.0853185705799423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD34,Hematopoietic progenitor cell antigen CD34,7618,209,1.65 [1.00-2.73],0.0516377773597612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD36,Platelet glycoprotein 4,6368,169,1.12 [0.81-1.55],0.5055202317623756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,7543,206,0.87 [0.60-1.27],0.4757488915760663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3D,T-cell surface glycoprotein CD3 delta chain,6400,169,0.92 [0.58-1.46],0.7342293498094996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3E,T-cell surface glycoprotein CD3 epsilon chain,6448,175,0.91 [0.59-1.41],0.676722504999159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD3G,T-cell surface glycoprotein CD3 gamma chain,6368,169,1.04 [0.88-1.23],0.6431500975457682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD4,T-cell surface glycoprotein CD4,7561,209,1.02 [0.68-1.54],0.9053186066239212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40,Tumor necrosis factor receptor superfamily member 5,7578,207,1.09 [0.85-1.40],0.493134722174733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD40LG,CD40 ligand,7660,209,0.97 [0.83-1.13],0.6861447009288659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD46,Membrane cofactor protein,7555,204,1.62 [1.07-2.43],0.0213140375971251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD48,CD48 antigen,7598,207,1.58 [1.06-2.37],0.0258610924894513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,7648,207,1.33 [0.93-1.90],0.1189219183085772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD55,Complement decay-accelerating factor,7327,203,1.28 [0.82-2.01],0.2753986293983532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD58,Lymphocyte function-associated antigen 3,7562,207,2.07 [1.03-4.19],0.0424420743001363
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD59,CD59 glycoprotein,7337,203,1.08 [0.64-1.81],0.7777424014245646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD5L,CD5 antigen-like,6564,178,1.13 [0.83-1.53],0.4338664143885266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD6,T-cell differentiation antigen CD6,7648,209,1.11 [0.87-1.41],0.40307124013757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD63,CD63 antigen,7488,206,1.05 [0.82-1.34],0.7236132555673034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD69,Early activation antigen CD69,7542,207,1.00 [0.87-1.15],0.9894396900337066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD7,T-cell antigen CD7,6354,168,1.08 [0.77-1.51],0.6657278989331391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,7573,209,0.87 [0.65-1.16],0.344549781763669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,6435,173,1.21 [0.85-1.71],0.2858188371562943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,7641,209,1.24 [0.87-1.77],0.2296537834277519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,7660,209,1.29 [0.99-1.68],0.0621382108125214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,6580,177,1.76 [1.18-2.63],0.0056749517556801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD82,CD82 antigen,6448,175,1.20 [0.87-1.65],0.2647907359546531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,7573,209,1.49 [1.05-2.10],0.0253912116581291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD84,SLAM family member 5,7573,209,0.86 [0.58-1.26],0.4374790626732809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD86,T-lymphocyte activation antigen CD86,6553,176,1.92 [1.21-3.06],0.0059352070299022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD8A,T-cell surface glycoprotein CD8 alpha chain,7641,209,1.33 [1.06-1.66],0.0134635373283349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD93,Complement component C1q receptor,7324,197,1.67 [1.13-2.45],0.0092456249539842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99,CD99 antigen,7592,208,1.39 [0.75-2.56],0.2949855662656796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CD99L2,CD99 antigen-like protein 2,7592,208,1.30 [0.79-2.14],0.2971068072388764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDA,Cytidine deaminase,6572,177,1.22 [0.91-1.64],0.1898989711323014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDAN1,Codanin-1,6567,172,1.12 [0.59-2.12],0.7320297405028442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC123,Cell division cycle protein 123 homolog,6350,168,0.87 [0.66-1.14],0.3023867996813213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC25A,M-phase inducer phosphatase 1,6350,168,0.78 [0.51-1.20],0.2562816368450106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC26,Anaphase-promoting complex subunit CDC26,6537,176,0.91 [0.73-1.13],0.4089670472795528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC27,Cell division cycle protein 27 homolog,7437,205,1.00 [0.81-1.23],0.9655762131553836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC37,Hsp90 co-chaperone Cdc37,7608,208,0.94 [0.81-1.10],0.4444307050041403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDC42BPB,Serine/threonine-protein kinase MRCK beta,6553,176,0.91 [0.78-1.05],0.1940521415318598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDCP1,CUB domain-containing protein 1,7503,207,1.21 [0.98-1.49],0.075518126756819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH1,Cadherin-1,7335,201,1.54 [1.19-2.00],0.0012035327119401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH15,Cadherin-15,7631,209,0.94 [0.79-1.12],0.4747165767575144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH17,Cadherin-17,7572,207,1.13 [0.95-1.34],0.162184976247013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH2,Cadherin-2,7572,207,1.21 [0.85-1.71],0.2889517502526414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH22,Cadherin-22,6448,175,0.72 [0.41-1.26],0.2521178172448618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH23,Cadherin-23,6567,172,1.22 [0.71-2.12],0.4719755233678817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH3,Cadherin-3,7641,209,1.34 [0.97-1.85],0.079159397905455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH4,Cadherin-4,6400,169,0.93 [0.67-1.31],0.6905927657122367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH5,Cadherin-5,7681,210,1.43 [0.96-2.14],0.0774217555755044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDH6,Cadherin-6,7572,207,1.29 [0.94-1.76],0.1124804727811391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR1,Cadherin-related family member 1,7422,204,1.11 [0.83-1.48],0.4767006866360236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR2,Cadherin-related family member 2,7543,206,0.93 [0.76-1.13],0.4405310309866739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDHR5,Cadherin-related family member 5,7572,207,1.55 [1.11-2.18],0.0103486582248658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK1,Cyclin-dependent kinase 1,6350,168,0.72 [0.48-1.08],0.1135802432537039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDK5RAP3,CDK5 regulatory subunit-associated protein 3,6571,175,0.95 [0.74-1.23],0.7175971260261433
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKL5,Cyclin-dependent kinase-like 5,6400,169,1.10 [0.83-1.45],0.5028534078741098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN1A,Cyclin-dependent kinase inhibitor 1,7543,206,0.93 [0.82-1.04],0.2075781012246603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDKN2D,Cyclin-dependent kinase 4 inhibitor D,7543,206,0.97 [0.85-1.11],0.6892044557812831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDNF,Cerebral dopamine neurotrophic factor,7543,206,1.08 [0.74-1.56],0.6960483630558373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDON,Cell adhesion molecule-related/down-regulated by oncogenes,7584,207,1.22 [0.75-1.99],0.4160831594987797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CDSN,Corneodesmosin,7646,209,0.94 [0.71-1.25],0.6749683399538589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,7595,206,0.86 [0.48-1.53],0.6144703022567608
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,6553,176,1.16 [0.96-1.39],0.1218316313400501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,6448,175,1.15 [0.97-1.38],0.1103540477139789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,6553,176,0.64 [0.45-0.92],0.0146549089409311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,6448,175,0.98 [0.70-1.37],0.913487341089166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,7573,209,0.88 [0.75-1.02],0.0843246682077783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,7437,205,1.00 [0.76-1.32],0.9850019158847696
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,7350,204,1.19 [0.98-1.44],0.0817300394672875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,6573,174,1.01 [0.71-1.43],0.9691238169438234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,7455,202,1.16 [0.90-1.49],0.2502205017893484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPA,CCAAT/enhancer-binding protein alpha,6368,169,0.95 [0.60-1.49],0.8232123322425565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEBPB,CCAAT/enhancer-binding protein beta,7455,202,1.17 [0.85-1.61],0.3377592665292824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA2A,Chymotrypsin-like elastase family member 2A,6573,174,1.04 [0.83-1.31],0.7124106788882343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELA3A,Chymotrypsin-like elastase family member 3A,7672,209,1.09 [0.90-1.34],0.3716628300942308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,6435,173,1.05 [0.64-1.73],0.8392162972996677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEMIP2,Cell surface hyaluronidase,6368,169,1.38 [0.89-2.15],0.1540890058503603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEND1,Cell cycle exit and neuronal differentiation protein 1,6400,169,1.14 [0.92-1.41],0.23218816005692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPF,Centromere protein F,6448,175,0.93 [0.71-1.23],0.6118052177362598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CENPJ,Centromere protein J,6448,175,0.90 [0.72-1.12],0.3356540654350558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP112,Centrosomal protein of 112 kDa,6354,169,1.01 [0.74-1.39],0.9425569764602264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP152,Centrosomal protein of 152 kDa,6350,168,0.89 [0.61-1.29],0.53263107393491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP164,Centrosomal protein of 164 kDa,7455,203,1.06 [0.87-1.29],0.5650127474828064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP170,Centrosomal protein of 170 kDa,6393,171,0.99 [0.81-1.22],0.959965389685702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP20,Centrosomal protein 20,7437,205,1.10 [0.93-1.29],0.2795214192645624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP290,Centrosomal protein of 290 kDa,6448,175,0.89 [0.66-1.19],0.4168733030983623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP350,Centrosome-associated protein 350,6350,168,1.19 [0.81-1.73],0.3766484527223619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP43,Centrosomal protein 43,7397,199,0.98 [0.81-1.18],0.8176685583515315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CEP85,Centrosomal protein of 85 kDa,7437,205,0.99 [0.81-1.21],0.941215995259409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CERT,Ceramide transfer protein,7422,204,1.03 [0.84-1.27],0.7584899205567203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES1,Liver carboxylesterase 1,7611,208,1.04 [0.90-1.21],0.5742548030472315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES2,Cocaine esterase,7543,206,0.97 [0.78-1.22],0.8108459136037949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CES3,Carboxylesterase 3,7543,206,0.93 [0.77-1.12],0.4232632471777565
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN2,Centrin-2,7422,204,1.01 [0.84-1.22],0.931538106687622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CETN3,Centrin-3,6553,176,0.96 [0.79-1.16],0.674232413473073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFB,Complement factor B,6476,173,1.75 [1.11-2.76],0.0159980752149779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFC1,Cryptic protein,7437,205,1.01 [0.77-1.33],0.9368070379555896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFD,Complement factor D,6589,178,0.82 [0.41-1.63],0.5667103033854164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFH,Complement factor H,6209,161,2.19 [1.14-4.21],0.0192831964278576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR2,Complement factor H-related protein 2,6545,177,1.32 [1.00-1.75],0.0518490390497823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR4,Complement factor H-related protein 4,6576,177,1.31 [1.06-1.63],0.0128799000290872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFHR5,Complement factor H-related protein 5,6511,175,1.15 [0.80-1.64],0.4425471794802734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFI,Complement factor I,6589,178,2.93 [1.39-6.17],0.0047786972742295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CFP,Properdin,6589,178,2.07 [1.33-3.22],0.001169855143107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGA,Glycoprotein hormones alpha chain,7592,208,1.43 [1.21-1.69],3.181375334169737e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,6592,177,1.21 [0.81-1.80],0.3616563229344873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGN,Cingulin,6413,172,1.47 [1.07-2.03],0.0188327316975521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CGREF1,Cell growth regulator with EF hand domain protein 1,7572,207,1.14 [0.86-1.52],0.3666498928441933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,7437,205,0.79 [0.63-0.99],0.0434324292472418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHAD,Chondroadherin,6435,173,1.12 [0.82-1.53],0.4591343930223469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",6567,172,1.18 [0.85-1.64],0.3279581614274479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHCHD6,MICOS complex subunit MIC25,6554,173,1.38 [0.87-2.18],0.1664508972848107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHEK2,Serine/threonine-protein kinase Chk2,7455,202,1.00 [0.68-1.47],0.989237632556195
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGA,Chromogranin-A,6573,174,1.14 [0.99-1.31],0.073999597411872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHGB,Secretogranin-1,7622,209,1.22 [0.92-1.62],0.1693153492658382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHI3L1,Chitinase-3-like protein 1,7438,203,1.02 [0.88-1.18],0.7895247753812143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHIT1,Chitotriosidase-1,7628,208,1.03 [0.95-1.11],0.4985222338618871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHL1,Neural cell adhesion molecule L1-like protein,7611,204,1.45 [0.97-2.16],0.0688988642793187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHM,Rab proteins geranylgeranyltransferase component A 1,6413,172,0.88 [0.68-1.14],0.3422909539020051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP1A,Charged multivesicular body protein 1a,7503,207,1.02 [0.87-1.20],0.7842738151235147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHMP6,Charged multivesicular body protein 6,6580,177,1.06 [0.82-1.37],0.6380858929484273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHP1,Calcineurin B homologous protein 1,6400,169,1.07 [0.88-1.30],0.5000459583035517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL1,Chordin-like protein 1,7598,207,1.36 [0.94-1.97],0.1072696578302307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRDL2,Chordin-like protein 2,7572,207,0.77 [0.58-1.01],0.0548034057570982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CHRM1,Muscarinic acetylcholine receptor M1,6413,172,1.25 [0.87-1.81],0.23142072353161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIAPIN1,Anamorsin,7608,208,0.89 [0.73-1.10],0.2826677366248921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CILP,Cartilage intermediate layer protein 1,6573,174,1.01 [0.78-1.32],0.919822323197843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CINP,Cyclin-dependent kinase 2-interacting protein,6448,175,1.01 [0.72-1.41],0.9581329663095364
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIRBP,Cold-inducible RNA-binding protein,6553,176,1.01 [0.86-1.17],0.9448697166009694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CIT,Citron Rho-interacting kinase,6413,172,1.03 [0.75-1.40],0.8659909236740126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKAP4,Cytoskeleton-associated protein 4,7628,209,1.29 [0.87-1.91],0.2036004713051532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKB,Creatine kinase B-type,6573,174,0.76 [0.58-0.98],0.0348966030585679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",7556,207,0.96 [0.80-1.16],0.6863065760391879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLASP1,CLIP-associating protein 1,6350,168,0.87 [0.70-1.08],0.204145669018933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLC,Galectin-10,7559,206,1.07 [0.89-1.29],0.4494104506403706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC10A,C-type lectin domain family 10 member A,7503,207,1.16 [0.82-1.65],0.3877633079115998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC11A,C-type lectin domain family 11 member A,7582,208,1.06 [0.82-1.38],0.6301077427398991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC12A,C-type lectin domain family 12 member A,6368,169,1.62 [0.78-3.35],0.1937148831072941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC14A,C-type lectin domain family 14 member A,7592,208,1.31 [0.91-1.89],0.1399504805394956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1A,C-type lectin domain family 1 member A,7455,202,1.53 [1.08-2.17],0.0171823643347117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC1B,C-type lectin domain family 1 member B,7641,209,1.04 [0.91-1.18],0.5499278631864903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC2L,C-type lectin domain family 2 member L,6413,172,1.19 [0.93-1.52],0.177817961794672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC3B,Tetranectin,6433,172,1.18 [0.60-2.34],0.6260150149487594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4A,C-type lectin domain family 4 member A,7573,209,0.91 [0.64-1.29],0.5955724847788393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4C,C-type lectin domain family 4 member C,7573,209,1.12 [0.87-1.45],0.3779995879748817
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4D,C-type lectin domain family 4 member D,7573,209,1.00 [0.81-1.22],0.964623607802068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4G,C-type lectin domain family 4 member G,7573,209,1.61 [1.11-2.32],0.0118612881000669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC4M,C-type lectin domain family 4 member M,6559,173,0.85 [0.62-1.15],0.2818123105660894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC5A,C-type lectin domain family 5 member A,7552,207,1.26 [0.85-1.88],0.2491268380662666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC6A,C-type lectin domain family 6 member A,7437,205,1.19 [0.91-1.55],0.2003368699171174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLEC7A,C-type lectin domain family 7 member A,7660,209,1.00 [0.82-1.21],0.9689168343287232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLGN,Calmegin,6413,172,1.61 [1.25-2.08],0.0002498472460435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIC5,Chloride intracellular channel protein 5,6413,172,0.92 [0.56-1.50],0.7350192776843741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLINT1,Clathrin interactor 1,6350,168,0.90 [0.63-1.27],0.538205614540796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLIP2,CAP-Gly domain-containing linker protein 2,7573,209,0.98 [0.88-1.10],0.7566545589879845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLMP,CXADR-like membrane protein,7659,207,1.89 [1.12-3.19],0.0165336730372722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLNS1A,Methylosome subunit pICln,6413,172,0.53 [0.33-0.85],0.0082994004409686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",7493,207,1.03 [0.90-1.17],0.7004370637301556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLPS,Colipase,7571,208,1.11 [0.94-1.31],0.2312148354432492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSPN,Claspin,7412,204,0.86 [0.59-1.27],0.4565207440204648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN1,Calsyntenin-1,7422,204,1.13 [0.91-1.41],0.274524691380999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN2,Calsyntenin-2,7660,209,0.67 [0.48-0.94],0.0213002338474897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLSTN3,Calsyntenin-3,6567,172,1.46 [0.93-2.29],0.1044387617194057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLTA,Clathrin light chain A,7455,202,0.99 [0.75-1.31],0.9593682785359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLU,Clusterin,6589,178,1.11 [0.67-1.85],0.6933932303050667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CLUL1,Clusterin-like protein 1,7561,207,1.13 [0.85-1.50],0.3990763630933743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMC1,COX assembly mitochondrial protein homolog,6580,177,1.03 [0.87-1.21],0.7371557485009231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CMIP,C-Maf-inducing protein,6554,173,0.90 [0.75-1.08],0.2624434812604697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNDP1,Beta-Ala-His dipeptidase,7623,207,1.44 [1.08-1.92],0.0123785181945965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNGB3,Cyclic nucleotide-gated cation channel beta-3,6400,169,1.37 [1.11-1.67],0.0027348756358043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",6379,171,0.88 [0.72-1.07],0.190623568718229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY2,Protein canopy homolog 2,7455,202,1.01 [0.82-1.24],0.9058543337875528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNPY4,Protein canopy homolog 4,7543,206,0.95 [0.80-1.12],0.5177754416732794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNST,Consortin,7572,207,0.99 [0.89-1.12],0.9299511307314362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTF,Ciliary neurotrophic factor,6400,169,1.24 [0.81-1.89],0.3156445372159783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN1,Contactin-1,7681,210,0.88 [0.57-1.37],0.5826229176942812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN2,Contactin-2,7659,207,0.91 [0.69-1.20],0.5013277645925726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN3,Contactin-3,7592,208,1.07 [0.68-1.68],0.7570448218298826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN4,Contactin-4,7592,208,1.46 [0.87-2.44],0.1483010104288628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTN5,Contactin-5,7596,208,1.07 [0.76-1.49],0.7023826319886279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP2,Contactin-associated protein-like 2,7573,209,0.94 [0.70-1.27],0.7001332088219514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CNTNAP4,Contactin-associated protein-like 4,6413,172,1.06 [0.93-1.21],0.3778681745853387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COCH,Cochlin,6580,177,0.97 [0.71-1.32],0.8389730803346185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL15A1,Collagen alpha-1(XV) chain,6573,174,0.90 [0.53-1.54],0.7073588225936107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL18A1,Collagen alpha-1(XVIII) chain,7629,209,1.61 [0.98-2.65],0.0626797494493968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL1A1,Collagen alpha-1(I) chain,7681,210,1.75 [1.07-2.87],0.0263512441541509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL24A1,Collagen alpha-1(XXIV) chain,6553,176,1.22 [0.94-1.57],0.1408525008914699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL28A1,Collagen alpha-1(XXVIII) chain,6413,172,1.02 [0.85-1.23],0.8062243086004306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL2A1,Collagen alpha-1(II) chain,6393,171,0.88 [0.73-1.08],0.2186775296075098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL3A1,Collagen alpha-1(III) chain,6573,174,1.29 [0.69-2.42],0.4201075163708425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A1,Collagen alpha-1(IV) chain,7572,207,0.87 [0.63-1.20],0.4030668941768198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL4A4,Collagen alpha-4(IV) chain,6437,175,1.14 [0.86-1.52],0.3730881245102337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL5A1,Collagen alpha-1(V) chain,6435,173,1.17 [0.82-1.67],0.3831573473933258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL6A3,Collagen alpha-3(VI) chain,7681,210,1.41 [1.03-1.91],0.0294030609607996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A1,Collagen alpha-1(IX) chain,7573,209,1.13 [0.87-1.47],0.3481460087868324
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COL9A2,Collagen alpha-2(IX) chain,6448,175,0.54 [0.36-0.81],0.0034381544904638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COLEC12,Collectin-12,7573,207,1.67 [1.09-2.56],0.0188439734418619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD1,COMM domain-containing protein 1,6393,171,0.90 [0.70-1.17],0.4421398879197178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMMD9,COMM domain-containing protein 9,6554,173,0.75 [0.49-1.13],0.162714354760868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMP,Cartilage oligomeric matrix protein,7512,202,1.03 [0.71-1.51],0.8608068064365937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COMT,Catechol O-methyltransferase,7379,198,0.86 [0.73-1.00],0.0560386521629397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPB2,Coatomer subunit beta',6354,169,0.79 [0.55-1.13],0.1879773553513039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COPE,Coatomer subunit epsilon,7422,204,0.90 [0.68-1.19],0.4664406564671691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",6393,171,1.18 [0.85-1.62],0.3277395978493621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO1A,Coronin-1A,7430,200,1.01 [0.88-1.17],0.8819190815806675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CORO6,Coronin-6,6400,169,1.14 [0.77-1.69],0.506025723335334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",7543,206,1.03 [0.86-1.24],0.7130957793950558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",COX6B1,Cytochrome c oxidase subunit 6B1,6580,177,1.23 [0.80-1.90],0.3490237448143088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA1,Carboxypeptidase A1,7681,210,1.00 [0.83-1.20],0.962953693946623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA2,Carboxypeptidase A2,7623,208,1.13 [0.94-1.35],0.1914962602375439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPA4,Carboxypeptidase A4,6303,167,1.07 [0.75-1.53],0.6908322803651208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB1,Carboxypeptidase B,7681,210,1.01 [0.83-1.22],0.9318237314720164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPB2,Carboxypeptidase B2,6579,178,2.51 [1.32-4.77],0.0049656577684404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPE,Carboxypeptidase E,7587,205,0.90 [0.66-1.22],0.4868656025910274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPLX2,Complexin-2,6350,168,1.05 [0.66-1.66],0.8470667137462994
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPM,Carboxypeptidase M,7600,209,1.08 [0.75-1.55],0.6927478346153018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",6368,169,0.79 [0.44-1.39],0.4100720146977105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPPED1,Serine/threonine-protein phosphatase CPPED1,7641,209,0.88 [0.73-1.07],0.1955819653456522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPQ,Carboxypeptidase Q,6562,174,1.21 [0.80-1.84],0.3610632879548209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPTP,Ceramide-1-phosphate transfer protein,6354,169,0.73 [0.48-1.13],0.1575804459479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPVL,Probable serine carboxypeptidase CPVL,7647,207,1.33 [0.97-1.83],0.0735316119876504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM1,Probable carboxypeptidase X1,7608,208,1.02 [0.85-1.22],0.8169608414116434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CPXM2,Inactive carboxypeptidase-like protein X2,6580,177,1.85 [1.08-3.17],0.0242049456470442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR1,Complement receptor type 1,6570,177,1.54 [1.03-2.29],0.0332325847848271
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,7623,207,1.21 [0.94-1.57],0.1452409394223601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRACR2A,EF-hand calcium-binding domain-containing protein 4B,7437,205,0.99 [0.85-1.16],0.937972713166323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRADD,Death domain-containing protein CRADD,7493,207,0.90 [0.76-1.06],0.2126597253272656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREB3,Cyclic AMP-responsive element-binding protein 3,6350,168,0.96 [0.73-1.28],0.8025517180652673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREBZF,CREB/ATF bZIP transcription factor,6350,168,1.19 [0.68-2.10],0.5402060438456626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CREG1,Protein CREG1,7498,206,0.99 [0.73-1.34],0.9407122814884528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD1,Protein disulfide isomerase CRELD1,6435,173,0.82 [0.55-1.24],0.3505833379261625
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRELD2,Protein disulfide isomerase CRELD2,7598,207,1.17 [0.92-1.48],0.1928009894519582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRH,Corticoliberin,7426,203,0.91 [0.79-1.06],0.2428416657728445
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHBP,Corticotropin-releasing factor-binding protein,7573,207,2.34 [1.48-3.68],0.0002458028518511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRHR1,Corticotropin-releasing factor receptor 1,7455,202,1.13 [0.93-1.37],0.2202824871785531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIM1,Cysteine-rich motor neuron 1 protein,7605,207,1.21 [0.67-2.18],0.518245017076665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRIP2,Cysteine-rich protein 2,7503,207,1.09 [0.80-1.50],0.5764712710714968
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP2,Cysteine-rich secretory protein 2,7659,207,0.95 [0.76-1.20],0.6741077295607689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRISP3,Cysteine-rich secretory protein 3,6528,175,0.91 [0.53-1.56],0.7292647217613235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRKL,Crk-like protein,7587,207,0.94 [0.84-1.06],0.3228132812553252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRLF1,Cytokine receptor-like factor 1,7605,207,1.77 [1.08-2.92],0.0240266660902108
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRNN,Cornulin,7376,201,1.17 [0.98-1.40],0.0875397796831681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAC1,Cartilage acidic protein 1,7681,210,1.01 [0.68-1.50],0.9605298342691524
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,7503,207,1.06 [0.83-1.35],0.6667068854782501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRTAP,Cartilage-associated protein,6413,172,1.07 [0.81-1.42],0.6369153952127113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRX,Cone-rod homeobox protein,7455,202,0.98 [0.86-1.10],0.7059721299097264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB1,Beta-crystallin B1,6580,177,0.98 [0.77-1.23],0.8416475945753992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYBB2,Beta-crystallin B2,6567,172,0.89 [0.72-1.10],0.2861753567998663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYGD,Gamma-crystallin D,6567,172,0.95 [0.82-1.11],0.5341730891676654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYM,Ketimine reductase mu-crystallin,6400,169,0.95 [0.77-1.18],0.6616124393876581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CRYZL1,Quinone oxidoreductase-like protein 1,6393,171,0.90 [0.76-1.06],0.2160707892846267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSDE1,Cold shock domain-containing protein E1,6354,169,0.97 [0.85-1.10],0.6422411205651136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1,Macrophage colony-stimulating factor 1,7605,207,1.98 [1.28-3.05],0.0020154220557369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF1R,Macrophage colony-stimulating factor 1 receptor,6592,177,1.33 [0.95-1.87],0.0958128183032634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2,Granulocyte-macrophage colony-stimulating factor,6354,169,1.05 [0.70-1.57],0.8170561494530443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,7503,207,1.06 [0.87-1.30],0.5492756118604982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF2RB,Cytokine receptor common subunit beta,6368,169,1.06 [0.74-1.51],0.7456454610223611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3,Granulocyte colony-stimulating factor,7455,203,1.22 [0.95-1.57],0.117522392034298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSF3R,Granulocyte colony-stimulating factor receptor,6368,169,0.97 [0.57-1.64],0.9025889083620908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSH1,Chorionic somatomammotropin hormone 1,6592,177,1.01 [0.61-1.66],0.9833694550218568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK1D,Casein kinase I isoform delta,6368,169,0.99 [0.78-1.27],0.9482148400059692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSNK2A1,Casein kinase II subunit alpha,6571,175,0.74 [0.53-1.03],0.07645132711555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG4,Chondroitin sulfate proteoglycan 4,6573,174,0.83 [0.54-1.29],0.4168757239056929
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSPG5,Chondroitin sulfate proteoglycan 5,6400,169,0.91 [0.67-1.25],0.5764242387383585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSRP3,Cysteine and glycine-rich protein 3,6354,169,0.82 [0.69-0.98],0.0249770375689331
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST1,Cystatin-SN,5724,154,0.99 [0.85-1.15],0.8746925094406217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST3,Cystatin-C,7610,207,1.54 [1.04-2.28],0.032106999370549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST5,Cystatin-D,7419,205,1.04 [0.84-1.30],0.7169935393165919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST6,Cystatin-M,7385,206,0.64 [0.50-0.82],0.0003314262860652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CST7,Cystatin-F,7585,207,1.14 [1.01-1.27],0.0279671185917609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CSTB,Cystatin-B,7480,207,0.85 [0.64-1.15],0.2931046579623891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTAG1A_CTAG1B,Cancer/testis antigen 1,6441,175,1.23 [0.93-1.63],0.1461223598165581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTBS,Di-N-acetylchitobiase,6493,176,1.26 [0.72-2.22],0.4232203307484599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTF1,Cardiotrophin-1,7455,202,0.95 [0.82-1.11],0.5137976095728656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTHRC1,Collagen triple helix repeat-containing protein 1,6573,174,1.02 [0.62-1.68],0.9445857179752124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTLA4,Cytotoxic T-lymphocyte protein 4,6573,174,1.10 [0.71-1.72],0.6650027311965954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTNNA1,Catenin alpha-1,6400,169,0.94 [0.58-1.51],0.795927654761985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRB1,Chymotrypsinogen B,7592,208,0.96 [0.78-1.18],0.7000255690674868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRC,Chymotrypsin-C,7572,207,1.06 [0.88-1.27],0.5590158529057666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTRL,Chymotrypsin-like protease CTRL-1,6567,172,1.04 [0.84-1.27],0.7323237203953386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSB,Cathepsin B,7597,209,0.84 [0.66-1.06],0.1384487623400265
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSC,Dipeptidyl peptidase 1,7562,206,0.91 [0.68-1.21],0.5063200560768076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSD,Cathepsin D,7100,199,0.99 [0.73-1.35],0.9575488473756916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSE,Cathepsin E,6435,173,1.01 [0.76-1.34],0.930622561586814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSF,Cathepsin F,7608,208,1.27 [0.93-1.73],0.1398951496403156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSH,Pro-cathepsin H,7421,202,1.22 [1.03-1.44],0.0209612751899173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSL,Cathepsin L1,7572,207,1.63 [1.00-2.64],0.049468350401332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSO,Cathepsin O,7660,209,1.02 [0.68-1.53],0.9233882013718075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSS,Cathepsin S,5968,160,1.55 [0.82-2.95],0.1784378277659917
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSV,Cathepsin L2,7631,207,0.76 [0.56-1.04],0.0892680431713865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CTSZ,Cathepsin Z,7599,207,1.18 [0.80-1.73],0.4112642434162326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CUZD1,CUB and zona pellucida-like domain-containing protein 1,6413,172,0.85 [0.56-1.28],0.4396379856931628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CWC15,Spliceosome-associated protein CWC15 homolog,6515,176,0.98 [0.77-1.25],0.8807502532637617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CX3CL1,Fractalkine,7503,207,1.25 [0.87-1.80],0.2341309685104661
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXADR,Coxsackievirus and adenovirus receptor,7573,209,1.09 [0.84-1.41],0.530680132081041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL1,Growth-regulated alpha protein,7565,207,0.96 [0.84-1.09],0.5138795962574916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL10,C-X-C motif chemokine 10,7605,207,1.13 [0.94-1.36],0.1821464781752754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL11,C-X-C motif chemokine 11,7641,209,1.04 [0.89-1.21],0.6130327770769354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL12,Stromal cell-derived factor 1,7455,203,0.69 [0.50-0.96],0.0279904016633806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,7641,209,1.05 [0.86-1.28],0.6362210201087192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL14,C-X-C motif chemokine 14,7455,203,0.93 [0.74-1.19],0.5758302042390725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL16,C-X-C motif chemokine 16,7670,210,1.10 [0.66-1.86],0.7089744620057082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL17,C-X-C motif chemokine 17,7660,209,1.46 [1.11-1.92],0.0074965858199852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL3,C-X-C motif chemokine 3,7578,207,0.97 [0.86-1.11],0.6948579772935997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL5,C-X-C motif chemokine 5,7548,207,1.02 [0.92-1.14],0.6896885847667693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL6,C-X-C motif chemokine 6,7660,209,0.99 [0.84-1.17],0.895521198825901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL8,Interleukin-8,7552,203,1.09 [0.92-1.30],0.3126776649056358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,7605,207,1.08 [0.90-1.31],0.3938622029191774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5A,Cytochrome b5,6350,168,1.07 [0.87-1.30],0.5368434651337692
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYB5R2,NADH-cytochrome b5 reductase 2,6493,175,1.11 [0.85-1.44],0.4562934252613361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",6354,169,0.98 [0.83-1.17],0.8571403659787888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTH3,Cytohesin-3,6350,168,0.96 [0.78-1.19],0.7085340863955873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",CYTL1,Cytokine-like protein 1,6573,174,0.88 [0.50-1.57],0.6730153086728056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAAM1,Disheveled-associated activator of morphogenesis 1,6435,173,1.02 [0.85-1.23],0.805318107143208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAB2,Disabled homolog 2,7659,207,0.98 [0.88-1.09],0.7041701715951055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAG1,Dystroglycan,7605,207,0.99 [0.76-1.30],0.9617517317131404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAND5,DAN domain family member 5,6368,169,1.05 [0.81-1.37],0.712706842260382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPK2,Death-associated protein kinase 2,6368,169,1.06 [0.81-1.38],0.6887603220638585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,7573,209,0.96 [0.87-1.06],0.4085494807399308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DARS1,"Aspartate--tRNA ligase, cytoplasmic",7493,207,0.82 [0.69-0.97],0.0216058435266366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBH,Dopamine beta-hydroxylase,6584,177,1.01 [0.89-1.15],0.894052222343732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBI,Acyl-CoA-binding protein,7559,208,0.98 [0.83-1.15],0.7965893246606114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBN1,Drebrin,6368,169,0.98 [0.72-1.34],0.9176058244646312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DBNL,Drebrin-like protein,7605,207,0.95 [0.83-1.09],0.4922067584906497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",7608,208,1.06 [0.75-1.50],0.7387084671645048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCC,Netrin receptor DCC,6413,172,1.18 [0.62-2.22],0.6147513336343525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCDC2C,Doublecortin domain-containing protein 2C,6350,168,0.98 [0.77-1.25],0.864293443448567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCLRE1C,Protein artemis,6350,168,0.63 [0.38-1.05],0.078432387947289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCN,Decorin,7455,202,1.23 [0.73-2.06],0.4378049090831933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTD,Deoxycytidylate deaminase,6435,173,0.99 [0.84-1.16],0.874135053110306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN1,Dynactin subunit 1,7659,207,0.94 [0.77-1.14],0.5144746672610726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN2,Dynactin subunit 2,7543,206,0.93 [0.81-1.07],0.2874383965478584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTN6,Dynactin subunit 6,7422,204,1.08 [0.92-1.27],0.3272126386946253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCTPP1,dCTP pyrophosphatase 1,7572,207,1.13 [0.77-1.68],0.5279002865692162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D1,DCN1-like protein 1,6400,169,1.10 [0.92-1.32],0.3104958594083082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCUN1D2,DCN1-like protein 2,6350,168,1.11 [0.93-1.32],0.246239935163106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DCXR,L-xylulose reductase,7608,208,0.85 [0.67-1.09],0.1964615540383841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDA1,DET1- and DDB1-associated protein 1,6354,169,1.20 [0.83-1.74],0.341632831683798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",7543,206,1.19 [0.90-1.57],0.2211175112541137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDC,Aromatic-L-amino-acid decarboxylase,7561,206,1.04 [0.80-1.35],0.7736978947563294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDHD2,Phospholipase DDHD2,6571,175,0.87 [0.69-1.09],0.2359692226528522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDI2,Protein DDI1 homolog 2,6435,173,0.77 [0.63-0.93],0.0082480561201657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDR1,Epithelial discoidin domain-containing receptor 1,7641,209,1.25 [0.75-2.10],0.3962345449105832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDT,D-dopachrome decarboxylase,6573,174,0.73 [0.50-1.06],0.0951574665826103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX1,ATP-dependent RNA helicase DDX1,6553,176,0.86 [0.62-1.20],0.3895964384511796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX25,ATP-dependent RNA helicase DDX25,6413,172,1.09 [0.73-1.65],0.6686881276672852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX39A,ATP-dependent RNA helicase DDX39A,6368,169,1.48 [0.93-2.38],0.1001971530177915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX4,Probable ATP-dependent RNA helicase DDX4,6368,169,1.24 [0.97-1.57],0.0802619595419576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX53,Probable ATP-dependent RNA helicase DDX53,6413,172,0.95 [0.63-1.43],0.7967701295284634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DDX58,Antiviral innate immune response receptor RIG-I,7437,205,1.02 [0.82-1.28],0.8399476546407397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",7573,209,0.98 [0.86-1.12],0.7962225981135619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFA1_DEFA1B,Neutrophil defensin 1,7440,201,1.20 [0.97-1.49],0.0868159942909657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB103A_DEFB103B,Beta-defensin 103,6321,168,1.25 [0.94-1.67],0.1211536427602567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB104A_DEFB104B,Beta-defensin 104,6400,169,1.29 [1.01-1.65],0.0390683854736159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB116,Beta-defensin 116,6400,169,1.02 [0.82-1.25],0.8841469338668262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB118,Beta-defensin 118,6400,169,0.73 [0.51-1.04],0.0833019103061617
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DEFB4A_DEFB4B,Beta-defensin 4A,7473,203,0.96 [0.88-1.05],0.4084587464238466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENND2B,DENN domain-containing protein 2B,6354,169,1.10 [0.84-1.44],0.4899072813959124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DENR,Density-regulated protein,6368,169,0.96 [0.73-1.25],0.7417195742052436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DFFA,DNA fragmentation factor subunit alpha,7660,209,0.81 [0.67-0.99],0.0420869481009607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGCR6,Protein DGCR6,6400,169,1.12 [0.80-1.56],0.5219478006927339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKA,Diacylglycerol kinase alpha,6368,169,0.91 [0.68-1.21],0.5216876185764245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DGKZ,Diacylglycerol kinase zeta,7455,203,0.79 [0.55-1.14],0.2056624606830611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHODH,Dihydroorotate dehydrogenase,6354,169,1.05 [0.78-1.42],0.7537112389035414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHPS,Deoxyhypusine synthase,6554,173,0.97 [0.67-1.40],0.8793569970636884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,6567,172,1.07 [0.79-1.45],0.6782782718897129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIABLO,"Diablo homolog, mitochondrial",7552,207,1.01 [0.90-1.14],0.8195948277511155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK1C,Divergent protein kinase domain 1C,6413,172,0.96 [0.67-1.39],0.8379745898350044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DIPK2B,Divergent protein kinase domain 2B,6435,173,0.78 [0.46-1.32],0.3526310161137636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK1,Dickkopf-related protein 1,7641,209,1.07 [0.87-1.33],0.5101480744262109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK3,Dickkopf-related protein 3,7681,210,0.97 [0.65-1.46],0.8930463921467442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKK4,Dickkopf-related protein 4,7490,207,1.12 [0.86-1.46],0.3964134553046292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DKKL1,Dickkopf-like protein 1,7543,206,1.03 [0.89-1.19],0.7317843362002361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLG4,Disks large homolog 4,6567,172,1.03 [0.84-1.26],0.7896665314464338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLGAP5,Disks large-associated protein 5,6571,175,0.91 [0.66-1.26],0.55986831273103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLK1,Protein delta homolog 1,7681,210,1.10 [0.89-1.36],0.3929171482925052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL1,Delta-like protein 1,7608,208,2.09 [1.44-3.02],9.58721408237402e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DLL4,Delta-like protein 4,6393,171,1.01 [0.87-1.18],0.8516479549458299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMD,Dystrophin,6393,171,0.96 [0.70-1.32],0.791445702079782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DMP1,Dentin matrix acidic phosphoprotein 1,6393,171,1.00 [0.76-1.31],0.9796510704856808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA1,DnaJ homolog subfamily A member 1,6350,168,0.97 [0.69-1.37],0.8538863994951431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA2,DnaJ homolog subfamily A member 2,7640,209,0.98 [0.84-1.14],0.7982024710962594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJA4,DnaJ homolog subfamily A member 4,6567,172,0.75 [0.61-0.92],0.0068515134012362
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB1,DnaJ homolog subfamily B member 1,7543,206,0.90 [0.77-1.04],0.1519466937451701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB14,DnaJ homolog subfamily B member 14,6553,176,0.93 [0.74-1.18],0.5695651830575856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB2,DnaJ homolog subfamily B member 2,6435,173,0.70 [0.52-0.93],0.0153283442291432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB6,DnaJ homolog subfamily B member 6,6374,173,1.02 [0.85-1.22],0.8472906315334847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJB8,DnaJ homolog subfamily B member 8,7455,202,1.00 [0.79-1.26],0.995476855672284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC21,DnaJ homolog subfamily C member 21,6567,172,0.97 [0.66-1.42],0.8633304178876042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC6,Putative tyrosine-protein phosphatase auxilin,6393,171,0.92 [0.77-1.10],0.3635304881360812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNAJC9,DnaJ homolog subfamily C member 9,6553,176,0.90 [0.74-1.09],0.2986938617785278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNER,Delta and Notch-like epidermal growth factor-related receptor,7559,207,1.39 [0.86-2.23],0.1756220860670291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNLZ,DNL-type zinc finger protein,6400,169,1.11 [0.94-1.30],0.2217729537668615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM1,Dynamin-1,6553,176,0.99 [0.87-1.13],0.8800918741880659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNM3,Dynamin-3,6571,175,0.95 [0.72-1.24],0.686830933696186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNMBP,Dynamin-binding protein,7503,207,1.00 [0.81-1.23],0.985388301333346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPEP,Aspartyl aminopeptidase,6567,172,0.81 [0.62-1.06],0.1313922091646902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,7594,207,0.85 [0.66-1.08],0.1802703697840559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOC2B,Double C2-like domain-containing protein beta,6413,172,1.11 [0.76-1.63],0.5814329462530166
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOCK9,Dedicator of cytokinesis protein 9,6400,169,1.09 [0.98-1.23],0.1259862399228167
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK1,Docking protein 1,6567,172,0.96 [0.86-1.07],0.4547830127391973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DOK2,Docking protein 2,7572,207,0.99 [0.89-1.09],0.802445474486114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP1,Dipeptidase 1,7493,207,1.05 [0.80-1.37],0.7261289122327392
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPEP2,Dipeptidase 2,7543,206,1.33 [0.89-1.99],0.1588626682545798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP10,Inactive dipeptidyl peptidase 10,7573,209,1.00 [0.71-1.40],0.9859717255263728
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP4,Dipeptidyl peptidase 4,7461,203,1.26 [0.79-2.01],0.3256016239613418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP6,Dipeptidyl aminopeptidase-like protein 6,7543,206,0.90 [0.63-1.29],0.5599925102658068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPP7,Dipeptidyl peptidase 2,7521,206,0.97 [0.79-1.19],0.7495073985451051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPT,Dermatopontin,7681,210,1.61 [0.97-2.66],0.0653230487989245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DPY30,Protein dpy-30 homolog,7632,206,1.23 [1.02-1.49],0.0338655248450908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRAXIN,Draxin,7503,207,1.06 [0.79-1.42],0.7098330617378075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DRG2,Developmentally-regulated GTP-binding protein 2,7543,206,0.96 [0.76-1.20],0.6938478330304148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSC2,Desmocollin-2,7511,208,1.39 [0.99-1.97],0.0602556311027747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSCAM,Down syndrome cell adhesion molecule,6571,175,1.22 [0.81-1.83],0.3394166821605572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG2,Desmoglein-2,7592,208,1.08 [0.69-1.70],0.7266018719457573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG3,Desmoglein-3,7631,206,0.89 [0.62-1.27],0.5116189917695887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DSG4,Desmoglein-4,7514,206,0.81 [0.63-1.04],0.0982737917751489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTD1,D-aminoacyl-tRNA deacylase 1,6435,173,1.06 [0.89-1.26],0.4909746870311657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTNB,Dystrobrevin beta,6538,173,0.75 [0.52-1.07],0.1160691732042834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX2,Probable E3 ubiquitin-protein ligase DTX2,6413,172,1.00 [0.78-1.28],0.982475588946318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTX3,Probable E3 ubiquitin-protein ligase DTX3,7543,206,1.19 [0.72-1.98],0.4964318866207903
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DTYMK,Thymidylate kinase,6580,177,0.94 [0.75-1.17],0.5677270879028878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUOX2,Dual oxidase 2,7455,202,1.01 [0.85-1.21],0.8796164489028633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP13,Dual specificity protein phosphatase 13 isoform A,6554,173,0.97 [0.68-1.38],0.8585980955003887
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP29,Dual specificity phosphatase 29,6413,172,0.74 [0.57-0.97],0.0288261953484247
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUSP3,Dual specificity protein phosphatase 3,7422,204,0.99 [0.86-1.15],0.9379991763601556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",6553,176,0.96 [0.84-1.11],0.612254155315821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DXO,Decapping and exoribonuclease protein,6567,172,1.09 [0.79-1.51],0.6052630226519347
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,6554,173,1.05 [0.77-1.44],0.7487719677703593
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT1,Dynein light chain Tctex-type 1,6413,172,1.07 [0.89-1.29],0.4759433442200508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",DYNLT3,Dynein light chain Tctex-type 3,6554,173,1.04 [0.74-1.45],0.8228648251502124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,7503,207,0.99 [0.87-1.13],0.8700192806393452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EBI3_IL27,Interleukin-27,7647,207,1.20 [0.80-1.80],0.3795653080148765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECE1,Endothelin-converting enzyme 1,7422,204,1.21 [0.87-1.68],0.2591013411532314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",6580,177,0.95 [0.77-1.17],0.6318910372065489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECHS1,"Enoyl-CoA hydratase, mitochondrial",6393,171,0.98 [0.83-1.15],0.792241437849706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECI2,Enoyl-CoA delta isomerase 2,6354,169,0.96 [0.74-1.24],0.7512115030949327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECM1,Extracellular matrix protein 1,6422,176,1.25 [0.83-1.89],0.2930163456080813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ECSCR,Endothelial cell-specific chemotaxis regulator,6400,169,1.12 [0.87-1.43],0.3874991165181309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDA2R,Tumor necrosis factor receptor superfamily member 27,7659,207,1.17 [0.88-1.56],0.2888915250849281
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDAR,Tumor necrosis factor receptor superfamily member EDAR,7573,209,0.95 [0.83-1.10],0.5175021806197311
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDDM3B,Epididymal secretory protein E3-beta,6554,173,0.89 [0.69-1.15],0.3627871104447059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,6354,169,0.97 [0.64-1.47],0.8965481336436316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDF1,Endothelial differentiation-related factor 1,6571,175,1.14 [0.94-1.38],0.1981398701571685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,7455,202,1.59 [1.14-2.21],0.005669265107068
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDN1,Endothelin-1,6393,171,1.21 [0.74-1.98],0.4370780599976491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EDNRB,Endothelin receptor type B,6368,169,1.12 [0.82-1.54],0.4730725808939291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EEF1D,Elongation factor 1-delta,6580,177,1.00 [0.85-1.17],0.9656369141438867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB14,EF-hand calcium-binding domain-containing protein 14,6553,176,1.38 [0.93-2.04],0.1105898134973244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFCAB2,Dynein regulatory complex protein 8,6448,175,1.12 [0.74-1.69],0.6043036871202356
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,7612,207,1.24 [0.86-1.81],0.2532420393237778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFHD1,EF-hand domain-containing protein D1,6571,175,1.34 [0.93-1.94],0.1158936294779055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA1,Ephrin-A1,7582,208,1.72 [1.18-2.51],0.0048203102336054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNA4,Ephrin-A4,7488,206,1.42 [0.99-2.04],0.0602530171201016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EFNB2,Ephrin-B2,6413,172,1.06 [0.82-1.38],0.6463932433904503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGF,Pro-epidermal growth factor,7568,207,0.95 [0.84-1.07],0.388609040036193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFL7,Epidermal growth factor-like protein 7,7437,205,1.04 [0.75-1.44],0.8182565239260757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFLAM,Pikachurin,6553,176,0.79 [0.48-1.28],0.3354604847729742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGFR,Epidermal growth factor receptor,7681,210,2.03 [0.95-4.33],0.0666541139037775
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EGLN1,Egl nine homolog 1,7573,209,0.97 [0.77-1.23],0.7953679312416752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHBP1,EH domain-binding protein 1,6580,177,0.99 [0.81-1.20],0.893296412889947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EHD3,EH domain-containing protein 3,6393,171,0.97 [0.85-1.10],0.6270392117669634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",6567,172,1.23 [0.98-1.55],0.0759836787030171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",6527,175,0.92 [0.80-1.06],0.2375583050365657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,6354,169,0.96 [0.76-1.21],0.719782183674675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,6393,171,0.99 [0.70-1.41],0.9565901739369294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4B,Eukaryotic translation initiation factor 4B,7503,207,0.81 [0.65-1.02],0.0676440418270301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4E,Eukaryotic translation initiation factor 4E,6368,169,0.95 [0.80-1.13],0.5675542869895782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,7572,207,0.76 [0.62-0.93],0.0090930742608893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,7660,209,0.94 [0.83-1.07],0.3570328936315361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,6571,175,0.90 [0.72-1.14],0.3849225723326761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5,Eukaryotic translation initiation factor 5,6354,169,0.91 [0.63-1.31],0.6199504562151161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EIF5A,Eukaryotic translation initiation factor 5A-1,7455,203,1.07 [0.72-1.59],0.7559492876971985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAC1,Zinc phosphodiesterase ELAC protein 1,6571,175,0.95 [0.80-1.14],0.5995646388564018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELAVL4,ELAV-like protein 4,6400,169,1.02 [0.85-1.22],0.852677630837555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELN,Elastin,6580,177,1.63 [1.09-2.45],0.0181365307079264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOA,Elongin-A,7543,206,1.12 [0.90-1.38],0.3184757441345599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ELOB,Elongin-B,6354,169,1.24 [0.90-1.72],0.1906684826488588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENAH,Protein enabled homolog,7455,203,0.88 [0.67-1.16],0.3634075670753002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENDOU,Poly(U)-specific endoribonuclease,6068,167,0.69 [0.53-0.90],0.0058474827958073
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENG,Endoglin,7681,210,1.26 [0.63-2.53],0.5169072763362372
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO1,Alpha-enolase,7564,208,0.96 [0.82-1.13],0.6147231058352747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO2,Gamma-enolase,7641,209,0.90 [0.74-1.09],0.2795114611729428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENO3,Beta-enolase,6393,171,0.89 [0.69-1.16],0.387684758905962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOPH1,Enolase-phosphatase E1,6554,173,1.07 [0.82-1.39],0.612315032817407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENOX2,Ecto-NOX disulfide-thiol exchanger 2,6354,169,0.79 [0.45-1.38],0.4055486329113352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPEP,Glutamyl aminopeptidase,6354,169,1.12 [0.82-1.53],0.4636899049144803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,7681,210,1.70 [1.06-2.73],0.0274632390058488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,7605,207,0.83 [0.65-1.08],0.1687595801183516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,6393,171,1.15 [0.76-1.74],0.5171999009911501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,7320,198,0.95 [0.81-1.11],0.5479383556161216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENSA,Alpha-endosulfine,6554,173,1.11 [0.85-1.46],0.4464363750966723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,7437,205,1.14 [0.85-1.52],0.3855508976640787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,7455,202,1.16 [0.65-2.07],0.6097240493493234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,7455,202,1.03 [0.66-1.62],0.8913778459017752
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ENTR1,Endosome-associated-trafficking regulator 1,6393,171,0.75 [0.56-0.99],0.0430265684471743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EP300,Histone acetyltransferase p300,6368,169,1.19 [0.74-1.90],0.4778170943315344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPB41L5,Band 4.1-like protein 5,6413,172,0.95 [0.74-1.22],0.684470814973086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPCAM,Epithelial cell adhesion molecule,7567,207,1.06 [0.93-1.21],0.3746880236275164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPGN,Epigen,6554,173,1.15 [0.88-1.51],0.2901180941657182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA1,Ephrin type-A receptor 1,7594,207,1.61 [1.07-2.42],0.021911287623284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA10,Ephrin type-A receptor 10,7422,204,1.11 [0.94-1.32],0.2290823158944946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA2,Ephrin type-A receptor 2,7323,196,1.86 [1.31-2.64],0.0005042113308759
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHA4,Ephrin type-A receptor 4,6435,173,1.40 [0.85-2.32],0.1862375447403148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB4,Ephrin type-B receptor 4,7681,210,1.79 [1.15-2.79],0.0102132408528016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHB6,Ephrin type-B receptor 6,7493,207,1.40 [0.96-2.03],0.0776461251566683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPHX2,Bifunctional epoxide hydrolase 2,7455,202,1.13 [0.93-1.36],0.2214948582208432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPN1,Epsin-1,6448,175,1.07 [0.77-1.47],0.6899662301529328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,7573,209,1.11 [0.95-1.31],0.1853183547831921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPPK1,Epiplakin,6393,171,1.00 [0.81-1.23],0.9664448196408378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,7644,206,1.20 [0.80-1.81],0.3702702646828986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB2,Receptor tyrosine-protein kinase erbB-2,7608,208,1.39 [0.83-2.33],0.2149932299530963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB3,Receptor tyrosine-protein kinase erbB-3,7553,207,2.71 [1.53-4.78],0.0005993300322007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBB4,Receptor tyrosine-protein kinase erbB-4,7608,208,1.68 [1.01-2.82],0.0465094526301502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERBIN,Erbin,7543,206,0.94 [0.83-1.06],0.3111409597998847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERC2,ERC protein 2,6413,172,1.05 [0.87-1.27],0.5991859178128501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERCC1,DNA excision repair protein ERCC-1,6350,168,1.02 [0.68-1.54],0.9065896801098912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EREG,Proepiregulin,7493,207,0.99 [0.84-1.16],0.8751624811514332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERI1,3'-5' exoribonuclease 1,6448,175,0.88 [0.56-1.39],0.5931576601990369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERMAP,Erythroid membrane-associated protein,6368,169,1.07 [0.76-1.49],0.7030324806881707
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,6554,173,0.95 [0.62-1.44],0.7961884052193164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP29,Endoplasmic reticulum resident protein 29,6435,173,1.02 [0.90-1.15],0.785524729495909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERP44,Endoplasmic reticulum resident protein 44,7532,206,1.21 [0.75-1.96],0.4376417944672736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,6354,169,0.95 [0.66-1.37],0.797901188979491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESAM,Endothelial cell-selective adhesion molecule,7681,210,1.33 [0.92-1.92],0.1293422064538011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESM1,Endothelial cell-specific molecule 1,7573,207,0.77 [0.53-1.10],0.1496834891023289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESPL1,Separin,6350,168,0.80 [0.58-1.10],0.1742617727487732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESR1,Estrogen receptor,6368,169,1.11 [0.86-1.43],0.4398791296501059
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ESYT2,Extended synaptotagmin-2,6567,172,1.04 [0.87-1.24],0.7035882118974223
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI2B,Protein EVI2B,6350,168,1.11 [0.78-1.57],0.5724995966121933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVI5,Ecotropic viral integration site 5 protein homolog,6368,169,0.94 [0.79-1.11],0.4523426893864444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EVPL,Envoplakin,6448,175,0.92 [0.57-1.48],0.7275517121019509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXOSC10,Exosome component 10,6354,169,1.06 [0.81-1.37],0.6753907611160275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EXTL1,Exostosin-like 1,6354,169,0.77 [0.54-1.11],0.164529579763582
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",EZR,Ezrin,7641,209,1.23 [0.74-2.06],0.4310703768818008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F10,Coagulation factor X,6592,177,1.53 [1.07-2.19],0.0213188124993029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11,Coagulation factor XI,6500,176,2.00 [1.41-2.83],9.639607226016742e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F11R,Junctional adhesion molecule A,7592,208,1.02 [0.82-1.27],0.8657965787127155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F12,Coagulation factor XII,6589,178,1.46 [1.00-2.12],0.0485502283068836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F13B,Coagulation factor XIII B chain,6564,178,1.96 [1.10-3.50],0.0232946513018781
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2,Prothrombin,6589,178,3.04 [1.15-8.05],0.0254475508019866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F2R,Proteinase-activated receptor 1,7598,207,1.01 [0.81-1.26],0.9300080053872436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F3,Tissue factor,7608,206,1.38 [0.86-2.22],0.1800392166987209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F7,Coagulation factor VII,7614,207,2.37 [1.56-3.61],4.9297691506020745e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",F9,Coagulation factor IX,7611,206,2.58 [1.33-5.03],0.0051858290147718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP1,"Fatty acid-binding protein, liver",7573,207,1.03 [0.90-1.17],0.697321019974122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP2,"Fatty acid-binding protein, intestinal",7572,207,1.03 [0.89-1.20],0.6706552764610114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP3,"Fatty acid-binding protein, heart",6580,177,0.79 [0.59-1.05],0.1078891959480182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP4,"Fatty acid-binding protein, adipocyte",7681,210,1.22 [0.97-1.54],0.092385021267526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP5,Fatty acid-binding protein 5,7612,209,0.97 [0.81-1.17],0.7717403872138213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP6,Gastrotropin,7441,202,1.05 [0.85-1.31],0.6355378306212284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FABP9,Fatty acid-binding protein 9,7573,209,0.66 [0.53-0.84],0.0004554247915287
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FADD,FAS-associated death domain protein,7572,207,0.92 [0.78-1.09],0.344578381761774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM13A,Protein FAM13A,6553,176,0.83 [0.66-1.04],0.1060553833136603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171A2,Protein FAM171A2,6571,175,1.03 [0.94-1.13],0.4995871152560224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM171B,Protein FAM171B,6554,173,1.25 [0.78-2.02],0.3544891157008035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM172A,Cotranscriptional regulator FAM172A,6393,171,1.01 [0.79-1.30],0.9313075030832544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM20A,Pseudokinase FAM20A,6580,177,0.85 [0.50-1.43],0.5352900638645894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3B,Protein FAM3B,7543,206,0.96 [0.67-1.38],0.8189612545410883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3C,Protein FAM3C,7561,206,1.11 [0.74-1.66],0.6250446427851979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAM3D,Protein FAM3D,6553,176,1.03 [0.88-1.22],0.7000025445610432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAP,Prolyl endopeptidase FAP,7681,210,1.33 [0.85-2.08],0.2119202308049762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FARSA,Phenylalanine--tRNA ligase alpha subunit,6413,172,1.05 [0.85-1.28],0.6691710373732305
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FAS,Tumor necrosis factor receptor superfamily member 6,7661,210,1.27 [0.93-1.74],0.1319691687105057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FASLG,Tumor necrosis factor ligand superfamily member 6,7660,209,0.94 [0.67-1.31],0.7063062582983495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBLN2,Fibulin-2,6573,174,0.82 [0.51-1.31],0.4068115907566787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBN2,Fibrillin-2,6413,172,0.92 [0.72-1.19],0.5389070832808831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FBP1,"Fructose-1,6-bisphosphatase 1",7572,207,0.93 [0.78-1.11],0.4248468740353848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,6580,177,1.24 [1.01-1.51],0.0371931095341029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCAR,Immunoglobulin alpha Fc receptor,7573,209,0.93 [0.72-1.20],0.5656717746421904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,6571,175,1.03 [0.55-1.92],0.9352496041570229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,7592,208,1.14 [0.89-1.44],0.2973474454742931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,7564,204,1.08 [0.86-1.35],0.4940182131834607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,7437,205,1.11 [0.90-1.38],0.327170370807723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,7603,207,1.39 [1.07-1.81],0.0150494475470962
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN1,Ficolin-1,6584,177,0.98 [0.76-1.26],0.8588258819343682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCN2,Ficolin-2,7562,202,1.47 [1.06-2.05],0.0217208286162915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,7572,207,1.42 [1.09-1.86],0.0100634366815212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,7620,209,1.23 [0.97-1.56],0.0940499135580709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,7455,203,1.15 [0.91-1.45],0.2307258944442504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL5,Fc receptor-like protein 5,7592,208,0.97 [0.79-1.20],0.8025750872292877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRL6,Fc receptor-like protein 6,7573,209,1.06 [0.89-1.27],0.5092493848560615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FCRLB,Fc receptor-like B,7437,205,0.98 [0.81-1.20],0.8635597181979616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX1,"Adrenodoxin, mitochondrial",6354,169,0.93 [0.72-1.20],0.5788801436275556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FDX2,"Ferredoxin-2, mitochondrial",6354,169,0.96 [0.74-1.26],0.7695293962225156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FEN1,Flap endonuclease 1,7437,205,1.09 [0.92-1.30],0.3019153599184682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FES,Tyrosine-protein kinase Fes/Fps,7437,205,1.01 [0.77-1.31],0.9703263352056188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FETUB,Fetuin-B,7611,206,3.81 [2.48-5.85],1.066341723006909e-09
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGA,Fibrinogen alpha chain,6429,169,1.22 [0.75-1.98],0.4245781038255679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",6571,175,0.94 [0.78-1.13],0.5019030177185291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF12,Fibroblast growth factor 12,6368,169,1.03 [0.76-1.40],0.8507601468507874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF16,Fibroblast growth factor 16,6368,169,0.92 [0.65-1.30],0.6187389419143474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF19,Fibroblast growth factor 19,7605,207,0.97 [0.82-1.13],0.6733439273957136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF2,Fibroblast growth factor 2,7573,209,0.84 [0.70-1.02],0.0742787531412633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF20,Fibroblast growth factor 20,6368,169,1.04 [0.75-1.45],0.8096879834315481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF21,Fibroblast growth factor 21,7647,207,1.07 [0.96-1.18],0.2211729506024754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF23,Fibroblast growth factor 23,7647,206,1.03 [0.82-1.29],0.7903233165116077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF3,Fibroblast growth factor 3,6368,169,1.19 [0.79-1.80],0.4053486591152953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF5,Fibroblast growth factor 5,7455,203,0.94 [0.64-1.37],0.7485505350935512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF6,Fibroblast growth factor 6,6368,169,0.68 [0.42-1.08],0.1032278607842172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF7,Fibroblast growth factor 7,6350,168,0.91 [0.74-1.13],0.4096899613605915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGF9,Fibroblast growth factor 9,6343,168,0.97 [0.67-1.39],0.8522901619596959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP1,Fibroblast growth factor-binding protein 1,7608,208,1.29 [0.89-1.87],0.1767592081461371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP2,Fibroblast growth factor-binding protein 2,6573,174,0.90 [0.67-1.19],0.4534043503819466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFBP3,Fibroblast growth factor-binding protein 3,6567,172,1.20 [0.81-1.78],0.3666589932528735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR2,Fibroblast growth factor receptor 2,7608,208,1.62 [0.95-2.78],0.0772023049493586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGFR4,Fibroblast growth factor receptor 4,6435,173,0.87 [0.65-1.16],0.330303452128719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGL1,Fibrinogen-like protein 1,6592,177,1.05 [0.84-1.30],0.6846569909951336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FGR,Tyrosine-protein kinase Fgr,7422,204,1.11 [0.91-1.34],0.3020593334431899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FH,"Fumarate hydratase, mitochondrial",6400,169,0.93 [0.77-1.13],0.4869477151229739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIP2A,FHF complex subunit HOOK interacting protein 2A,6354,169,1.09 [0.81-1.46],0.5671661813336428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FHIT,Bis(5'-adenosyl)-triphosphatase,7422,204,0.93 [0.78-1.12],0.4560919568564979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FIS1,Mitochondrial fission 1 protein,7574,207,0.99 [0.84-1.17],0.9359537667527904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,6571,175,1.06 [0.91-1.22],0.4599970068438573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,7594,208,0.98 [0.88-1.10],0.7632686666498683
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,7503,207,0.85 [0.63-1.15],0.2878231025311988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,7503,207,0.97 [0.85-1.11],0.6824336479739379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,7412,204,0.94 [0.71-1.24],0.6733024039094773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FKBPL,FK506-binding protein-like,6553,176,0.92 [0.71-1.18],0.5084462412795626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLI1,Friend leukemia integration 1 transcription factor,7437,205,1.00 [0.89-1.12],0.9664496997284164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLRT2,Leucine-rich repeat transmembrane protein FLRT2,7503,207,1.37 [0.90-2.09],0.1430493771111807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT1,Vascular endothelial growth factor receptor 1,7519,206,1.08 [0.62-1.86],0.7942020532685026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3,Receptor-type tyrosine-protein kinase FLT3,7437,205,0.91 [0.60-1.39],0.679076342012884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT3LG,Fms-related tyrosine kinase 3 ligand,7660,209,1.22 [0.86-1.72],0.2726758220169911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FLT4,Vascular endothelial growth factor receptor 3,7608,208,1.59 [1.09-2.33],0.0171495134949841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMNL1,Formin-like protein 1,7422,204,1.06 [0.88-1.27],0.5565423393614848
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FMR1,Synaptic functional regulator FMR1,7437,205,0.78 [0.54-1.12],0.1814996604231604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FN1,Fibronectin,6589,178,1.09 [0.63-1.86],0.7627720683096225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNDC1,Fibronectin type III domain-containing protein 1,6567,172,1.31 [0.96-1.78],0.0897493804225077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,6554,173,0.96 [0.62-1.48],0.8413952525578452
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLH1,Glutamate carboxypeptidase 2,6368,169,0.91 [0.77-1.08],0.2839908531873288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR1,Folate receptor alpha,7575,208,1.19 [0.79-1.78],0.4038630302773274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR2,Folate receptor beta,7641,209,1.80 [1.19-2.73],0.0056628366200456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOLR3,Folate receptor gamma,7583,206,1.00 [0.94-1.07],0.9347575944059404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOS,Proto-oncogene c-Fos,6343,168,1.00 [0.65-1.54],0.9981963416383132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOSB,Protein fosB,7422,204,1.02 [0.72-1.44],0.9108848154495393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXJ3,Forkhead box protein J3,6368,169,0.74 [0.51-1.08],0.1226958893670616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO1,Forkhead box protein O1,7573,209,0.96 [0.83-1.11],0.5649512074848233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FOXO3,Forkhead box protein O3,7437,205,0.91 [0.79-1.04],0.1660972350678269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD4B,FERM domain-containing protein 4B,6354,169,0.87 [0.69-1.09],0.2367693159166183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRMD7,FERM domain-containing protein 7,6413,172,1.30 [0.87-1.94],0.192888597603036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FRZB,Secreted frizzled-related protein 3,7477,206,1.28 [0.75-2.18],0.3663869101699624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSHB,Follitropin subunit beta,6393,171,1.50 [1.15-1.96],0.0027267366776365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FST,Follistatin,7598,207,1.00 [0.77-1.30],0.9797845352739112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL1,Follistatin-related protein 1,6393,171,1.23 [0.64-2.38],0.5379159777978513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FSTL3,Follistatin-related protein 3,7557,207,1.42 [0.99-2.03],0.0580004170600635
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FTCD,Formimidoyltransferase-cyclodeaminase,6551,172,0.88 [0.73-1.06],0.170685840522932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUCA1,Tissue alpha-L-fucosidase,7635,210,0.96 [0.83-1.12],0.6242598869569094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUOM,Fucose mutarotase,6435,173,0.96 [0.75-1.22],0.7344052579082284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FURIN,Furin,7608,208,1.36 [0.92-2.02],0.1211394587713233
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUS,RNA-binding protein FUS,7425,204,1.24 [0.90-1.70],0.1842278025631764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",6433,174,0.94 [0.73-1.21],0.6498082720542128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,7641,209,1.23 [0.95-1.59],0.1203019858556881
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FUT8,"Alpha-(1,6)-fucosyltransferase",7503,207,1.11 [0.89-1.37],0.3539515699175813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXN,"Frataxin, mitochondrial",7659,207,0.97 [0.82-1.15],0.7443266065906455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FXYD5,FXYD domain-containing ion transport regulator 5,7455,203,0.96 [0.79-1.17],0.6885034620290361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FYB1,FYN-binding protein 1,7571,208,0.99 [0.87-1.13],0.8721942514742975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD10,Frizzled-10,6413,172,0.82 [0.61-1.11],0.2018170571956913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",FZD8,Frizzled-8,6400,169,1.22 [0.91-1.63],0.1824553974747743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAP,Gamma-aminobutyric acid receptor-associated protein,6554,173,1.02 [0.75-1.40],0.8878291446694143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,6448,175,1.08 [0.88-1.33],0.4550166456033149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,6400,169,1.07 [0.85-1.34],0.5617933454577884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD1,Glutamate decarboxylase 1,6350,168,1.07 [0.60-1.90],0.8313367560773388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAD2,Glutamate decarboxylase 2,6368,169,0.93 [0.66-1.31],0.6819095603114802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,6448,175,0.68 [0.45-1.03],0.071097030577094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,6393,171,1.04 [0.78-1.38],0.7841959720285236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAGE2A,G antigen 2A,6350,168,0.79 [0.60-1.04],0.0943077005708158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAL,Galanin peptides,7605,207,0.78 [0.65-0.95],0.0119366714571863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,7543,206,0.92 [0.58-1.44],0.7067909886859878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,7659,207,0.68 [0.43-1.07],0.0961349504593665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,7455,203,1.24 [0.94-1.65],0.1283528573450235
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,6580,177,1.45 [0.91-2.32],0.1181742755507936
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GALNT7,N-acetylgalactosaminyltransferase 7,7543,206,1.93 [1.05-3.56],0.0347257033478705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAMT,Guanidinoacetate N-methyltransferase,6354,169,0.92 [0.57-1.49],0.7371579677928985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,6279,168,0.75 [0.47-1.21],0.2410900573312435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GART,Trifunctional purine biosynthetic protein adenosine-3,6571,175,1.00 [0.57-1.75],0.9901645600291954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS2,Growth arrest-specific protein 2,6448,175,1.36 [1.11-1.66],0.0025536739376298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAS6,Growth arrest-specific protein 6,7639,209,1.34 [0.82-2.19],0.2419119036485958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GASK1A,Golgi-associated kinase 1A,6354,169,1.57 [1.12-2.21],0.0095839898580017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GAST,Gastrin,6567,172,1.08 [0.98-1.19],0.1167549087428596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATA3,Trans-acting T-cell-specific transcription factor GATA-3,6350,168,0.55 [0.31-0.98],0.0407992980868365
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",6393,171,0.98 [0.80-1.20],0.8757945512943685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBA,Lysosomal acid glucosylceramidase,6413,172,0.99 [0.75-1.30],0.9428199635132004
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP1,Guanylate-binding protein 1,6555,172,1.03 [0.82-1.30],0.7849284642192118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP2,Guanylate-binding protein 2,7455,203,0.87 [0.70-1.09],0.2232224939079333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP4,Guanylate-binding protein 4,7422,204,1.11 [0.87-1.43],0.4032732071769935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GBP6,Guanylate-binding protein 6,6354,169,1.06 [0.76-1.48],0.7305353862325474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GC,Vitamin D-binding protein,6589,178,1.97 [1.14-3.41],0.0158744805371896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCC1,GRIP and coiled-coil domain-containing protein 1,6567,172,1.02 [0.89-1.17],0.7923779367531488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCG,Pro-glucagon,7437,205,0.98 [0.89-1.09],0.7661168802581103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,6278,169,0.99 [0.73-1.35],0.9430656927899738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCLM,Glutamate--cysteine ligase regulatory subunit,6354,169,0.77 [0.52-1.12],0.1730167213921002
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",7543,206,1.17 [0.82-1.68],0.3778241616384876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF15,Growth/differentiation factor 15,7681,210,1.21 [0.95-1.55],0.1171404033842766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDF2,Growth/differentiation factor 2,7572,207,1.78 [1.26-2.51],0.0009842778248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GDNF,Glial cell line-derived neurotrophic factor,7422,204,1.05 [0.75-1.47],0.769185025756724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GET3,ATPase GET3,6580,177,0.83 [0.61-1.12],0.2269329662738786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFAP,Glial fibrillary acidic protein,7424,204,1.15 [0.89-1.50],0.285908007267262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFER,FAD-linked sulfhydryl oxidase ALR,7437,205,0.91 [0.74-1.12],0.3842969267117665
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,7437,205,1.09 [1.00-1.20],0.0563955777340656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA1,GDNF family receptor alpha-1,7647,207,2.08 [1.42-3.04],0.000182211506447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA2,GDNF family receptor alpha-2,7543,206,1.29 [0.71-2.34],0.4020471651958049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRA3,GDNF family receptor alpha-3,7484,205,0.94 [0.60-1.47],0.78947083623637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GFRAL,GDNF family receptor alpha-like,6361,168,1.13 [0.89-1.44],0.3009407379050871
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGA1,ADP-ribosylation factor-binding protein GGA1,7422,204,0.97 [0.80-1.18],0.7722746908756719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGACT,Gamma-glutamylaminecyclotransferase,6580,177,0.91 [0.73-1.12],0.3704200490827678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGCT,Gamma-glutamylcyclotransferase,6569,177,0.87 [0.63-1.19],0.3775356112865107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGH,Gamma-glutamyl hydrolase,7467,205,1.61 [1.13-2.28],0.0076534166716992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT1,Glutathione hydrolase 1 proenzyme,7582,208,0.84 [0.65-1.10],0.1994688720140717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GGT5,Glutathione hydrolase 5 proenzyme,7503,207,1.44 [0.86-2.39],0.1634461404234762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH1,Somatotropin,7561,206,0.97 [0.90-1.05],0.4563915279704933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GH2,Growth hormone variant,7437,205,0.97 [0.89-1.05],0.4551048950692304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHR,Growth hormone receptor,6435,173,1.34 [0.79-2.28],0.2795374018167001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRHR,Growth hormone-releasing hormone receptor,7422,204,0.91 [0.70-1.17],0.4494252231033138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GHRL,Appetite-regulating hormone,7572,207,1.09 [0.94-1.26],0.2406224700205126
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GID8,Glucose-induced degradation protein 8 homolog,6571,175,0.68 [0.40-1.15],0.1507268396118497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIGYF2,GRB10-interacting GYF protein 2,6571,175,1.00 [0.82-1.21],0.96086374383632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP7,GTPase IMAP family member 7,6435,173,0.85 [0.51-1.40],0.5172333604129123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIMAP8,GTPase IMAP family member 8,6350,168,0.98 [0.72-1.33],0.880299969982711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIP,Gastric inhibitory polypeptide,6393,171,1.04 [0.81-1.34],0.7331432148350251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC2,PDZ domain-containing protein GIPC2,6567,172,0.88 [0.55-1.41],0.5920411800690695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPC3,PDZ domain-containing protein GIPC3,6553,176,0.93 [0.80-1.07],0.3058467756867743
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIPR,Gastric inhibitory polypeptide receptor,6368,169,0.92 [0.64-1.32],0.6480967546511691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GIT1,ARF GTPase-activating protein GIT1,6368,169,0.92 [0.78-1.08],0.2917024174274648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GJA8,Gap junction alpha-8 protein,6350,168,1.00 [0.78-1.27],0.97513605901071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GKN1,Gastrokine-1,7280,197,1.28 [0.81-2.01],0.2894535259666442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLA,Alpha-galactosidase A,6425,173,0.86 [0.58-1.28],0.4544840478344468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLB1,Beta-galactosidase,7503,207,1.10 [0.82-1.48],0.5279728651314493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLI2,Zinc finger protein GLI2,6368,169,0.79 [0.47-1.33],0.3806237666614886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLO1,Lactoylglutathione lyase,7455,202,0.81 [0.65-1.01],0.0638716614472988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLOD4,Glyoxalase domain-containing protein 4,7567,207,0.74 [0.51-1.07],0.1057856149555198
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLP1R,Glucagon-like peptide 1 receptor,6400,169,1.09 [0.74-1.60],0.6603418287613458
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX,Glutaredoxin-1,7525,205,0.79 [0.63-1.00],0.0462772241157131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLRX5,"Glutaredoxin-related protein 5, mitochondrial",6435,173,1.04 [0.88-1.23],0.6567952317295829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLT8D2,Glycosyltransferase 8 domain-containing protein 2,7422,204,1.17 [0.92-1.47],0.2001409666259154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GLYR1,Putative oxidoreductase GLYR1,6554,173,0.94 [0.72-1.24],0.6594272551618025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GM2A,Ganglioside GM2 activator,6421,170,1.11 [0.77-1.62],0.5698021539509219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMFG,Glia maturation factor gamma,6580,177,1.01 [0.82-1.24],0.9477510380187202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR,GMP reductase 1,7660,209,0.78 [0.61-0.99],0.0453110590245089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GMPR2,GMP reductase 2,6435,173,0.86 [0.69-1.08],0.2033401396727137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNAS,Neuroendocrine secretory protein 55,6571,175,0.97 [0.81-1.16],0.7601650413986685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,7437,205,0.97 [0.80-1.17],0.7239874428260835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,6413,172,1.11 [0.84-1.47],0.4716095609657815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNLY,Granulysin,7592,208,1.02 [0.82-1.28],0.839289371300046
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA1,Glucosamine-6-phosphate isomerase 1,6393,171,1.13 [0.77-1.66],0.5300903969592736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GNPDA2,Glucosamine-6-phosphate isomerase 2,6435,173,0.97 [0.64-1.46],0.8732301313185122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLGA3,Golgin subfamily A member 3,6571,175,0.96 [0.79-1.16],0.6616159427406969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOLM2,Protein GOLM2,7641,209,1.66 [1.06-2.59],0.0257479357346823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,7573,209,0.95 [0.84-1.07],0.4235997433443501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GORASP2,Golgi reassembly-stacking protein 2,6553,176,1.06 [0.78-1.44],0.728313726859672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GOT1,"Aspartate aminotransferase, cytoplasmic",6573,174,0.59 [0.41-0.87],0.0077646408011384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BA,Platelet glycoprotein Ib alpha chain,7569,203,1.54 [1.07-2.21],0.0188885843605406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP1BB,Platelet glycoprotein Ib beta chain,6354,169,0.91 [0.73-1.14],0.4229408890415463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP2,Pancreatic secretory granule membrane major glycoprotein GP2,7363,200,0.89 [0.76-1.05],0.1786619568662202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP5,Platelet glycoprotein V,6435,173,0.88 [0.59-1.31],0.5324850391390915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GP6,Platelet glycoprotein VI,7571,208,0.98 [0.85-1.13],0.7953537733585206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPA33,Cell surface A33 antigen,7543,206,1.05 [0.96-1.15],0.3129592746801494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC1,Glypican-1,7659,207,0.97 [0.64-1.47],0.8718169557889832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPC5,Glypican-5,7503,207,0.95 [0.76-1.19],0.6657088334070544
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPD1,Glycerol-3-phosphate dehydrogenase,6554,173,1.06 [0.80-1.41],0.6978970901625594
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPHA2,Glycoprotein hormone alpha-2,6553,176,1.37 [1.03-1.80],0.0279431543295517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPI,Glucose-6-phosphate isomerase,6592,177,0.96 [0.70-1.32],0.8048700689321358
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,6553,176,1.14 [0.92-1.42],0.2216943675166812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPKOW,G-patch domain and KOW motifs-containing protein,7422,204,1.41 [1.01-1.96],0.0446501702226576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPNMB,Transmembrane glycoprotein NMB,7377,202,1.52 [1.00-2.33],0.0527357361349255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR101,Probable G-protein coupled receptor 101,6400,169,1.13 [0.89-1.43],0.3315572905964637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR158,Probable G-protein coupled receptor 158,6571,175,1.33 [0.93-1.91],0.1218346261473801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR15L,Protein GPR15L,6553,176,0.96 [0.76-1.22],0.7518036366207295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPR37,Prosaposin receptor GPR37,7455,202,0.99 [0.82-1.20],0.9222686074534232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GPRC5C,G-protein coupled receptor family C group 5 member C,6554,173,1.04 [0.80-1.36],0.7654628316892567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRAP2,GRB2-related adapter protein 2,7572,207,0.97 [0.88-1.07],0.5347184263296739
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,6580,177,0.94 [0.74-1.19],0.6025984515211282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIK2,"Glutamate receptor ionotropic, kainate 2",6571,175,1.18 [0.88-1.58],0.2674191946199546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",6400,169,1.18 [0.95-1.47],0.141031060551051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRK5,G protein-coupled receptor kinase 5,7455,202,1.03 [0.80-1.33],0.8018115884426951
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRN,Progranulin,7549,208,1.39 [0.83-2.32],0.2152652948361231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRP,Gastrin-releasing peptide,6393,171,1.23 [0.94-1.62],0.1376458486336231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRPEL1,"GrpE protein homolog 1, mitochondrial",7543,206,1.19 [0.97-1.46],0.0974045682231084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GRSF1,G-rich sequence factor 1,6319,167,0.91 [0.75-1.10],0.3076353733454741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSAP,Gamma-secretase-activating protein,7437,205,0.90 [0.76-1.07],0.233682062663178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSN,Gelsolin,6565,176,0.78 [0.36-1.71],0.5404887278370084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSR,"Glutathione reductase, mitochondrial",6555,177,0.93 [0.48-1.79],0.8175481601332054
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA1,Glutathione S-transferase A1,7559,206,0.90 [0.77-1.05],0.1821992724913316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTA3,Glutathione S-transferase A3,7437,205,1.06 [0.90-1.26],0.465787524924307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTM4,Glutathione S-transferase Mu 4,6354,169,0.96 [0.78-1.19],0.7161280149578118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTP1,Glutathione S-transferase P,7379,203,0.86 [0.71-1.05],0.1429510100925423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GSTT2B,Glutathione S-transferase theta-2B,6567,172,0.96 [0.91-1.02],0.238617371317481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,6448,175,0.94 [0.75-1.19],0.6128980768118624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GTPBP2,GTP-binding protein 2,6413,172,0.97 [0.80-1.17],0.7384888768383064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCA2A,Guanylin,7545,207,1.10 [0.78-1.55],0.602390447194391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUCY2C,Heat-stable enterotoxin receptor,6448,175,1.07 [0.90-1.28],0.4262586734664945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUK1,Guanylate kinase,6354,169,0.81 [0.53-1.26],0.355268417167138
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GUSB,Beta-glucuronidase,7626,210,0.93 [0.76-1.13],0.4557134997076359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GYS1,"Glycogen [starch] synthase, muscle",7455,202,0.99 [0.86-1.14],0.8951806010012783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMA,Granzyme A,7660,209,0.85 [0.59-1.24],0.4031980604713754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMB,Granzyme B,7573,209,0.85 [0.70-1.04],0.1188887577671148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",GZMH,Granzyme H,7455,202,1.02 [0.87-1.20],0.8307797960265338
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",H2AP,Huntingtin-interacting protein M,6350,168,0.94 [0.69-1.29],0.7107544079932765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",6354,169,1.07 [0.88-1.30],0.4793434882270835
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",7636,207,0.77 [0.64-0.92],0.0037504226210845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAO1,Hydroxyacid oxidase 1,7659,207,0.95 [0.85-1.05],0.3097856052535821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HARS1,"Histidine--tRNA ligase, cytoplasmic",7592,208,0.94 [0.80-1.11],0.453866226732864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR1,Hepatitis A virus cellular receptor 1,7648,207,1.30 [1.08-1.55],0.0052030730707413
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HAVCR2,Hepatitis A virus cellular receptor 2,7592,208,1.50 [1.08-2.08],0.0152165111723469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBEGF,Proheparin-binding EGF-like growth factor,7636,207,0.99 [0.84-1.18],0.9403051059594884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBQ1,Hemoglobin subunit theta-1,7659,207,0.80 [0.66-0.99],0.0365879785762159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HBZ,Hemoglobin subunit zeta,6580,177,0.94 [0.81-1.08],0.3522635934291741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCG22,Protein PBMUCL2,6354,169,1.14 [0.91-1.42],0.2444607506605219
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HCLS1,Hematopoietic lineage cell-specific protein,7660,209,0.93 [0.74-1.16],0.5199836903023434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC8,Histone deacetylase 8,6368,169,0.96 [0.73-1.25],0.7444626810457274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDAC9,Histone deacetylase 9,6400,169,1.04 [0.84-1.29],0.7075201814350264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDDC2,5'-deoxynucleotidase HDDC2,6553,176,0.93 [0.66-1.30],0.6692545265278494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGF,Hepatoma-derived growth factor,7638,207,0.91 [0.79-1.04],0.1776657544036308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HDGFL2,Hepatoma-derived growth factor-related protein 2,6567,172,1.06 [0.85-1.34],0.5972595386926876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEBP1,Heme-binding protein 1,7455,202,1.04 [0.82-1.33],0.7213998211411412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEG1,Protein HEG homolog 1,6435,173,1.08 [0.63-1.86],0.7769569661045085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPACAM2,HEPACAM family member 2,6567,172,1.02 [0.73-1.43],0.90538017335559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEPH,Hephaestin,6580,177,1.58 [0.90-2.78],0.1111615639146062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HEXIM1,Protein HEXIM1,7573,209,0.93 [0.80-1.09],0.3931660891984169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGF,Hepatocyte growth factor,7660,209,0.83 [0.58-1.19],0.3058765297723343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGFAC,Hepatocyte growth factor activator,6536,176,1.25 [0.72-2.18],0.4249105881869377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,7437,205,0.93 [0.79-1.10],0.4198522892999901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HHEX,Hematopoietically-expressed homeobox protein HHEX,6567,172,1.07 [0.89-1.30],0.4666344842366564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIF1A,Hypoxia-inducible factor 1-alpha,6368,169,0.68 [0.49-0.94],0.0208921260877278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1,Huntingtin-interacting protein 1,6354,169,1.32 [0.92-1.90],0.1303022055492201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HIP1R,Huntingtin-interacting protein 1-related protein,6550,172,1.14 [0.85-1.53],0.3839134096413359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HJV,Hemojuvelin,6571,175,1.18 [0.85-1.63],0.3344461149073806
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HK2,Hexokinase-2,7455,202,1.38 [0.90-2.14],0.1436941947227643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-A,"HLA class I histocompatibility antigen, A alpha chain",6571,175,1.55 [0.99-2.43],0.0538210073976422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",7547,205,1.04 [0.74-1.47],0.8003496361058123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",7573,209,1.54 [1.05-2.26],0.0266796173613162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMBS,Porphobilinogen deaminase,7659,207,0.66 [0.49-0.88],0.0051452297689478
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMCN2,Hemicentin-2,6424,173,0.90 [0.70-1.16],0.402600468584648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",6393,171,1.04 [0.76-1.42],0.8185552455109528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",6354,169,1.08 [0.77-1.51],0.6702423783015152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMMR,Hyaluronan mediated motility receptor,6334,168,1.04 [0.76-1.40],0.8213385216260187
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX1,Heme oxygenase 1,7500,206,0.93 [0.72-1.20],0.5709856902143137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HMOX2,Heme oxygenase 2,7422,204,1.27 [1.00-1.62],0.0515854335875516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNF1A,Hepatocyte nuclear factor 1-alpha,6413,172,0.92 [0.73-1.17],0.5076611997953513
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNMT,Histamine N-methyltransferase,7468,206,1.14 [0.87-1.48],0.3443884399559506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPK,Heterogeneous nuclear ribonucleoprotein K,7432,202,0.86 [0.73-1.03],0.0960821956641069
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,6571,175,0.95 [0.70-1.28],0.733744088070827
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPCAL1,Hippocalcin-like protein 1,7660,209,0.96 [0.82-1.14],0.6653537715835277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPGDS,Hematopoietic prostaglandin D synthase,7437,205,0.96 [0.69-1.34],0.8155743605304688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HPSE,Heparanase,6490,173,1.05 [0.89-1.23],0.5867296072699753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRAS,GTPase Hras,6432,175,1.03 [0.89-1.19],0.687514549895111
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,6393,171,0.64 [0.39-1.07],0.0874339239144822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HRG,Histidine-rich glycoprotein,6564,178,1.16 [0.74-1.82],0.5277702861286309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS1BP3,HCLS1-binding protein 3,6393,171,0.99 [0.83-1.17],0.8639897292113141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,7543,206,1.34 [0.95-1.88],0.0916010833622029
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,7659,207,0.99 [0.70-1.41],0.9707842196742557
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,6368,169,0.99 [0.67-1.47],0.9681202797573656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSBP1,Heat shock factor-binding protein 1,6393,171,0.98 [0.83-1.15],0.8117700063383141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,7573,209,0.84 [0.62-1.15],0.2889790538705519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,6567,172,1.03 [0.81-1.31],0.8141871279528663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSD17B3,Testosterone 17-beta-dehydrogenase 3,6354,169,1.18 [0.91-1.54],0.2134693607930774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSDL2,Hydroxysteroid dehydrogenase-like protein 2,6393,171,0.86 [0.62-1.18],0.3378749116940768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSP90B1,Endoplasmin,7381,203,0.91 [0.73-1.13],0.3877873135059547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA1A,Heat shock 70 kDa protein 1A,7594,207,0.98 [0.82-1.18],0.8276076865788239
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPA2,Heat shock-related 70 kDa protein 2,6554,173,0.69 [0.44-1.09],0.1125339274924837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB1,Heat shock protein beta-1,7467,206,1.01 [0.84-1.20],0.9564440712611418
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPB6,Heat shock protein beta-6,7659,207,0.78 [0.56-1.06],0.1153880624822849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,7535,203,1.31 [0.85-2.02],0.2130425476267526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1A,5-hydroxytryptamine receptor 1A,6400,169,1.02 [0.83-1.25],0.8684479373001373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTR1B,5-hydroxytryptamine receptor 1B,6400,169,1.36 [1.03-1.79],0.0304636780619293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HTRA2,"Serine protease HTRA2, mitochondrial",7608,208,0.97 [0.79-1.19],0.759053539907071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYAL1,Hyaluronidase-1,7560,206,1.47 [0.86-2.53],0.1579697983453456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",HYOU1,Hypoxia up-regulated protein 1,7681,210,2.12 [1.28-3.53],0.0037466435822003
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICA1,Islet cell autoantigen 1,7455,203,0.97 [0.83-1.14],0.7356491384259272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM1,Intercellular adhesion molecule 1,7565,203,1.74 [1.16-2.62],0.0080180324813207
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM2,Intercellular adhesion molecule 2,7681,210,1.52 [1.04-2.22],0.0295132156689975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM3,Intercellular adhesion molecule 3,7681,210,1.28 [0.80-2.04],0.2984722605436803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM4,Intercellular adhesion molecule 4,7573,209,1.07 [0.84-1.36],0.5666627029171132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICAM5,Intercellular adhesion molecule 5,7572,207,0.98 [0.75-1.27],0.8566290557622058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ICOSLG,ICOS ligand,7543,206,1.27 [0.66-2.44],0.4669232434376136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ID4,DNA-binding protein inhibitor ID-4,6448,175,0.90 [0.62-1.31],0.5674522966890503
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDI2,Isopentenyl-diphosphate delta-isomerase 2,7422,204,0.87 [0.67-1.13],0.2944747247460421
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDO1,"Indoleamine 2,3-dioxygenase 1",6393,171,1.01 [0.80-1.29],0.9135916891935738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDS,Iduronate 2-sulfatase,7660,209,1.07 [0.27-4.14],0.926928986656576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IDUA,Alpha-L-iduronidase,7659,207,1.03 [0.79-1.35],0.8289618618206012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFI30,Gamma-interferon-inducible lysosomal thiol reductase,6395,175,1.18 [0.82-1.71],0.3717153081637205
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,6448,175,1.13 [0.87-1.49],0.3598978853244506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,6448,175,1.01 [0.68-1.50],0.9430933634806437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNAR1,Interferon alpha/beta receptor 1,6553,176,1.06 [0.59-1.89],0.8450494306168371
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNG,Interferon gamma,7455,203,1.04 [0.93-1.17],0.4597109502229382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR1,Interferon gamma receptor 1,7605,207,2.00 [1.19-3.36],0.0086680870615913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNGR2,Interferon gamma receptor 2,7503,207,0.95 [0.75-1.21],0.6807524923791572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL1,Interferon lambda-1,7422,204,1.12 [0.86-1.48],0.4000666214720685
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNL2,Interferon lambda-2,6400,169,1.13 [0.90-1.41],0.2967913132625944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNLR1,Interferon lambda receptor 1,7573,209,1.32 [0.95-1.82],0.0982429250734985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFNW1,Interferon omega-1,6354,169,1.08 [0.72-1.60],0.7189849432075601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IFT20,Intraflagellar transport protein 20 homolog,6413,172,1.01 [0.72-1.41],0.9731902156862088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGBP1,Immunoglobulin-binding protein 1,6571,175,0.84 [0.65-1.08],0.1719147543375612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC3,Immunoglobulin superfamily DCC subclass member 3,6400,169,1.23 [0.96-1.59],0.0993764032331105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGDCC4,Immunoglobulin superfamily DCC subclass member 4,6573,174,1.02 [0.60-1.75],0.9303033626208148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF1R,Insulin-like growth factor 1 receptor,7543,206,1.71 [1.04-2.80],0.0343116797249434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,6354,169,0.96 [0.68-1.36],0.8242727499935634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGF2R,Cation-independent mannose-6-phosphate receptor,7592,208,1.04 [0.62-1.75],0.8714649796726628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP1,Insulin-like growth factor-binding protein 1,7673,210,0.93 [0.84-1.02],0.1372936644762886
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP2,Insulin-like growth factor-binding protein 2,7669,209,0.91 [0.74-1.12],0.3879024060699485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP3,Insulin-like growth factor-binding protein 3,7623,207,2.65 [1.76-3.98],2.952737131050063e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP4,Insulin-like growth factor-binding protein 4,7495,203,1.30 [1.02-1.67],0.0352277193944704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP6,Insulin-like growth factor-binding protein 6,7554,203,0.99 [0.67-1.46],0.966729173512366
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBP7,Insulin-like growth factor-binding protein 7,7681,210,1.12 [0.77-1.63],0.538576033105342
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFBPL1,Insulin-like growth factor-binding protein-like 1,7572,207,0.98 [0.68-1.41],0.9280760420605976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGFL4,Insulin growth factor-like family member 4,6368,169,0.93 [0.74-1.17],0.5209269688054506
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGHMBP2,DNA-binding protein SMUBP-2,6354,169,0.98 [0.75-1.28],0.8661343480159791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLC2,Immunoglobulin lambda constant 2,6579,178,1.07 [0.63-1.82],0.8104568397228405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGLON5,IgLON family member 5,6350,168,1.10 [0.95-1.27],0.1926456818438481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF21,Immunoglobulin superfamily member 21,6393,171,0.93 [0.63-1.38],0.7302944204515536
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF3,Immunoglobulin superfamily member 3,7543,206,1.12 [0.78-1.61],0.5398952598469631
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF8,Immunoglobulin superfamily member 8,7572,207,1.04 [0.70-1.55],0.8540973720665486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IGSF9,Protein turtle homolog A,6580,177,0.97 [0.81-1.15],0.7069347257856439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKBKG,NF-kappa-B essential modulator,7573,209,0.89 [0.77-1.02],0.100401210546404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IKZF2,Zinc finger protein Helios,7437,205,0.95 [0.81-1.11],0.4994281485062801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,7455,203,1.13 [0.97-1.31],0.1184393946257457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RA,Interleukin-10 receptor subunit alpha,7455,203,1.08 [0.88-1.33],0.4395527641264255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL10RB,Interleukin-10 receptor subunit beta,7605,207,1.65 [1.14-2.41],0.0087849874742543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL11,Interleukin-11,7455,203,0.85 [0.68-1.07],0.1664683425480698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,7543,206,1.10 [0.94-1.29],0.2210420003778314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,7660,209,1.15 [0.92-1.44],0.2163405028798725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB1,Interleukin-12 receptor subunit beta-1,7455,203,1.46 [1.05-2.03],0.0246354713376322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL12RB2,Interleukin-12 receptor subunit beta-2,6368,169,0.85 [0.57-1.26],0.4111837988077133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13,Interleukin-13,7455,203,0.76 [0.54-1.05],0.1003338213201785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA1,Interleukin-13 receptor subunit alpha-1,7499,206,2.17 [1.29-3.62],0.0032823836306913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL13RA2,Interleukin-13 receptor subunit alpha-2,6400,169,1.45 [0.87-2.44],0.1574771445836645
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15,Interleukin-15,7573,209,1.25 [0.87-1.79],0.2322993714466857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL15RA,Interleukin-15 receptor subunit alpha,7455,203,1.37 [0.96-1.95],0.0800427757622913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL16,Pro-interleukin-16,7660,209,1.12 [0.85-1.49],0.4223867385756505
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17A,Interleukin-17A,7442,202,1.08 [0.81-1.43],0.5938867777166956
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17C,Interleukin-17C,7455,203,1.00 [0.84-1.18],0.9710279888907456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17D,Interleukin-17D,7455,203,0.92 [0.63-1.34],0.655948753999215
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17F,Interleukin-17F,7455,203,1.07 [0.91-1.26],0.3936418074901636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RA,Interleukin-17 receptor A,7592,208,1.40 [1.06-1.86],0.0187607830106779
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL17RB,Interleukin-17 receptor B,7485,207,0.98 [0.78-1.24],0.8820651689391162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18,Interleukin-18,7552,207,1.22 [0.93-1.61],0.1566752196592622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18BP,Interleukin-18-binding protein,7623,207,1.77 [1.23-2.55],0.0021174378973406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18R1,Interleukin-18 receptor 1,7660,209,1.07 [0.73-1.56],0.7194288570319615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL18RAP,Interleukin-18 receptor accessory protein,7457,205,1.05 [0.98-1.13],0.1935796816370079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL19,Interleukin-19,7376,203,0.98 [0.82-1.17],0.8072040349647882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1A,Interleukin-1 alpha,7455,203,1.05 [0.86-1.28],0.6248348179136836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1B,Interleukin-1 beta,7425,203,0.93 [0.73-1.17],0.5099095756354277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R1,Interleukin-1 receptor type 1,7582,208,2.10 [1.27-3.45],0.00353950949658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1R2,Interleukin-1 receptor type 2,7564,207,1.11 [0.60-2.06],0.7422644350302778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RAP,Interleukin-1 receptor accessory protein,7592,208,1.34 [1.04-1.74],0.0260409610957094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL1,Interleukin-1 receptor-like 1,7661,210,0.70 [0.54-0.91],0.0080293115070118
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RL2,Interleukin-1 receptor-like 2,7455,203,1.24 [0.88-1.74],0.2212293589135949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL1RN,Interleukin-1 receptor antagonist protein,7561,207,1.14 [0.91-1.44],0.2424217506711914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2,Interleukin-2,7455,203,1.00 [0.67-1.48],0.9869267901836964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20,Interleukin-20,7455,203,0.89 [0.67-1.18],0.4290750634844787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RA,Interleukin-20 receptor subunit alpha,7455,203,0.80 [0.57-1.12],0.186857305136267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL20RB,Interleukin-20 receptor subunit beta,6368,169,1.15 [0.80-1.64],0.4495367634896058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL21R,Interleukin-21 receptor,6368,169,1.20 [0.97-1.48],0.089446284613403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22,Interleukin-22,6554,173,0.99 [0.80-1.22],0.9045016572977947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL22RA1,Interleukin-22 receptor subunit alpha-1,7455,203,1.10 [0.84-1.43],0.4937700109510334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL24,Interleukin-24,7455,203,1.09 [0.86-1.39],0.4655180286371497
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL25,Interleukin-25,6326,167,1.05 [0.67-1.62],0.8422474714604697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,7530,209,1.39 [1.04-1.86],0.0275246513067802
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RB,Interleukin-2 receptor subunit beta,7455,203,1.16 [0.83-1.61],0.3803466619729051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL2RG,Cytokine receptor common subunit gamma,6554,173,1.04 [0.68-1.58],0.8545408491003896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3,Interleukin-3,6350,168,0.99 [0.78-1.26],0.930077017074232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31,Interleukin-31,6368,169,1.13 [0.88-1.45],0.3451073131980634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL31RA,Interleukin-31 receptor subunit alpha,6340,168,1.36 [0.90-2.06],0.1388448880457495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL32,Interleukin-32,7573,209,0.87 [0.65-1.16],0.3315694316898181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL33,Interleukin-33,7455,203,0.77 [0.56-1.06],0.1108723021735169
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL34,Interleukin-34,7410,204,1.30 [0.91-1.84],0.1509108883501293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36A,Interleukin-36 alpha,6368,169,0.96 [0.73-1.25],0.7517663103088745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL36G,Interleukin-36 gamma,6346,169,1.12 [0.91-1.38],0.2789225519557543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL3RA,Interleukin-3 receptor subunit alpha,7455,203,1.32 [0.89-1.94],0.1649380409142777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4,Interleukin-4,7455,203,0.94 [0.83-1.06],0.3102392220538571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL4R,Interleukin-4 receptor subunit alpha,7573,209,1.27 [0.91-1.76],0.1603683734490404
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5,Interleukin-5,7455,203,0.95 [0.86-1.04],0.2727710625011762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL5RA,Interleukin-5 receptor subunit alpha,7573,209,1.01 [0.82-1.26],0.8940213858824814
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6,Interleukin-6,7543,206,1.10 [0.95-1.28],0.1927384224384957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6R,Interleukin-6 receptor subunit alpha,7558,203,1.52 [1.06-2.19],0.0245651560627279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL6ST,Interleukin-6 receptor subunit beta,7572,207,1.80 [0.90-3.61],0.096793159239471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7,Interleukin-7,7573,209,0.99 [0.82-1.21],0.9519165158227216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL7R,Interleukin-7 receptor subunit alpha,7592,208,1.19 [0.93-1.51],0.1606575126053241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IL9,Interleukin-9,6448,175,1.09 [0.85-1.39],0.4929976042486285
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,7410,203,0.95 [0.76-1.19],0.6835530521586171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMMT,MICOS complex subunit MIC60,6554,173,0.86 [0.61-1.21],0.383656350097181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPA1,Inositol monophosphatase 1,7503,207,0.97 [0.79-1.20],0.7772365167391144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPACT,Protein IMPACT,6567,172,0.74 [0.56-0.97],0.0299226968520484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IMPG1,Interphotoreceptor matrix proteoglycan 1,6400,169,0.77 [0.45-1.32],0.349056762352204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ING1,Inhibitor of growth protein 1,7412,204,1.22 [0.97-1.53],0.0905497725400336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBB,Inhibin beta B chain,6435,173,1.09 [0.83-1.43],0.5375201775141212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INHBC,Inhibin beta C chain,7592,208,1.15 [0.83-1.58],0.4061502475611754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP1,Inositol polyphosphate 1-phosphatase,7543,206,0.98 [0.77-1.24],0.8433913407463083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",6393,171,0.86 [0.65-1.13],0.2646133696915537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",6571,175,0.69 [0.46-1.03],0.0708113353738097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",7543,206,0.95 [0.84-1.08],0.4508481758380898
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL3,Insulin-like 3,6567,172,0.70 [0.60-0.81],3.221058113594795e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL4,Early placenta insulin-like peptide,6554,173,0.62 [0.42-0.91],0.0144033688032075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSL5,Insulin-like peptide INSL5,6553,176,1.03 [0.89-1.19],0.6840292205854035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",INSR,Insulin receptor,6368,169,1.21 [0.50-2.93],0.6649793618142954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IPCEF1,Interactor protein for cytohesin exchange factors 1,7488,206,0.99 [0.86-1.14],0.9030800410445476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IQGAP2,Ras GTPase-activating-like protein IQGAP2,7543,206,0.94 [0.74-1.19],0.5988230790823088
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",7455,202,0.98 [0.85-1.14],0.8103223714727459
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK1,Interleukin-1 receptor-associated kinase 1,7455,203,0.83 [0.68-1.00],0.0511534560518518
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IRAK4,Interleukin-1 receptor-associated kinase 4,7573,209,0.91 [0.81-1.03],0.1370269556713131
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,7318,200,1.30 [0.94-1.80],0.1178869510501953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM1,Isthmin-1,7573,209,1.16 [0.85-1.59],0.3558141137505491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ISM2,Isthmin-2,6573,174,0.91 [0.63-1.30],0.6058673598363022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IST1,IST1 homolog,6500,175,1.00 [0.85-1.16],0.9493367166141292
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA11,Integrin alpha-11,7573,209,0.65 [0.45-0.93],0.0182842338490753
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA2,Integrin alpha-2,6435,173,1.32 [0.87-2.01],0.1923154915484251
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA5,Integrin alpha-5,7592,208,1.12 [0.68-1.86],0.6542352601652147
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGA6,Integrin alpha-6,7573,209,1.13 [0.89-1.43],0.3116587916482598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAL,Integrin alpha-L,6368,169,0.80 [0.58-1.11],0.1915594288863343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAM,Integrin alpha-M,7592,208,1.14 [0.78-1.69],0.4974233862656172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAV,Integrin alpha-V,7659,207,1.13 [0.54-2.37],0.7398557705038519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGAX,Integrin alpha-X,6448,175,0.80 [0.59-1.08],0.1375693111758525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1,Integrin beta-1,7591,207,1.61 [0.91-2.85],0.1031366864479538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP1,Integrin beta-1-binding protein 1,7437,205,1.28 [0.93-1.75],0.1285279653541286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB1BP2,Integrin beta-1-binding protein 2,7455,202,0.94 [0.84-1.05],0.2952025422505225
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB2,Integrin beta-2,7553,207,1.04 [0.67-1.62],0.8538660200544186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB5,Integrin beta-5,7608,208,1.04 [0.74-1.44],0.8350672218617248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB6,Integrin beta-6,7455,203,0.81 [0.54-1.20],0.2952934104495902
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGB7,Integrin beta-7,7659,207,1.30 [1.01-1.68],0.0432314570368809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITGBL1,Integrin beta-like protein 1,6573,174,0.97 [0.67-1.42],0.8918478996763053
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,6589,178,1.92 [0.86-4.27],0.1104924916825188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,7623,207,1.48 [1.06-2.06],0.0216339865456129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,6589,178,2.36 [1.38-4.03],0.001717799667473
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,6554,173,1.22 [0.91-1.64],0.1864489565410537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITM2A,Integral membrane protein 2A,7573,209,1.04 [0.85-1.27],0.6963388920648501
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPA,Inosine triphosphate pyrophosphatase,6354,169,0.82 [0.65-1.03],0.0868926771231284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",6393,171,1.13 [0.92-1.39],0.2474354500373278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",6400,169,0.75 [0.51-1.12],0.1579171322346039
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",7422,204,1.04 [0.82-1.33],0.7425374455210945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",IZUMO1,Izumo sperm-egg fusion protein 1,6350,168,1.14 [0.84-1.54],0.4097904165649784
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM2,Junctional adhesion molecule B,7641,209,1.55 [1.02-2.36],0.0410038423190071
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JAM3,Junctional adhesion molecule C,6435,173,1.18 [0.89-1.56],0.2411319267065749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JCHAIN,Immunoglobulin J chain,7455,203,0.93 [0.76-1.14],0.5005615819670932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,6350,168,0.95 [0.72-1.24],0.6888604119621939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JPT2,Jupiter microtubule associated homolog 2,6553,176,0.93 [0.79-1.11],0.4215759154590546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",JUN,Transcription factor AP-1,7455,203,0.93 [0.70-1.23],0.5974537851814836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,7543,206,1.13 [0.85-1.49],0.3939826307007085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KAZN,Kazrin,6553,176,0.92 [0.80-1.06],0.2464152099265015
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNC4,Potassium voltage-gated channel subfamily C member 4,6400,169,1.15 [0.90-1.47],0.2732548399947475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNH2,Potassium voltage-gated channel subfamily H member 2,6413,172,1.12 [0.94-1.33],0.1955876897675164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCNIP4,Kv channel-interacting protein 4,7422,204,1.12 [0.89-1.40],0.3485459342964666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KCTD5,BTB/POZ domain-containing protein KCTD5,6445,169,0.90 [0.63-1.28],0.5562180941645551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDM3A,Lysine-specific demethylase 3A,6368,169,0.85 [0.69-1.05],0.1405727178776106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KDR,Vascular endothelial growth factor receptor 2,7608,208,3.02 [1.81-5.02],2.0796049977585423e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KEL,Kell blood group glycoprotein,7422,204,1.12 [0.79-1.59],0.5112833033598394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHDC3L,KH domain-containing protein 3,6350,168,0.83 [0.64-1.08],0.1711281535046762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KHK,Ketohexokinase,6393,171,1.01 [0.79-1.29],0.957346401777217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA0319,Dyslexia-associated protein KIAA0319,6567,172,1.03 [0.65-1.63],0.8911335925927648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549,UPF0606 protein KIAA1549,6448,175,0.90 [0.73-1.11],0.3370120951081411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA1549L,UPF0606 protein KIAA1549L,6448,175,0.91 [0.53-1.56],0.7258185431995174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIAA2013,Uncharacterized protein KIAA2013,6554,173,1.11 [0.86-1.43],0.4093364204744965
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF1C,Kinesin-like protein KIF1C,6354,169,0.90 [0.56-1.46],0.6766456914961614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF20B,Kinesin-like protein KIF20B,6400,169,0.96 [0.78-1.18],0.6792104769257307
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIF22,Kinesin-like protein KIF22,6354,169,1.01 [0.89-1.14],0.910850723106658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIFBP,KIF-binding protein,7543,206,0.98 [0.85-1.14],0.8274833513780308
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,6554,173,1.09 [0.93-1.28],0.2914144555610922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,7437,205,1.03 [0.88-1.21],0.690167263916378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,6553,176,1.03 [0.95-1.12],0.472998235425386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,7437,205,0.95 [0.86-1.05],0.3120005658089408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,6350,168,0.96 [0.79-1.16],0.6629331877087947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL1,Kin of IRRE-like protein 1,6400,169,0.96 [0.72-1.27],0.7763079926625915
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIRREL2,Kin of IRRE-like protein 2,7422,204,1.33 [1.00-1.78],0.052801427157765
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KIT,Mast/stem cell growth factor receptor Kit,7611,206,1.53 [1.01-2.32],0.0459417503717796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KITLG,Kit ligand,7572,207,1.13 [0.80-1.58],0.4949687314247041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLB,Beta-klotho,7422,204,1.03 [0.87-1.21],0.7652424979407656
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLF4,Krueppel-like factor 4,6400,169,1.10 [0.78-1.54],0.5991623179131216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLHL41,Kelch-like protein 41,6571,175,0.64 [0.45-0.91],0.0133676188922526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK1,Kallikrein-1,7519,207,0.97 [0.89-1.07],0.5990574008226799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK10,Kallikrein-10,7590,208,1.14 [0.85-1.53],0.3709432636749052
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK11,Kallikrein-11,7534,207,1.30 [0.94-1.81],0.1149971402202937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK12,Kallikrein-12,7437,205,1.03 [0.94-1.13],0.5089734863667106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK13,Kallikrein-13,7419,202,1.23 [0.94-1.62],0.135292711755482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK14,Kallikrein-14,7659,207,1.23 [0.95-1.59],0.1140947347123014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK15,Kallikrein-15,6540,173,1.39 [1.06-1.82],0.0176573170799067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK3,Prostate-specific antigen,6573,174,0.42 [0.36-0.48],6.62496838725625e-35
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK4,Kallikrein-4,7659,207,1.44 [1.24-1.69],3.975482077919954e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK6,Kallikrein-6,7594,207,0.86 [0.58-1.28],0.4546058077695599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK7,Kallikrein-7,6264,167,0.80 [0.53-1.19],0.2716455749475579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLK8,Kallikrein-8,7342,202,0.99 [0.70-1.40],0.9566623428471492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLKB1,Plasma kallikrein,6447,175,2.82 [1.52-5.23],0.0010340696707408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRB1,Killer cell lectin-like receptor subfamily B member 1,7660,209,1.44 [1.06-1.95],0.0188612538888063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRC1,NKG2-A/NKG2-B type II integral membrane protein,6400,169,1.27 [1.05-1.53],0.0128016561377199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRD1,Natural killer cells antigen CD94,7660,209,1.18 [0.91-1.53],0.2040875619237165
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRF1,Killer cell lectin-like receptor subfamily F member 1,6368,169,1.15 [0.87-1.54],0.3265371770943894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KLRK1,NKG2-D type II integral membrane protein,6567,172,1.46 [1.11-1.91],0.006747030090977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT14,"Keratin, type I cytoskeletal 14",7190,197,0.84 [0.53-1.35],0.4810388480689194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT17,"Keratin, type I cytoskeletal 17",6354,169,1.20 [0.85-1.69],0.3097847472162232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT18,"Keratin, type I cytoskeletal 18",7543,206,0.95 [0.81-1.11],0.4944948908687144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT19,"Keratin, type I cytoskeletal 19",7555,209,0.97 [0.81-1.16],0.7289842451599275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT5,"Keratin, type II cytoskeletal 5",7422,204,1.00 [0.79-1.28],0.9746648131223284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT6C,"Keratin, type II cytoskeletal 6C",6354,169,0.91 [0.58-1.42],0.6755203153560556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KRT8,"Keratin, type II cytoskeletal 8",6400,169,1.03 [0.87-1.22],0.7050676038998831
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYAT1,Kynurenine--oxoglutarate transaminase 1,7561,207,0.77 [0.61-0.98],0.0303851909796558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",KYNU,Kynureninase,7660,209,0.96 [0.72-1.27],0.7646517491780878
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L1CAM,Neural cell adhesion molecule L1,7608,208,1.08 [0.71-1.64],0.7141570539729982
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,6580,177,1.03 [0.87-1.21],0.7393157980652438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACRT,Extracellular glycoprotein lacritin,6541,173,1.09 [0.81-1.47],0.5543763003059297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LACTB2,Endoribonuclease LACTB2,7572,207,0.94 [0.77-1.14],0.532087404103489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,7543,206,1.22 [0.90-1.65],0.203330012839757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,7573,207,1.35 [1.01-1.81],0.0423394751303778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,7503,207,0.94 [0.84-1.05],0.2880550525632033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA1,Laminin subunit alpha-1,6354,169,1.00 [0.74-1.35],0.9896958691925796
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMA4,Laminin subunit alpha-4,7605,207,1.53 [1.08-2.18],0.0168665923035966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMB1,Laminin subunit beta-1,6393,171,1.63 [1.00-2.67],0.0501549430776894
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP1,Lysosome-associated membrane glycoprotein 1,6404,170,1.35 [0.81-2.25],0.2533599221878987
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP2,Lysosome-associated membrane glycoprotein 2,7346,201,2.38 [1.27-4.45],0.0066789775138097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMP3,Lysosome-associated membrane glycoprotein 3,7648,209,0.99 [0.79-1.25],0.9544481917002322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAMTOR5,Ragulator complex protein LAMTOR5,6554,173,0.93 [0.63-1.36],0.7003667226360346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAP3,Cytosol aminopeptidase,7455,203,1.06 [0.82-1.36],0.660079462135222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LARP1,La-related protein 1,6554,173,0.86 [0.67-1.11],0.2498595128443104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT,Linker for activation of T-cells family member 1,7660,209,0.97 [0.82-1.13],0.67442707054484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAT2,Linker for activation of T-cells family member 2,7543,206,0.96 [0.87-1.06],0.4507576914755424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LATS1,Serine/threonine-protein kinase LATS1,6368,169,0.96 [0.80-1.14],0.6281502607495133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LAYN,Layilin,7493,207,1.11 [0.80-1.56],0.5233706223638517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBP,Lipopolysaccharide-binding protein,7623,207,1.39 [1.13-1.72],0.0019611284864025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LBR,Delta(14)-sterol reductase LBR,7641,209,1.06 [0.89-1.26],0.4968308726596766
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCAT,Phosphatidylcholine-sterol acyltransferase,6592,177,1.79 [0.92-3.49],0.0883151702791548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN15,Lipocalin-15,6571,175,0.99 [0.77-1.27],0.9340009410136556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCN2,Neutrophil gelatinase-associated lipocalin,7368,203,1.28 [0.95-1.72],0.1082737994457595
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LCP1,Plastin-2,6573,174,1.21 [0.90-1.62],0.2022333807155455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLR,Low-density lipoprotein receptor,7611,210,1.41 [1.11-1.80],0.0047803867305649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LDLRAP1,Low density lipoprotein receptor adapter protein 1,6571,175,0.98 [0.85-1.14],0.8042265598522327
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LECT2,Leukocyte cell-derived chemotaxin-2,6580,177,1.36 [1.09-1.68],0.0054445837397457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEFTY2,Left-right determination factor 2,7647,207,1.07 [0.84-1.36],0.574695140392254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEG1,Protein LEG1 homolog,6239,172,0.99 [0.80-1.23],0.9310133370945272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LELP1,Late cornified envelope-like proline-rich protein 1,6400,169,1.01 [0.82-1.25],0.9212660122669564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEO1,RNA polymerase-associated protein LEO1,6571,175,1.24 [0.87-1.75],0.2319651635879547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEP,Leptin,7572,207,1.45 [1.21-1.75],5.523711562410815e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LEPR,Leptin receptor,7572,207,0.97 [0.66-1.44],0.8882995267602024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LETM1,Mitochondrial proton/calcium exchanger protein,6571,175,1.12 [0.86-1.45],0.4094746854470422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS1,Galectin-1,7572,207,1.20 [0.85-1.70],0.2949114434201606
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3,Galectin-3,7615,208,1.29 [0.85-1.95],0.2351612045571384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS3BP,Galectin-3-binding protein,6589,178,1.83 [1.23-2.73],0.0029721761680456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS4,Galectin-4,7573,207,1.14 [0.92-1.41],0.2280665331552899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS7_LGALS7B,Galectin-7,7572,204,0.82 [0.61-1.10],0.1831398136936528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS8,Galectin-8,7641,209,1.14 [0.93-1.39],0.2089176173690882
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGALS9,Galectin-9,7578,207,1.54 [1.05-2.25],0.0281366955006231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LGMN,Legumain,7605,207,1.06 [0.75-1.50],0.7441768598561154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHB,Lutropin subunit beta,7437,205,1.04 [0.91-1.19],0.5580383266028
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,7581,207,0.78 [0.64-0.96],0.0163739599406284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIF,Leukemia inhibitory factor,7422,204,1.07 [0.84-1.35],0.5999886018889269
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIFR,Leukemia inhibitory factor receptor,7573,209,1.56 [0.94-2.59],0.0850236170996357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,7592,208,1.50 [1.05-2.14],0.0249877719301904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,6573,174,0.97 [0.88-1.07],0.5788298477270354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,6354,169,0.98 [0.72-1.33],0.8809603648256238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,7561,206,1.71 [1.17-2.50],0.0056621759257534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,6580,177,0.87 [0.72-1.06],0.1640624910829499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,7681,210,1.75 [1.12-2.74],0.0147492099128531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,7649,209,1.59 [1.10-2.31],0.0140469749847568
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,7455,203,1.24 [0.94-1.63],0.1254874042161813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,7681,210,0.97 [0.81-1.15],0.7065333316227216
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LIPF,Gastric triacylglycerol lipase,6393,171,1.27 [1.01-1.60],0.0385986364626708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB1,Lamin-B1,6546,176,0.97 [0.76-1.23],0.7920343584837646
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMNB2,Lamin-B2,6567,172,1.95 [1.29-2.95],0.0016135232111958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD1,Leiomodin-1,6571,175,0.83 [0.53-1.30],0.4168003803483032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LMOD2,Leiomodin-2,6400,169,1.08 [0.84-1.37],0.5563243840519563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LONP1,"Lon protease homolog, mitochondrial",6393,171,0.96 [0.80-1.14],0.6315835233180481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPA,Apolipoprotein(a),6443,173,1.05 [0.97-1.14],0.2417025330256214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPCAT2,Lysophosphatidylcholine acyltransferase 2,7543,206,1.19 [0.94-1.51],0.1394816224093152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPL,Lipoprotein lipase,7572,207,1.08 [0.83-1.41],0.5589968565042476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPO,Lactoperoxidase,7298,202,1.06 [0.86-1.31],0.5857494198822266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LPP,Lipoma-preferred partner,6354,169,0.91 [0.72-1.15],0.4153580719970621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,6354,169,0.92 [0.73-1.16],0.5024168887090178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,6413,172,1.21 [0.89-1.64],0.2201896636632112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRG1,Leucine-rich alpha-2-glycoprotein,6589,178,1.23 [0.72-2.11],0.4402879557960103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,7636,207,1.30 [0.93-1.83],0.1264626622063534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,6348,169,0.88 [0.50-1.56],0.6575639024986808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP1,Prolow-density lipoprotein receptor-related protein 1,7543,206,1.22 [0.77-1.93],0.3931872701557507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP11,Low-density lipoprotein receptor-related protein 11,7572,207,1.35 [0.98-1.86],0.0701520322227718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2,Low-density lipoprotein receptor-related protein 2,6413,172,1.07 [0.72-1.61],0.727323756977019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRP2BP,LRP2-binding protein,6413,172,1.12 [0.96-1.32],0.1504382478661234
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRPAP1,Alpha-2-macroglobulin receptor-associated protein,7641,209,1.05 [0.85-1.30],0.6580018479243535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC25,Leucine-rich repeat-containing protein 25,7543,206,1.41 [1.08-1.86],0.0127214166855851
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC37A2,Leucine-rich repeat-containing protein 37A2,6553,176,1.65 [1.18-2.30],0.0033166674633428
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC38,Leucine-rich repeat-containing protein 38,6413,172,0.99 [0.73-1.34],0.928732881226613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRC59,Leucine-rich repeat-containing protein 59,6580,177,1.26 [0.95-1.68],0.1096360454603405
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,6554,173,0.80 [0.58-1.10],0.1718608667667008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRRN1,Leucine-rich repeat neuronal protein 1,7455,203,1.24 [0.91-1.70],0.1733847983677648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,6413,172,1.00 [0.70-1.44],0.980130037213006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,6571,175,1.40 [0.83-2.39],0.2097862856012723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM1,U6 snRNA-associated Sm-like protein LSm1,7437,205,1.03 [0.82-1.29],0.7932834525975974
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSM8,U6 snRNA-associated Sm-like protein LSm8,6448,175,0.98 [0.81-1.19],0.8667171250884914
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LSP1,Lymphocyte-specific protein 1,7573,209,1.13 [0.83-1.54],0.4408069018376812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,7573,209,1.10 [0.81-1.51],0.5405920025584791
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTA4H,Leukotriene A-4 hydrolase,7659,207,1.11 [0.90-1.36],0.342603246103735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTB,Lymphotoxin-beta,6554,173,1.05 [0.71-1.55],0.816644127248855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP2,Latent-transforming growth factor beta-binding protein 2,7681,210,1.22 [0.84-1.75],0.2951485493684904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBP3,Latent-transforming growth factor beta-binding protein 3,7437,205,1.19 [0.95-1.47],0.1229415581438989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTBR,Tumor necrosis factor receptor superfamily member 3,7542,207,1.41 [0.96-2.09],0.0828999647290284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LTO1,Protein LTO1 homolog,7455,203,0.98 [0.71-1.34],0.8904168719018573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LUZP2,Leucine zipper protein 2,6554,173,1.17 [0.86-1.59],0.3234431007975038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LXN,Latexin,7472,207,0.78 [0.65-0.95],0.0136733603187532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY6D,Lymphocyte antigen 6D,7542,207,1.04 [0.76-1.42],0.8214506284751721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY75,Lymphocyte antigen 75,7573,209,1.08 [0.79-1.48],0.6410574858957789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,7466,208,1.12 [0.73-1.72],0.5909141820772654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LY96,Lymphocyte antigen 96,7503,207,0.87 [0.61-1.24],0.4388613011863493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYAR,Cell growth-regulating nucleolar protein,7437,205,0.84 [0.64-1.10],0.2000125988539979
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYN,Tyrosine-protein kinase Lyn,7543,206,1.01 [0.87-1.16],0.9361177233091325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD1,Ly6/PLAUR domain-containing protein 1,7422,204,1.04 [0.86-1.26],0.6888081946121978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD3,Ly6/PLAUR domain-containing protein 3,7549,207,1.03 [0.71-1.48],0.8797812147320339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPD8,Ly6/PLAUR domain-containing protein 8,7437,205,1.07 [0.85-1.35],0.5711047835194241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYPLA2,Acyl-protein thioesterase 2,6400,169,1.00 [0.87-1.14],0.9574105273094612
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,6413,172,1.00 [0.87-1.15],0.9739922634290136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,6589,178,2.86 [1.43-5.70],0.0029375903031731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LYZL2,Lysozyme-like protein 2,6350,168,0.68 [0.44-1.06],0.0875006253621931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",LZTFL1,Leucine zipper transcription factor-like protein 1,6435,173,0.96 [0.77-1.18],0.6822184939503397
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",M6PR,Cation-dependent mannose-6-phosphate receptor,6393,171,1.02 [0.69-1.52],0.9088652485622192
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,7477,206,1.15 [0.92-1.43],0.2342616440490684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAEA,E3 ubiquitin-protein transferase MAEA,7437,205,0.78 [0.55-1.11],0.1624873557917006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAG,Myelin-associated glycoprotein,6413,172,1.08 [0.80-1.46],0.5987805024803563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGEA3,Melanoma-associated antigen 3,6448,175,0.89 [0.76-1.04],0.1349512885398809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAGED1,Melanoma-associated antigen D1,7437,205,1.14 [0.88-1.48],0.317643549395322
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC2,MAM domain-containing protein 2,6580,177,1.23 [0.85-1.79],0.2745106614698934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAMDC4,Apical endosomal glycoprotein,6554,173,1.01 [0.77-1.31],0.956611735348716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",6393,171,1.24 [0.68-2.25],0.4863928316623319
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAN2B2,Epididymis-specific alpha-mannosidase,6580,177,0.95 [0.75-1.21],0.6874273583659911
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",6350,168,1.02 [0.76-1.37],0.8847482450678905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANF,Mesencephalic astrocyte-derived neurotrophic factor,7605,207,0.98 [0.89-1.09],0.7315804814238172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC1,MANSC domain-containing protein 1,7608,208,1.30 [0.84-2.01],0.2423373032514368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MANSC4,MANSC domain-containing protein 4,6354,169,1.12 [0.91-1.37],0.2814997864297325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,6400,169,1.11 [0.69-1.79],0.6566168859145514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,6354,169,0.98 [0.77-1.24],0.8464519992932757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2,Microtubule-associated protein 2,6567,172,1.08 [0.79-1.48],0.610265623131905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,6553,176,0.87 [0.69-1.10],0.2484246535045272
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,7573,209,0.93 [0.82-1.05],0.2559362943687577
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP3K5,Mitogen-activated protein kinase kinase kinase 5,7437,205,0.93 [0.82-1.07],0.3261212840737699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,7493,207,0.94 [0.84-1.06],0.3048792941130502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK13,Mitogen-activated protein kinase 13,6350,168,1.09 [0.77-1.55],0.6168257757757489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPK9,Mitogen-activated protein kinase 9,7573,209,0.95 [0.71-1.27],0.7124841496471024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPKAPK2,MAP kinase-activated protein kinase 2,6448,175,0.86 [0.70-1.06],0.1604198402151258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPRE3,Microtubule-associated protein RP/EB family member 3,6350,168,0.99 [0.89-1.10],0.8314810190628241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAPT,Microtubule-associated protein tau,7422,204,0.97 [0.76-1.23],0.7862244467639761
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARCO,Macrophage receptor MARCO,7572,207,1.43 [0.88-2.33],0.1470496169513075
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MARS1,"Methionine--tRNA ligase, cytoplasmic",6425,173,0.94 [0.79-1.13],0.5341715272976552
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MASP1,Mannan-binding lectin serine protease 1,7493,207,1.25 [0.73-2.14],0.4179275390560675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN2,Matrilin-2,7584,207,1.19 [0.78-1.82],0.4170555649286483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MATN3,Matrilin-3,7488,206,0.90 [0.62-1.31],0.5877054625184919
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAVS,Mitochondrial antiviral-signaling protein,7437,205,0.92 [0.79-1.06],0.2443782603699545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MAX,Protein max,7422,204,1.00 [0.89-1.13],0.9753303631366332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MB,Myoglobin,7681,210,0.74 [0.59-0.94],0.0130775503019859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MBL2,Mannose-binding protein C,6497,174,1.15 [1.00-1.32],0.0452569699696277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCAM,Cell surface glycoprotein MUC18,7623,207,1.06 [0.73-1.54],0.768873944767847
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",6571,175,0.84 [0.58-1.24],0.3841248087865669
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCEMP1,Mast cell-expressed membrane protein 1,6368,169,0.87 [0.73-1.05],0.1426931952742741
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCFD2,Multiple coagulation factor deficiency protein 2,7534,206,1.03 [0.78-1.37],0.8373997264394026
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MCTS1,Malignant T-cell-amplified sequence 1,6553,176,0.74 [0.41-1.34],0.3173968733585119
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,7503,207,1.07 [0.89-1.28],0.4789471954482841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDH1,"Malate dehydrogenase, cytoplasmic",6559,177,0.72 [0.49-1.06],0.0985133601422378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDK,Midkine,7584,208,1.20 [0.96-1.50],0.1117591016503942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MDM1,Nuclear protein MDM1,6413,172,0.92 [0.56-1.50],0.7276795846004185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",6393,171,1.02 [0.87-1.21],0.7788621338828865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED18,Mediator of RNA polymerase II transcription subunit 18,7437,205,0.94 [0.80-1.11],0.4889346516388655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MED21,Mediator of RNA polymerase II transcription subunit 21,6354,169,1.07 [0.81-1.42],0.6391370195841726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF10,Multiple epidermal growth factor-like domains protein 10,7573,207,1.04 [0.76-1.42],0.8104644945273246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF11,Multiple epidermal growth factor-like domains protein 11,6354,169,1.29 [0.87-1.91],0.1999384645109316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEGF9,Multiple epidermal growth factor-like domains protein 9,7661,210,1.80 [0.94-3.42],0.0746159496161809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MELTF,Melanotransferrin,6580,177,1.18 [0.74-1.89],0.4858802144986868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MENT,Protein MENT,6435,173,0.89 [0.48-1.65],0.7148605972395605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1A,Meprin A subunit alpha,6553,176,1.04 [0.86-1.27],0.675118590995966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEP1B,Meprin A subunit beta,7572,207,1.04 [0.93-1.17],0.4503412624967067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MEPE,Matrix extracellular phosphoglycoprotein,7573,207,1.27 [0.75-2.14],0.3794068804944682
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MERTK,Tyrosine-protein kinase Mer,7660,209,1.33 [0.82-2.17],0.2522675859114056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MESD,LRP chaperone MESD,7592,208,0.99 [0.89-1.10],0.8498636250012774
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MET,Hepatocyte growth factor receptor,7609,207,1.82 [0.97-3.42],0.0626988927618931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1,Methionine aminopeptidase 1,7422,204,1.23 [0.80-1.89],0.3419313110959737
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP1D,"Methionine aminopeptidase 1D, mitochondrial",7573,209,0.98 [0.84-1.14],0.7508501827291263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",METAP2,Methionine aminopeptidase 2,7647,207,0.80 [0.64-0.99],0.0443353591991618
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3,Microfibril-associated glycoprotein 3,7455,202,1.01 [0.77-1.31],0.9579160390159484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP3L,Microfibrillar-associated protein 3-like,6413,172,1.05 [0.85-1.31],0.6397950504717401
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP4,Microfibril-associated glycoprotein 4,6435,173,0.74 [0.47-1.17],0.1956395465863724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFAP5,Microfibrillar-associated protein 5,7681,210,1.02 [0.76-1.38],0.8817021036485939
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MFGE8,Lactadherin,7592,208,1.05 [0.79-1.40],0.7263844284031316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGLL,Monoglyceride lipase,7598,207,0.97 [0.84-1.12],0.6758656891447444
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MGMT,Methylated-DNA--protein-cysteine methyltransferase,7573,209,0.97 [0.88-1.08],0.5910113509649312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIA,Melanoma-derived growth regulatory protein,7608,208,1.07 [0.77-1.49],0.6847994886421438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICALL2,MICAL-like protein 2,6413,172,0.97 [0.78-1.22],0.8070634948955543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,7573,209,1.01 [0.93-1.10],0.7807065668202927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MIF,Macrophage migration inhibitory factor,7579,208,0.90 [0.75-1.09],0.2687657725557181
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MILR1,Allergin-1,7455,203,0.98 [0.77-1.26],0.8931492984753852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,6554,173,0.94 [0.82-1.08],0.3566862054831212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MINK1,Misshapen-like kinase 1,6567,172,1.01 [0.86-1.18],0.9294288586301078
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MITD1,MIT domain-containing protein 1,7503,207,0.96 [0.85-1.09],0.5515173828967888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MKI67,Proliferation marker protein Ki-67,6368,169,0.81 [0.52-1.25],0.3351162518507868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLLT1,Protein ENL,6350,168,1.00 [0.80-1.26],0.999884598522258
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MLN,Promotilin,7573,209,0.97 [0.85-1.12],0.7238521248122709
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MME,Neprilysin,7543,206,0.82 [0.69-0.97],0.0228906206779155
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP1,Interstitial collagenase,7318,202,0.97 [0.84-1.11],0.6316234044447194
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP10,Stromelysin-2,7561,206,1.16 [0.95-1.42],0.1544743915895408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP12,Macrophage metalloelastase,7602,206,1.29 [1.04-1.59],0.0180358750150005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP13,Collagenase 3,7422,204,1.60 [1.10-2.34],0.0147215764634583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP15,Matrix metalloproteinase-15,6580,177,1.17 [0.90-1.53],0.2453355429396174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP3,Stromelysin-1,7592,208,0.64 [0.49-0.82],0.0005172431653158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP7,Matrilysin,7444,202,1.16 [0.90-1.51],0.247397137918975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP8,Neutrophil collagenase,7629,209,1.09 [0.92-1.29],0.3309856661310275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMP9,Matrix metalloproteinase-9,7584,208,1.08 [0.88-1.32],0.486231724093663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MMUT,"Methylmalonyl-CoA mutase, mitochondrial",6354,169,0.98 [0.72-1.34],0.9212479437258954
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MN1,Transcriptional activator MN1,6413,172,1.02 [0.79-1.31],0.8735739077474018
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNAT1,CDK-activating kinase assembly factor MAT1,6448,175,0.89 [0.62-1.27],0.5193192076240161
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MNDA,Myeloid cell nuclear differentiation antigen,7559,206,1.04 [0.92-1.17],0.5308861918318315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOCS2,Molybdopterin synthase catalytic subunit,6435,173,0.91 [0.72-1.15],0.4093272447349554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MOG,Myelin-oligodendrocyte glycoprotein,7659,207,1.22 [0.86-1.75],0.2643838584936091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORC3,MORC family CW-type zinc finger protein 3,6567,172,1.32 [0.82-2.14],0.2542611357550005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L1,Mortality factor 4-like protein 1,6448,175,1.02 [0.70-1.50],0.9170079996592336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORF4L2,Mortality factor 4-like protein 2,6350,168,0.88 [0.58-1.32],0.5322970392772224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MORN4,MORN repeat-containing protein 4,6350,168,1.07 [0.89-1.28],0.4913665406126152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPHOSPH8,M-phase phosphoprotein 8,7455,202,0.98 [0.83-1.17],0.8367196385547697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPI,Mannose-6-phosphate isomerase,7543,206,0.96 [0.83-1.12],0.5988454570940294
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,7598,207,0.99 [0.84-1.16],0.8571071043490961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPO,Myeloperoxidase,7592,208,1.21 [0.94-1.56],0.1350396708733137
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MPRIP,Myosin phosphatase Rho-interacting protein,6539,172,1.12 [0.81-1.56],0.480173197655248
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRC1,Macrophage mannose receptor 1,6592,177,1.40 [0.85-2.29],0.1829812249865385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRI1,Methylthioribose-1-phosphate isomerase,6413,172,1.03 [0.82-1.28],0.82068356878182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL24,"39S ribosomal protein L24, mitochondrial",6354,169,1.26 [0.90-1.77],0.1848724995914952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL28,"39S ribosomal protein L28, mitochondrial",6571,175,0.94 [0.62-1.42],0.7675970884614106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL46,"39S ribosomal protein L46, mitochondrial",7422,204,1.58 [1.11-2.24],0.0112140319593463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL52,"39S ribosomal protein L52, mitochondrial",6334,168,1.17 [0.74-1.85],0.5054213118996596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",6571,175,0.99 [0.80-1.22],0.9100388895607868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MRPS16,"28S ribosomal protein S16, mitochondrial",6368,169,0.86 [0.49-1.52],0.6067462096208744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLN,Mesothelin,7527,203,1.06 [0.87-1.30],0.5389880172549715
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSLNL,Mesothelin-like protein,6413,172,1.09 [0.76-1.56],0.6496452233959666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSMB,Beta-microseminoprotein,7586,204,0.51 [0.43-0.60],8.128108310476567e-16
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSR1,Macrophage scavenger receptor types I and II,7641,209,1.35 [1.04-1.76],0.0241923245431622
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSRA,Mitochondrial peptide methionine sulfoxide reductase,7608,208,0.99 [0.83-1.18],0.9286291354400422
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MST1,Hepatocyte growth factor-like protein,6488,174,0.97 [0.79-1.19],0.7784595492253579
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MSTN,Growth/differentiation factor 8,7455,202,0.84 [0.66-1.06],0.1377673304304361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTDH,Protein LYRIC,6368,169,1.01 [0.86-1.18],0.9391132100509132
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",6567,172,0.66 [0.35-1.27],0.2133219536784747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,6448,175,1.00 [0.88-1.14],0.9715804208899238
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTIF3,"Translation initiation factor IF-3, mitochondrial",6553,176,1.01 [0.86-1.20],0.8830378848049236
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTPN,Myotrophin,7455,202,0.86 [0.57-1.30],0.485694912393344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTR,Methionine synthase,6354,169,1.00 [0.80-1.25],0.9682861340598417
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS1,Protein MTSS 1,6553,176,0.93 [0.81-1.06],0.2534686993597561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTSS2,Protein MTSS 2,6554,173,0.91 [0.79-1.06],0.2354555646676872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MTUS1,Microtubule-associated tumor suppressor 1,6448,175,1.00 [0.76-1.30],0.9727568551514112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC13,Mucin-13,7422,204,0.94 [0.74-1.19],0.5980298798000243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC16,Mucin-16,7543,206,1.06 [0.99-1.14],0.0997201236560563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUC2,Mucin-2,6573,174,0.91 [0.78-1.07],0.2723318941140942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MUCL3,Mucin-like protein 3,6350,168,0.80 [0.53-1.22],0.3078191590765913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MVK,Mevalonate kinase,7455,203,0.90 [0.76-1.05],0.1861385165218122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MXRA8,Matrix remodeling-associated protein 8,6435,173,0.71 [0.44-1.15],0.1608744091754035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC1,"Myosin-binding protein C, slow-type",6580,177,0.82 [0.67-1.01],0.0582179432758855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYBPC2,"Myosin-binding protein C, fast-type",6393,171,0.85 [0.70-1.04],0.1073487938988514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYCBP2,E3 ubiquitin-protein ligase MYCBP2,6571,175,1.00 [0.79-1.25],0.9664983707071024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYDGF,Myeloid-derived growth factor,6580,177,1.04 [0.90-1.21],0.5921000265085657
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH4,Myosin-4,6354,169,0.74 [0.50-1.10],0.1378386768137554
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH7B,Myosin-7B,6350,168,1.18 [0.86-1.62],0.2982672421309116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYH9,Myosin-9,6573,174,0.97 [0.86-1.10],0.6650551943345795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL1,"Myosin light chain 1/3, skeletal muscle isoform",6354,169,0.97 [0.65-1.44],0.8684232919609423
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL3,Myosin light chain 3,6393,171,0.85 [0.69-1.04],0.1079644190438468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL4,Myosin light chain 4,6393,171,0.74 [0.54-1.01],0.0547737040612332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYL6B,Myosin light chain 6B,6413,172,1.10 [0.95-1.27],0.2021726784273773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",6413,172,0.84 [0.62-1.14],0.2581789468579561
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO6,Unconventional myosin-VI,6571,175,1.02 [0.69-1.50],0.923565064345374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYO9B,Unconventional myosin-IXb,7455,203,0.90 [0.74-1.11],0.3284879390883212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOC,Myocilin,7592,208,0.84 [0.64-1.11],0.2217856766907993
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM1,Myomesin-1,6400,169,1.04 [0.76-1.43],0.7932999453545014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM2,Myomesin-2,6354,169,0.84 [0.62-1.12],0.2335884110560186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MYOM3,Myomesin-3,6435,173,0.91 [0.77-1.06],0.231107404017532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZB1,Marginal zone B- and B1-cell-specific protein,7591,207,1.14 [0.90-1.45],0.2755332547256599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",MZT1,Mitotic-spindle organizing protein 1,7437,205,0.99 [0.77-1.27],0.9504866425337144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA10,N-alpha-acetyltransferase 10,6354,169,0.89 [0.66-1.20],0.4513266262338484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAA80,N-alpha-acetyltransferase 80,6413,172,1.01 [0.89-1.14],0.9103033050569996
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAAA,N-acylethanolamine-hydrolyzing acid amidase,7470,206,1.08 [0.88-1.32],0.4560800810826386
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NACC1,Nucleus accumbens-associated protein 1,6554,173,0.78 [0.59-1.04],0.0890738368913121
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NADK,NAD kinase,7572,207,1.10 [0.89-1.37],0.3785461550179384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGA,Alpha-N-acetylgalactosaminidase,6354,168,0.87 [0.65-1.18],0.3801124315440494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGK,N-acetyl-D-glucosamine kinase,6379,171,0.87 [0.66-1.15],0.3211057872111639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,6435,173,1.41 [0.71-2.78],0.3292660239833295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAMPT,Nicotinamide phosphoribosyltransferase,7437,205,1.05 [0.83-1.31],0.7032244831257519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAP1L4,Nucleosome assembly protein 1-like 4,6537,176,0.91 [0.64-1.29],0.5985175237103337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NAPRT,Nicotinate phosphoribosyltransferase,6567,172,0.81 [0.51-1.28],0.3668103523406549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NARS1,"Asparagine--tRNA ligase, cytoplasmic",6571,175,0.89 [0.65-1.21],0.4524679554766884
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBL1,Neuroblastoma suppressor of tumorigenicity 1,7608,208,1.59 [1.03-2.46],0.0351458443218346
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NBN,Nibrin,7455,203,1.01 [0.79-1.28],0.9608389893982284
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM1,Neural cell adhesion molecule 1,7623,207,0.92 [0.63-1.36],0.6882668203633934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAM2,Neural cell adhesion molecule 2,7592,208,1.04 [0.66-1.63],0.8722334832317611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCAN,Neurocan core protein,7641,209,1.08 [0.78-1.49],0.6363712983787447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCF2,Neutrophil cytosol factor 2,7559,209,1.00 [0.87-1.16],0.9628794904209056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCK2,Cytoplasmic protein NCK2,7605,207,0.99 [0.88-1.11],0.8542904156492842
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCLN,Nicalin,7455,203,0.92 [0.69-1.21],0.5281595959235222
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR1,Natural cytotoxicity triggering receptor 1,7561,209,1.26 [0.92-1.72],0.15446251776335
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,6553,176,1.46 [1.00-2.13],0.0486027790203971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NCS1,Neuronal calcium sensor 1,7659,207,1.37 [0.90-2.08],0.1383444111946076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDRG1,Protein NDRG1,7422,204,1.10 [0.91-1.33],0.3068245174360351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,6554,173,0.93 [0.72-1.20],0.5895449149614626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,6361,169,0.97 [0.63-1.49],0.8781321930189547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,6553,176,0.99 [0.84-1.17],0.8809459547136596
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",7437,205,0.91 [0.76-1.09],0.3000952514551149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEB,Nebulin,6354,169,0.71 [0.46-1.11],0.1376893262393564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECAP2,Adaptin ear-binding coat-associated protein 2,6354,169,1.00 [0.80-1.26],0.981274191743953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN1,Nectin-1,6368,169,1.26 [0.83-1.91],0.2838310959533648
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN2,Nectin-2,7561,206,1.41 [0.97-2.05],0.0732790553045703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NECTIN4,Nectin-4,7608,208,1.63 [1.18-2.25],0.0029152079421136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,6368,169,0.77 [0.58-1.04],0.0839134261702139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEDD9,Enhancer of filamentation 1,6368,169,0.97 [0.62-1.51],0.8957359540375482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEFL,Neurofilament light polypeptide,7403,204,1.00 [0.76-1.30],0.9771438059550854
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEK7,Serine/threonine-protein kinase Nek7,6448,175,0.96 [0.78-1.18],0.6773970362380537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL1,Protein kinase C-binding protein NELL1,7608,208,0.87 [0.65-1.17],0.363576430886687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NELL2,Protein kinase C-binding protein NELL2,7605,207,0.88 [0.58-1.34],0.5598326325914369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NENF,Neudesin,6554,173,0.97 [0.85-1.11],0.6893504630302663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEO1,Neogenin,6571,175,1.37 [0.77-2.44],0.2776340982288924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NEXN,Nexilin,6592,177,0.98 [0.80-1.22],0.8774514245884278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFASC,Neurofascin,7660,209,0.75 [0.49-1.16],0.1936811161978469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFAT5,Nuclear factor of activated T-cells 5,6368,169,0.86 [0.71-1.04],0.1206475342874141
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",7573,209,0.93 [0.82-1.06],0.2712583781124567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",7455,203,1.00 [0.81-1.23],0.965599681087725
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFE2,Transcription factor NF-E2 45 kDa subunit,6393,171,0.94 [0.77-1.16],0.5850913505736945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFIC,Nuclear factor 1 C-type,6571,175,1.23 [0.97-1.55],0.0880336750312006
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB1,Nuclear factor NF-kappa-B p105 subunit,6354,169,0.94 [0.76-1.16],0.5469293193427485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKB2,Nuclear factor NF-kappa-B p100 subunit,6448,175,0.88 [0.64-1.21],0.4249182143351033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFKBIE,NF-kappa-B inhibitor epsilon,7437,205,0.83 [0.63-1.10],0.1918587383820128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",6553,176,0.99 [0.86-1.14],0.8934804889028345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFX1,Transcriptional repressor NF-X1,6354,169,0.91 [0.72-1.14],0.4060906724967079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NFYA,Nuclear transcription factor Y subunit alpha,6354,169,1.07 [0.74-1.54],0.7198051388497466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGF,Beta-nerve growth factor,7503,207,1.06 [0.39-2.88],0.913762258208315
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGFR,Tumor necrosis factor receptor superfamily member 16,6580,177,1.40 [0.90-2.17],0.1309961848063507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NGRN,Neugrin,6567,172,1.35 [0.74-2.44],0.3265367416940891
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NHLRC3,NHL repeat-containing protein 3,6260,170,1.10 [0.68-1.77],0.7009394445331447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID1,Nidogen-1,7598,204,0.94 [0.66-1.33],0.7201908091680174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NID2,Nidogen-2,7592,208,1.00 [0.85-1.19],0.9676078680850264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NINJ1,Ninjurin-1,7437,205,0.99 [0.78-1.25],0.9055528487741415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT1,Deaminated glutathione amidase,6393,171,0.87 [0.63-1.21],0.4123992458726533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NIT2,Omega-amidase NIT2,6561,176,0.96 [0.78-1.18],0.6846749882209058
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN1,Neuroligin-1,6413,172,1.00 [0.80-1.25],0.9876698016026866
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NLGN2,Neuroligin-2,6400,169,1.07 [0.78-1.45],0.6830450258868512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME1,Nucleoside diphosphate kinase A,6368,169,1.02 [0.51-2.06],0.9540625313182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NME3,Nucleoside diphosphate kinase 3,7584,207,1.26 [0.78-2.04],0.3483435218981389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMI,N-myc-interactor,6533,173,0.90 [0.72-1.11],0.315736451272431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,7503,207,1.02 [0.87-1.20],0.7960699068347549
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMRK2,Nicotinamide riboside kinase 2,6350,168,0.81 [0.52-1.27],0.3670540180030383
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NMT1,Glycylpeptide N-tetradecanoyltransferase 1,6571,175,0.99 [0.80-1.24],0.9588968404947604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOMO1,Nodal modulator 1,7592,208,1.72 [1.00-2.96],0.0481678961631103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOP56,Nucleolar protein 56,6354,169,1.01 [0.88-1.15],0.9312355216427772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS1,"Nitric oxide synthase, brain",7422,204,0.95 [0.76-1.18],0.6165140984844328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS2,"Nitric oxide synthase, inducible",6354,169,1.35 [0.96-1.89],0.0825264587741834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",7422,204,0.86 [0.66-1.12],0.2661122516660278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH1,Neurogenic locus notch homolog protein 1,7681,210,2.88 [1.37-6.05],0.0053436694647722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH2,Neurogenic locus notch homolog protein 2,6573,174,1.78 [0.93-3.38],0.0794409939269035
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NOTCH3,Neurogenic locus notch homolog protein 3,7681,210,0.92 [0.63-1.33],0.6404538663635732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPC2,NPC intracellular cholesterol transporter 2,6472,171,1.23 [0.80-1.89],0.3492478360929655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPDC1,Neural proliferation differentiation and control protein 1,7572,207,1.12 [0.78-1.61],0.5261839765208581
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS1,Nephrin,6368,169,1.06 [0.68-1.66],0.7981669712416224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPHS2,Podocin,6368,169,0.94 [0.80-1.10],0.4185465317531122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPL,N-acetylneuraminate lyase,6580,177,0.85 [0.62-1.16],0.3039849279125899
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPB,Natriuretic peptides B,7455,202,0.93 [0.85-1.01],0.0768937592291689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPPC,C-type natriuretic peptide,7573,209,0.84 [0.66-1.07],0.1605836956008636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPR1,Atrial natriuretic peptide receptor 1,6354,169,0.89 [0.59-1.32],0.5496795347089124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTN,Neuroplastin,7437,205,0.99 [0.84-1.17],0.8895395651642999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX1,Neuronal pentraxin-1,7592,208,1.02 [0.76-1.37],0.9092906584361208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTX2,Neuronal pentraxin-2,6573,174,0.39 [0.25-0.59],1.3147338906594254e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPTXR,Neuronal pentraxin receptor,7572,207,0.74 [0.51-1.09],0.1255363630258747
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NPY,Pro-neuropeptide Y,7659,207,1.17 [0.96-1.42],0.1316342379196013
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRCAM,Neuronal cell adhesion molecule,7572,207,1.33 [0.87-2.03],0.1823829123184254
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRGN,Neurogranin,6592,177,0.95 [0.81-1.12],0.5733832623404821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRN1,Neuritin,6571,175,1.12 [0.77-1.64],0.542586205489495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP1,Neuropilin-1,7632,207,1.25 [0.79-1.97],0.3356909180449777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRP2,Neuropilin-2,7592,208,1.69 [1.10-2.57],0.0153950997544163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRTN,Neurturin,7455,203,1.14 [0.89-1.45],0.3027808863452875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NRXN3,Neurexin-3,6413,172,1.26 [0.89-1.80],0.1970448244383186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NSFL1C,NSFL1 cofactor p47,7641,209,0.84 [0.69-1.03],0.0877756950375105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",6580,177,0.98 [0.80-1.20],0.8276079164548263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C1A,Cytosolic 5'-nucleotidase 1A,6567,172,1.14 [0.73-1.79],0.556970883539512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5C3A,Cytosolic 5'-nucleotidase 3A,7559,208,0.88 [0.76-1.02],0.0943845590979323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NT5E,5'-nucleotidase,7608,208,0.87 [0.68-1.11],0.2542768727803942
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF3,Neurotrophin-3,7573,209,1.12 [0.79-1.57],0.5225245430931602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTF4,Neurotrophin-4,7437,205,1.05 [0.74-1.50],0.7781857831404408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK2,BDNF/NT-3 growth factors receptor,7572,207,1.33 [0.83-2.15],0.2397134264767716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTRK3,NT-3 growth factor receptor,7641,209,1.46 [0.82-2.59],0.1936191075137687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NTproBNP,N-terminal prohormone of brain natriuretic peptide,7572,207,0.88 [0.79-0.98],0.0211943598430742
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUB1,NEDD8 ultimate buster 1,7573,209,0.95 [0.81-1.10],0.4723446062714872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,6554,173,1.05 [0.91-1.21],0.4902214836172937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUCB2,Nucleobindin-2,7640,206,1.18 [0.85-1.65],0.3224146067229537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDC,Nuclear migration protein nudC,7660,209,0.91 [0.75-1.10],0.3342269453351456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,6393,171,1.21 [0.70-2.11],0.4935791692741391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT15,Nucleotide triphosphate diphosphatase NUDT15,6354,169,0.89 [0.65-1.22],0.4570799371320551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT16,U8 snoRNA-decapping enzyme,6541,176,0.99 [0.83-1.17],0.9020473433382024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],7543,206,0.79 [0.62-1.00],0.0483057984196412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUDT5,ADP-sugar pyrophosphatase,7592,208,0.88 [0.68-1.14],0.3275407740891538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUMB,Protein numb homolog,6368,169,0.95 [0.79-1.14],0.5490899470401369
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NUP50,Nuclear pore complex protein Nup50,6354,169,1.23 [0.82-1.83],0.3206125564119202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPE4,NXPE family member 4,6354,169,1.14 [0.71-1.82],0.5996407055055966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH1,Neurexophilin-1,7422,204,0.91 [0.65-1.27],0.5864582430756721
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",NXPH3,Neurexophilin-3,6368,169,1.35 [0.82-2.22],0.2309490826046109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OBP2B,Odorant-binding protein 2b,7481,206,0.78 [0.63-0.95],0.0163480058754333
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OCLN,Occludin,6571,175,1.13 [0.82-1.54],0.4653474081363183
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ODAM,Odontogenic ameloblast-associated protein,7410,204,1.11 [0.89-1.38],0.3680324172420072
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OFD1,Oral-facial-digital syndrome 1 protein,6448,175,0.87 [0.67-1.13],0.2850959091275149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGA,Protein O-GlcNAcase,6553,176,0.87 [0.71-1.08],0.2173993653333857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGFR,Opioid growth factor receptor,7543,206,0.88 [0.59-1.31],0.5248794995401833
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGN,Mimecan,7592,208,1.61 [1.24-2.09],0.0003597536436005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,6448,175,0.90 [0.70-1.15],0.3912551169450133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLFM4,Olfactomedin-4,6176,164,1.01 [0.89-1.15],0.8467681104054697
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OLR1,Oxidized low-density lipoprotein receptor 1,7493,206,1.07 [0.87-1.32],0.5000649058263489
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMD,Osteomodulin,7605,207,1.14 [0.84-1.55],0.4096865347536295
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMG,Oligodendrocyte-myelin glycoprotein,7543,206,0.79 [0.66-0.95],0.0114149813873773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OMP,Olfactory marker protein,6400,169,0.95 [0.69-1.30],0.727853672938673
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPHN1,Oligophrenin-1,6567,172,0.98 [0.85-1.12],0.742524558178353
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPLAH,5-oxoprolinase,6393,171,0.90 [0.72-1.13],0.3533581341097686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OPTC,Opticin,7543,206,1.07 [0.83-1.39],0.5876680772239304
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ORM1,Alpha-1-acid glycoprotein 1,6560,176,2.75 [1.39-5.43],0.0036910564065576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSBPL2,Oxysterol-binding protein-related protein 2,6567,172,1.15 [0.81-1.63],0.4321729931902859
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSCAR,Osteoclast-associated immunoglobulin-like receptor,7584,207,1.33 [0.93-1.89],0.1209431747118034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSM,Oncostatin-M,7538,209,1.00 [0.84-1.20],0.9951801438900062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSMR,Oncostatin-M-specific receptor subunit beta,7632,207,2.44 [1.31-4.54],0.0050770584304253
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OSTN,Osteocrin,6413,172,0.91 [0.63-1.33],0.6412332526761801
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTOA,Otoancorin,6400,169,0.95 [0.70-1.28],0.7174294641455301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD6B,Deubiquitinase OTUD6B,6553,176,0.87 [0.67-1.12],0.2823071471075179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OTUD7B,OTU domain-containing protein 7B,6571,175,0.95 [0.75-1.21],0.6969717317451387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",6393,171,1.08 [0.88-1.34],0.4685695802734083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",OXT,Oxytocin-neurophysin 1,7641,209,0.94 [0.86-1.02],0.1447023396956651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",P4HB,Protein disulfide-isomerase,7549,206,1.16 [0.84-1.61],0.3561186277516712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PACS2,Phosphofurin acidic cluster sorting protein 2,6354,169,0.95 [0.74-1.22],0.694903983850589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI2,Protein-arginine deiminase type-2,7455,203,0.88 [0.68-1.13],0.3168787570784644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PADI4,Protein-arginine deiminase type-4,7410,204,1.05 [0.89-1.23],0.5692097546902981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAEP,Glycodelin,7503,207,0.97 [0.86-1.09],0.6335309895131782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,6571,175,1.08 [0.97-1.21],0.1806107057168297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",6448,175,0.93 [0.69-1.26],0.640129476950027
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,7455,202,0.95 [0.76-1.20],0.6918793013230325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAGR1,PAXIP1-associated glutamate-rich protein 1,6393,171,0.89 [0.61-1.30],0.5578968518491934
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAIP2B,Polyadenylate-binding protein-interacting protein 2B,6343,168,0.88 [0.65-1.19],0.4115098033876744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAK4,Serine/threonine-protein kinase PAK 4,7422,204,0.97 [0.78-1.19],0.7441449090775243
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALLD,Palladin,6368,169,0.77 [0.49-1.22],0.2656165008886354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM,Paralemmin-1,6513,175,1.48 [0.98-2.24],0.0603210681190545
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM2,Paralemmin-2,6567,172,1.15 [0.79-1.69],0.4663662531392613
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PALM3,Paralemmin-3,6354,169,1.04 [0.86-1.25],0.7058494212171494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAM,Peptidyl-glycine alpha-amidating monooxygenase,7648,208,1.46 [0.94-2.28],0.0952190099901689
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAMR1,Inactive serine protease PAMR1,7592,208,2.16 [1.34-3.49],0.0014886092201604
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAPPA,Pappalysin-1,7455,203,0.76 [0.58-0.99],0.0453690962201856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARD3,Partitioning defective 3 homolog,6448,175,0.93 [0.76-1.15],0.5157121638077171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARK7,Parkinson disease protein 7,7592,208,0.82 [0.64-1.06],0.1239958521825454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PARP1,Poly [ADP-ribose] polymerase 1,7573,209,0.95 [0.75-1.20],0.6419423172560567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PAXX,Protein PAXX,6435,173,0.84 [0.60-1.19],0.3350531451670163
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBK,Lymphokine-activated killer T-cell-originated protein kinase,6350,168,0.80 [0.50-1.29],0.3633507282777426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBLD,Phenazine biosynthesis-like domain-containing protein,7422,204,1.06 [0.82-1.36],0.6592656280552867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,6553,176,1.33 [0.86-2.08],0.2003409685195409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCARE,Photoreceptor cilium actin regulator,6400,169,0.98 [0.81-1.18],0.8145440197673476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBD1,Pterin-4-alpha-carbinolamine dehydratase,6421,173,0.90 [0.64-1.26],0.5394105459502361
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCBP2,Poly(rC)-binding protein 2,6571,175,0.96 [0.78-1.17],0.6701100090604312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH1,Protocadherin-1,7636,209,1.13 [0.63-2.05],0.6738239516395441
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH12,Protocadherin-12,6571,175,1.26 [0.71-2.26],0.4303710268000986
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH17,Protocadherin-17,7572,207,1.17 [0.85-1.63],0.3384438917803541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH7,Protocadherin-7,6553,176,1.25 [0.88-1.78],0.210537796416616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDH9,Protocadherin-9,6553,176,1.36 [0.88-2.09],0.1667884948663355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCDHB15,Protocadherin beta-15,6554,173,1.17 [0.82-1.67],0.3755697144401438
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCNA,Proliferating cell nuclear antigen,6350,168,0.94 [0.73-1.21],0.6177500112347653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK7,Proprotein convertase subtilisin/kexin type 7,6554,173,1.03 [0.75-1.41],0.844849682088415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCSK9,Proprotein convertase subtilisin/kexin type 9,7681,210,1.33 [0.98-1.80],0.0632993135921643
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PCYT2,Ethanolamine-phosphate cytidylyltransferase,6553,176,0.89 [0.73-1.09],0.2563838773458695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDAP1,28 kDa heat- and acid-stable phosphoprotein,6580,177,0.95 [0.82-1.11],0.5214749490057127
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,7645,207,1.27 [0.96-1.70],0.0974164016033963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD1LG2,Programmed cell death 1 ligand 2,7543,206,1.29 [0.88-1.89],0.1912062865589426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD5,Programmed cell death protein 5,7641,209,0.87 [0.70-1.09],0.2291710468294958
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCD6,Programmed cell death protein 6,7572,207,1.03 [0.86-1.23],0.7455598077023224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDCL2,Phosducin-like protein 2,6350,168,1.28 [1.02-1.61],0.032192151399031
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",6350,168,1.20 [0.94-1.54],0.1421580209140038
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",6354,169,1.19 [0.95-1.49],0.1383977933170133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",6435,173,0.92 [0.80-1.06],0.2519435190620621
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFA,Platelet-derived growth factor subunit A,7681,210,0.97 [0.81-1.14],0.6833151493244525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFB,Platelet-derived growth factor subunit B,7605,207,0.99 [0.85-1.14],0.8403988535375877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFC,Platelet-derived growth factor C,7437,205,1.77 [1.12-2.79],0.0143848790884214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRA,Platelet-derived growth factor receptor alpha,7572,207,0.91 [0.59-1.42],0.6887188363231043
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDGFRB,Platelet-derived growth factor receptor beta,7681,210,1.18 [0.82-1.69],0.3734286037423546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA2,Protein disulfide-isomerase A2,6350,168,0.88 [0.59-1.29],0.5088007193827202
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA3,Protein disulfide-isomerase A3,6435,173,1.02 [0.56-1.85],0.9497535071129584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA4,Protein disulfide-isomerase A4,6573,174,1.06 [0.83-1.35],0.6293008843116745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDIA5,Protein disulfide-isomerase A5,6350,168,0.89 [0.68-1.16],0.3998005106583738
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM5,PDZ and LIM domain protein 5,6571,175,0.96 [0.85-1.09],0.55159139677323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDLIM7,PDZ and LIM domain protein 7,7605,207,1.00 [0.91-1.11],0.9913571997594472
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",7437,205,0.86 [0.65-1.14],0.2944268486607826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDRG1,p53 and DNA damage-regulated protein 1,6413,172,1.10 [0.84-1.45],0.4744760429703546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,6350,168,1.08 [0.85-1.39],0.5186975717715065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZD2,PDZ domain-containing protein 2,6354,169,1.00 [0.77-1.29],0.981399281420032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,6368,169,0.91 [0.64-1.31],0.6240329941905955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEAR1,Platelet endothelial aggregation receptor 1,7681,210,1.57 [0.92-2.68],0.1006716758701566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEBP1,Phosphatidylethanolamine-binding protein 1,7592,208,0.82 [0.65-1.03],0.0838947255170159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECAM1,Platelet endothelial cell adhesion molecule,7592,208,1.28 [0.85-1.91],0.2337854726361261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PECR,Peroxisomal trans-2-enoyl-CoA reductase,6393,171,1.04 [0.59-1.81],0.9030052392696736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PENK,Proenkephalin-A,6435,173,1.19 [0.77-1.82],0.4358468991355082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PEPD,Xaa-Pro dipeptidase,6592,177,0.75 [0.43-1.31],0.3164729267171642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PER3,Period circadian protein homolog 3,6368,169,1.00 [0.88-1.13],0.961104172678609
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PF4,Platelet factor 4,6538,177,1.06 [0.91-1.24],0.4558195610233615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN2,Prefoldin subunit 2,7422,204,1.15 [0.92-1.44],0.2231879038635905
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN4,Prefoldin subunit 4,6350,168,0.78 [0.56-1.07],0.1269544272807461
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFDN6,Prefoldin subunit 6,6413,172,0.98 [0.77-1.24],0.8479081298999482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",7532,206,0.85 [0.72-1.01],0.0594115684672872
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGA4,Pepsin A-4,6592,177,1.12 [0.94-1.33],0.2015870798784298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGD,"6-phosphogluconate dehydrogenase, decarboxylating",6580,177,0.92 [0.69-1.22],0.5685386737001532
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGF,Placenta growth factor,7660,209,1.27 [0.81-2.01],0.2972595251784548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP1,Peptidoglycan recognition protein 1,7649,209,1.09 [0.82-1.44],0.5544292573498341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP2,N-acetylmuramoyl-L-alanine amidase,6510,177,1.06 [0.64-1.74],0.8339278446212989
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGLYRP4,Peptidoglycan recognition protein 4,6354,169,0.90 [0.68-1.20],0.4794674809051312
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGM2,Phosphoglucomutase-2,6413,172,0.97 [0.75-1.26],0.8264124556633651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PGR,Progesterone receptor,6368,169,0.99 [0.84-1.15],0.8548982671165064
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHACTR2,Phosphatase and actin regulator 2,6571,175,0.97 [0.85-1.10],0.62506545508395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB1,Pleckstrin homology-like domain family B member 1,6553,176,1.11 [0.84-1.47],0.4712843707904615
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHLDB2,Pleckstrin homology-like domain family B member 2,6350,168,0.91 [0.76-1.09],0.3164043274241355
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,7503,207,1.21 [0.80-1.85],0.3666617576238589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,6435,173,1.03 [0.72-1.48],0.8751575745771174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI16,Peptidase inhibitor 16,6592,177,0.86 [0.47-1.55],0.6140848374445714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PI3,Elafin,7500,206,0.82 [0.65-1.04],0.0958275540969636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",6571,175,0.96 [0.79-1.17],0.6986989437494437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIGR,Polymeric immunoglobulin receptor,7497,206,1.26 [0.90-1.77],0.1719324439878776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,7573,209,0.80 [0.65-0.99],0.0365505259697723
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,7592,208,1.29 [0.87-1.93],0.2052670382605449
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,6368,169,0.73 [0.53-1.00],0.0473486821831154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRA,Paired immunoglobulin-like type 2 receptor alpha,7592,208,1.31 [0.98-1.76],0.0700267049673042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PILRB,Paired immunoglobulin-like type 2 receptor beta,7572,207,1.20 [0.96-1.50],0.1053451833533516
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,6435,173,0.83 [0.68-1.02],0.0764462975959152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PITHD1,PITH domain-containing protein 1,6343,168,0.98 [0.80-1.20],0.8524079675700427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD1,Polycystin-1,6580,177,1.49 [0.87-2.54],0.146871585944809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKD2,Polycystin-2,6354,169,1.08 [0.84-1.39],0.562980831373279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKLR,Pyruvate kinase PKLR,7587,207,0.77 [0.63-0.93],0.0085625629783583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PKN3,Serine/threonine-protein kinase N3,6448,175,1.03 [0.85-1.27],0.7392155947044385
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G10,Group 10 secretory phospholipase A2,7503,207,0.90 [0.72-1.12],0.3599688122422082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G15,Phospholipase A2 group XV,7608,208,1.33 [0.85-2.08],0.2130331040212034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G1B,Phospholipase A2,7673,210,0.96 [0.74-1.25],0.7612883067833134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G2A,"Phospholipase A2, membrane associated",7588,206,1.24 [1.00-1.54],0.0537402996901377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G4A,Cytosolic phospholipase A2,7605,207,0.97 [0.84-1.12],0.6934418964229387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLA2G7,Platelet-activating factor acetylhydrolase,7592,208,1.21 [0.83-1.75],0.3160138965744853
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAT,Tissue-type plasminogen activator,7661,210,0.97 [0.76-1.24],0.8110913788045185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAU,Urokinase-type plasminogen activator,7592,208,1.19 [0.81-1.75],0.3701841863451667
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLAUR,Urokinase plasminogen activator surface receptor,7534,207,1.45 [0.96-2.21],0.0794230781943136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLB1,"Phospholipase B1, membrane-associated",6567,172,0.72 [0.56-0.91],0.0073210103460125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",6368,169,1.05 [0.74-1.51],0.771828960296008
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",6567,172,1.00 [0.86-1.17],0.9871102769931772
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLEKHO1,Pleckstrin homology domain-containing family O member 1,6567,172,1.01 [0.81-1.25],0.937614133081666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLG,Plasminogen,6425,173,1.78 [0.91-3.48],0.0901596255995178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN1,Perilipin-1,7422,204,1.10 [0.77-1.58],0.6014420290025941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLIN3,Perilipin-3,7572,207,1.04 [0.77-1.39],0.8173909427424313
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLPBP,Pyridoxal phosphate homeostasis protein,7572,207,0.89 [0.74-1.08],0.2461762526300021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLSCR3,Phospholipid scramblase 3,6556,171,0.93 [0.72-1.22],0.6118122351546136
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLTP,Phospholipid transfer protein,7659,209,0.97 [0.70-1.35],0.8597131212198103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC1,Plexin domain-containing protein 1,7437,205,0.71 [0.46-1.11],0.1330875852869173
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXDC2,Plexin domain-containing protein 2,6567,172,0.87 [0.50-1.50],0.610762282906868
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNA4,Plexin-A4,7573,209,0.98 [0.84-1.14],0.7725834556513922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB2,Plexin-B2,7650,209,1.10 [0.67-1.81],0.7122980452482717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PLXNB3,Plexin-B3,7549,207,1.00 [0.77-1.30],0.9876714276245246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,7532,206,1.02 [0.95-1.09],0.6212341099367735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMCH,Pro-MCH,6354,169,0.88 [0.70-1.09],0.2436688873762407
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMM2,Phosphomannomutase 2,6354,169,1.01 [0.78-1.30],0.9562308124927787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMS1,PMS1 protein homolog 1,6413,172,1.39 [1.10-1.75],0.0055539330809282
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PMVK,Phosphomevalonate kinase,7411,204,0.97 [0.87-1.09],0.6243724088181624
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIP,Pancreatic triacylglycerol lipase,6592,177,0.95 [0.77-1.18],0.6586755149698471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP1,Inactive pancreatic lipase-related protein 1,6567,172,1.16 [0.98-1.38],0.0911940005832896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNLIPRP2,Pancreatic lipase-related protein 2,7573,207,0.97 [0.93-1.01],0.1443366143640051
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA1,Paraneoplastic antigen Ma1,6393,171,0.99 [0.76-1.30],0.9510202901221286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNMA2,Paraneoplastic antigen Ma2,6400,169,0.97 [0.70-1.36],0.8667840397699812
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",7455,203,0.91 [0.80-1.03],0.1193569978444469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL,Podocalyxin,7543,206,1.69 [0.75-3.84],0.2076211718999179
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PODXL2,Podocalyxin-like protein 2,7608,208,1.49 [0.97-2.28],0.0682854207068484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POF1B,Protein POF1B,6368,169,1.07 [0.77-1.48],0.6825415855452652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2A,DNA-directed RNA polymerase II subunit RPB1,6368,169,1.37 [0.84-2.24],0.2030173830896485
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",7543,206,1.10 [0.78-1.56],0.5818874185481199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POMC,Pro-opiomelanocortin,6393,171,0.84 [0.68-1.04],0.1063983924015829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON1,Serum paraoxonase/arylesterase 1,6592,177,1.25 [0.73-2.11],0.4145573734124316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON2,Serum paraoxonase/arylesterase 2,7455,202,1.09 [0.76-1.55],0.6455727877662351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PON3,Serum paraoxonase/lactonase 3,7605,207,1.22 [0.79-1.90],0.3683808996248918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",POSTN,Periostin,6573,174,1.15 [0.78-1.68],0.4845100469486293
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPBP,Platelet basic protein,6539,177,1.01 [0.85-1.20],0.8954875032278611
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPCDC,Phosphopantothenoylcysteine decarboxylase,7641,209,0.82 [0.62-1.08],0.1519892048463773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIB,Peptidyl-prolyl cis-trans isomerase B,7601,209,0.99 [0.87-1.13],0.8645206626054787
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIE,Peptidyl-prolyl cis-trans isomerase E,6448,175,0.89 [0.68-1.16],0.3766533611490712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",6573,174,0.99 [0.78-1.25],0.90915074874943
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPL,Periplakin,6368,169,0.72 [0.44-1.18],0.1918698663909636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1A,Protein phosphatase 1A,7437,205,0.97 [0.65-1.45],0.8904719620817639
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1B,Protein phosphatase 1B,6368,169,0.63 [0.44-0.90],0.0118118760886834
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPM1F,Protein phosphatase 1F,6580,177,0.98 [0.74-1.29],0.8661632696841431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPME1,Protein phosphatase methylesterase 1,7543,206,0.68 [0.55-0.84],0.0002943936169538
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,6554,173,0.96 [0.80-1.14],0.6190245927940496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,7608,208,1.00 [0.88-1.15],0.9424054746314694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,6448,175,1.06 [0.87-1.30],0.5792984378736947
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,6571,175,0.99 [0.82-1.19],0.8833316289550203
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,6571,175,1.20 [0.86-1.66],0.2838542441934101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R2,Protein phosphatase inhibitor 2,7572,207,0.96 [0.82-1.13],0.6173121197297607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP1R9B,Neurabin-2,7660,209,0.94 [0.82-1.07],0.350930476749337
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,6553,176,0.97 [0.85-1.10],0.6019270513853883
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPP3R1,Calcineurin subunit B type 1,7503,207,0.91 [0.67-1.24],0.5513836408864017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPT1,Palmitoyl-protein thioesterase 1,6413,172,1.00 [0.82-1.21],0.9615856956336948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PPY,Pancreatic prohormone,7570,208,1.05 [0.93-1.18],0.4391109936211895
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PQBP1,Polyglutamine-binding protein 1,7437,205,1.36 [1.17-1.59],9.593308543754398e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAME,Melanoma antigen preferentially expressed in tumors,6350,168,1.07 [0.59-1.92],0.82407573335706
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRAP1,Proline-rich acidic protein 1,6573,174,1.13 [0.77-1.66],0.5462386656205598
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRC1,Protein regulator of cytokinesis 1,6554,173,1.00 [0.72-1.38],0.9901900038005756
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRCP,Lysosomal Pro-X carboxypeptidase,7638,210,1.18 [0.80-1.72],0.4049543290085443
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX1,Peroxiredoxin-1,7350,205,0.82 [0.70-0.95],0.0089713740316837
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX2,Peroxiredoxin-2,6471,173,0.75 [0.59-0.97],0.0252125760514644
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",7455,203,0.96 [0.80-1.14],0.6145842711360289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX5,"Peroxiredoxin-5, mitochondrial",7660,209,0.88 [0.73-1.05],0.1635996479630261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRDX6,Peroxiredoxin-6,7659,207,0.86 [0.70-1.05],0.1435054173588877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PREB,Prolactin regulatory element-binding protein,7455,203,1.16 [0.76-1.76],0.4978055656172128
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRELP,Prolargin,7573,207,1.05 [0.62-1.78],0.8492055871606283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG2,Bone marrow proteoglycan,6573,174,1.08 [0.81-1.43],0.5948580354356676
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRG3,Proteoglycan 3,6573,174,1.17 [0.86-1.57],0.314024246433493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAB1,5'-AMP-activated protein kinase subunit beta-1,7455,203,0.88 [0.69-1.13],0.3221812204080674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,6413,172,1.08 [0.69-1.69],0.727459835768351
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,7572,207,1.03 [0.88-1.20],0.7364701612279893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,6553,172,0.94 [0.77-1.13],0.495082967768326
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKCQ,Protein kinase C theta type,7455,203,0.86 [0.63-1.17],0.3462678184662969
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKD2,Serine/threonine-protein kinase D2,6354,169,0.94 [0.65-1.36],0.7458290617118714
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKG1,cGMP-dependent protein kinase 1,6435,173,1.00 [0.88-1.12],0.936523124303133
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,7437,205,0.99 [0.82-1.19],0.8910428637468675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRL,Prolactin,7641,209,1.02 [0.87-1.20],0.8213366895913897
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRND,Prion-like protein doppel,6567,172,1.75 [1.33-2.30],6.612415654612457e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROC,Vitamin K-dependent protein C,7611,206,2.87 [1.76-4.68],2.515267797568897e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROCR,Endothelial protein C receptor,6354,169,1.08 [0.69-1.70],0.7304883600587901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROK1,Prokineticin-1,7573,209,0.64 [0.50-0.83],0.0006893648938154
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PROS1,Vitamin K-dependent protein S,6589,178,1.80 [1.04-3.10],0.0347916013438818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR4,Proline-rich protein 4,6389,169,1.13 [0.91-1.39],0.2616759635264647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRR5,Proline-rich protein 5,6368,169,0.95 [0.68-1.33],0.762113257063432
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRRT3,Proline-rich transmembrane protein 3,6393,171,1.23 [0.84-1.81],0.2868881167517341
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS2,Trypsin-2,7623,207,1.09 [0.89-1.34],0.4019938147292082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS22,Brain-specific serine protease 4,6368,169,0.92 [0.59-1.43],0.7075740073925484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS27,Serine protease 27,7552,207,1.10 [0.81-1.51],0.5331785673799019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS53,Serine protease 53,6567,172,1.10 [0.75-1.62],0.6116447769878867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRSS8,Prostasin,7553,207,1.16 [0.86-1.56],0.3235978487100113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,7422,204,0.95 [0.85-1.07],0.418629829721957
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTG,Protogenin,7659,207,0.83 [0.52-1.33],0.4428188226769196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRTN3,Myeloblastin,7395,204,1.12 [0.87-1.43],0.3793249254938199
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PRUNE2,Protein prune homolog 2,6448,175,1.40 [0.90-2.17],0.1367469477722344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAP,Prosaposin,6519,174,1.33 [0.79-2.24],0.2846889956800048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSAPL1,Proactivator polypeptide-like 1,6553,176,0.99 [0.74-1.32],0.9329480124800758
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSCA,Prostate stem cell antigen,6553,176,1.00 [0.95-1.06],0.8853270085941704
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSG1,Pregnancy-specific beta-1-glycoprotein 1,7503,207,1.03 [0.92-1.15],0.5983290763530085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSIP1,PC4 and SFRS1-interacting protein,7573,209,1.04 [0.86-1.25],0.6839535057491712
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMA1,Proteasome subunit alpha type-1,7437,205,0.83 [0.61-1.12],0.2149238674498855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMC3,26S proteasome regulatory subunit 6A,6350,168,1.03 [0.64-1.66],0.8937707151590548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD1,26S proteasome non-ATPase regulatory subunit 1,6571,175,0.77 [0.56-1.06],0.1050593414354818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD5,26S proteasome non-ATPase regulatory subunit 5,6413,172,0.96 [0.73-1.27],0.7830803421432732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMD9,26S proteasome non-ATPase regulatory subunit 9,7543,206,0.76 [0.60-0.96],0.0233210805879945
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME1,Proteasome activator complex subunit 1,7482,207,0.76 [0.54-1.08],0.1276974096942065
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSME2,Proteasome activator complex subunit 2,7471,203,0.65 [0.46-0.94],0.0203953300257819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG3,Proteasome assembly chaperone 3,7573,209,0.73 [0.57-0.94],0.0147838871694367
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSMG4,Proteasome assembly chaperone 4,6368,169,0.78 [0.59-1.03],0.0806989966488873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSPN,Persephin,7573,209,0.94 [0.81-1.08],0.3479215129399777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSRC1,Proline/serine-rich coiled-coil protein 1,7437,205,0.93 [0.75-1.16],0.5405816500997767
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,6208,164,1.01 [0.87-1.16],0.9380144384400716
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",7422,204,1.34 [0.89-2.00],0.1557214261856632
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGDS,Prostaglandin-H2 D-isomerase,7542,203,1.22 [0.85-1.77],0.2829121125585447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGES2,Prostaglandin E synthase 2,6322,168,0.88 [0.66-1.18],0.3987253495989067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTGR1,Prostaglandin reductase 1,6580,177,0.99 [0.84-1.18],0.9534758689666564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH,Parathyroid hormone,6413,172,1.04 [0.87-1.25],0.636000961709074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,7573,209,1.23 [0.93-1.63],0.1470379441627813
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTK7,Inactive tyrosine-protein kinase 7,7422,204,1.23 [0.88-1.72],0.229458887587411
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTN,Pleiotrophin,7455,202,1.10 [0.86-1.42],0.4457726097945244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTP4A3,Protein tyrosine phosphatase type IVA 3,6368,169,0.85 [0.62-1.17],0.318382367020526
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN1,Tyrosine-protein phosphatase non-receptor type 1,7503,207,0.99 [0.84-1.16],0.8711308414129703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN6,Tyrosine-protein phosphatase non-receptor type 6,7598,207,0.96 [0.84-1.10],0.5801091594282117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPN9,Tyrosine-protein phosphatase non-receptor type 9,6359,169,0.72 [0.46-1.11],0.1333775012737469
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRB,Receptor-type tyrosine-protein phosphatase beta,6580,177,0.74 [0.45-1.21],0.2318471140216175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRC,Receptor-type tyrosine-protein phosphatase C,6573,174,1.24 [0.66-2.35],0.5070339608601798
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRF,Receptor-type tyrosine-protein phosphatase F,7681,210,1.44 [0.95-2.19],0.0880414407245843
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRH,Receptor-type tyrosine-protein phosphatase H,6553,176,1.12 [0.84-1.51],0.4369982251923479
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRK,Receptor-type tyrosine-protein phosphatase kappa,6553,176,1.56 [0.85-2.86],0.1545744475587807
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRM,Receptor-type tyrosine-protein phosphatase mu,7561,209,1.22 [0.73-2.04],0.4373142636274654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRN2,Receptor-type tyrosine-protein phosphatase N2,7480,207,1.11 [0.78-1.60],0.5545333083716499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRR,Receptor-type tyrosine-protein phosphatase R,6567,172,1.22 [0.84-1.76],0.2908733870343901
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRS,Receptor-type tyrosine-protein phosphatase S,7681,210,1.72 [1.07-2.78],0.0255978458579663
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,6580,177,1.21 [0.77-1.90],0.4017400659132354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,6435,173,0.91 [0.71-1.18],0.49527563720174
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTS,6-pyruvoyl tetrahydrobiopterin synthase,7380,202,0.90 [0.70-1.15],0.3946296552265652
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTTG1,Securin,6448,175,0.83 [0.57-1.22],0.3457087928524748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PTX3,Pentraxin-related protein PTX3,7573,209,1.08 [0.84-1.40],0.5421794841553017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVALB,Parvalbumin alpha,7622,207,0.94 [0.85-1.05],0.3031758602224426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PVR,Poliovirus receptor,7641,209,1.15 [0.83-1.61],0.3975971898241658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXDNL,Peroxidasin-like protein,6554,173,0.98 [0.74-1.28],0.8609325676349822
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PXN,Paxillin,7422,204,0.96 [0.75-1.24],0.7679493639259387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYDC1,Pyrin domain-containing protein 1,6393,171,0.74 [0.49-1.10],0.1381502634343531
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PYY,Peptide YY,6354,169,0.98 [0.85-1.13],0.8069895443698973
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",PZP,Pregnancy zone protein,6589,178,1.68 [1.18-2.40],0.0042103786116345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QDPR,Dihydropteridine reductase,7541,207,0.89 [0.66-1.20],0.450570560962977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QPCT,Glutaminyl-peptide cyclotransferase,7606,210,1.04 [0.66-1.63],0.8692536943969699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",QSOX1,Sulfhydryl oxidase 1,6459,175,1.07 [0.74-1.53],0.733448757216144
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB10,Ras-related protein Rab-10,6580,177,1.09 [0.83-1.43],0.5507585604580104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB11FIP3,Rab11 family-interacting protein 3,6580,177,0.96 [0.84-1.10],0.526034948611946
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB27B,Ras-related protein Rab-27B,6580,177,0.97 [0.81-1.15],0.7223111125132098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB2B,Ras-related protein Rab-2B,6554,173,0.95 [0.74-1.22],0.6824784024312499
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB33A,Ras-related protein Rab-33A,6354,169,0.88 [0.70-1.12],0.306439890702007
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB37,Ras-related protein Rab-37,7455,203,1.05 [0.90-1.22],0.5084891508648717
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB39B,Ras-related protein Rab-39B,6354,169,1.09 [0.94-1.26],0.2478971503541486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,6400,169,1.10 [0.87-1.39],0.4249669696911852
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB44,Ras-related protein Rab-44,6554,173,1.03 [0.74-1.43],0.8790497480608785
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6A,Ras-related protein Rab-6A,7573,209,1.23 [0.94-1.62],0.1342400569361655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAB6B,Ras-related protein Rab-6B,7422,204,1.25 [1.00-1.56],0.049514407951719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEP1,Rab GTPase-binding effector protein 1,6435,173,0.90 [0.73-1.10],0.2858122914547286
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABEPK,Rab9 effector protein with kelch motifs,7437,205,0.93 [0.74-1.17],0.5448398289375261
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RABGAP1L,Rab GTPase-activating protein 1-like,7455,203,0.76 [0.61-0.96],0.0184919635840651
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAC3,Ras-related C3 botulinum toxin substrate 3,6413,172,1.02 [0.82-1.26],0.8684724334330229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD23B,UV excision repair protein RAD23 homolog B,7437,205,0.92 [0.70-1.22],0.5635695853185875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAD51,DNA repair protein RAD51 homolog 1,6448,175,0.94 [0.70-1.26],0.6699123395720912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALB,Ras-related protein Ral-B,6368,169,1.11 [0.67-1.84],0.672761862994393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RALY,RNA-binding protein Raly,6554,173,0.99 [0.73-1.35],0.9661677466234188
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP1,Ran-specific GTPase-activating protein,6393,171,0.89 [0.66-1.19],0.421422604442718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANBP2,E3 SUMO-protein ligase RanBP2,6400,169,1.45 [0.96-2.18],0.0794198045780521
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RANGAP1,Ran GTPase-activating protein 1,7437,205,0.99 [0.75-1.30],0.9365831977310164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAP1A,Ras-related protein Rap-1A,6368,169,1.05 [0.86-1.29],0.6119756264534149
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RAPGEF2,Rap guanine nucleotide exchange factor 2,6448,175,0.77 [0.56-1.04],0.0899020371084727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES1,Retinoic acid receptor responder protein 1,7437,205,1.14 [0.80-1.63],0.4587788840873092
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RARRES2,Retinoic acid receptor responder protein 2,7632,207,1.57 [1.25-1.96],7.555095145040087e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASA1,Ras GTPase-activating protein 1,7422,204,1.31 [0.91-1.88],0.1420307329204586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,6350,168,1.06 [0.76-1.50],0.7172512004251809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RASSF2,Ras association domain-containing protein 2,7437,205,1.15 [0.94-1.40],0.174690795396865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBFOX3,RNA binding protein fox-1 homolog 3,6571,175,1.09 [0.77-1.55],0.633544092095085
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBKS,Ribokinase,7391,205,0.75 [0.60-0.93],0.0106996103730471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM17,Splicing factor 45,6571,175,0.98 [0.81-1.19],0.8351923555194679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM19,Probable RNA-binding protein 19,6354,169,1.05 [0.76-1.44],0.7687224624193867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBM25,RNA-binding protein 25,6350,168,0.93 [0.67-1.30],0.6808855089757769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP1,Retinol-binding protein 1,6413,172,1.00 [0.81-1.23],0.983595782190084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP2,Retinol-binding protein 2,7543,206,0.99 [0.85-1.17],0.9414381462509376
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP5,Retinol-binding protein 5,7543,206,1.10 [0.87-1.38],0.4266673577483605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBP7,Retinoid-binding protein 7,6553,176,1.12 [0.89-1.40],0.3379128621494841
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS,RNA-binding protein with multiple splicing,6368,169,0.94 [0.73-1.21],0.6326699565854139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RBPMS2,RNA-binding protein with multiple splicing 2,6393,171,1.05 [0.90-1.22],0.5272248571349863
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCC1,Regulator of chromosome condensation,6554,173,1.05 [0.78-1.41],0.7405883097219879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RCOR1,REST corepressor 1,7455,202,1.08 [0.81-1.43],0.5990377106194966
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,6393,171,1.47 [0.73-2.95],0.2758326416165494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REEP4,Receptor expression-enhancing protein 4,6571,175,0.87 [0.68-1.12],0.274638191645066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1A,Lithostathine-1-alpha,7545,202,1.25 [0.99-1.58],0.0566415701461502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG1B,Lithostathine-1-beta,7681,210,1.09 [0.88-1.34],0.4212601381550117
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3A,Regenerating islet-derived protein 3-alpha,7681,210,1.19 [1.00-1.42],0.0514164071100921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG3G,Regenerating islet-derived protein 3-gamma,6554,173,1.03 [0.72-1.49],0.854556429337783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REG4,Regenerating islet-derived protein 4,7584,207,1.40 [1.12-1.75],0.0030143910482466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELB,Transcription factor RelB,6368,169,1.19 [0.89-1.59],0.2416624882135453
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RELT,Tumor necrosis factor receptor superfamily member 19L,7592,208,1.25 [0.84-1.85],0.2746752776178619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REN,Renin,7572,207,0.84 [0.73-0.98],0.0238528353009825
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REPS1,RalBP1-associated Eps domain-containing protein 1,6368,169,0.95 [0.64-1.40],0.7821353288182231
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REST,RE1-silencing transcription factor,6350,168,0.84 [0.54-1.32],0.4529328516693394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RET,Proto-oncogene tyrosine-protein kinase receptor Ret,7543,206,1.03 [0.74-1.43],0.8475435783357876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RETN,Resistin,7570,207,1.19 [0.90-1.56],0.227414486006109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",REXO2,"Oligoribonuclease, mitochondrial",6354,169,1.00 [0.74-1.36],0.9956372457388172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RFC4,Replication factor C subunit 4,6554,173,0.89 [0.44-1.82],0.7533767334222328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGCC,Regulator of cell cycle RGCC,6571,175,0.98 [0.81-1.19],0.8476924752860686
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGL2,Ral guanine nucleotide dissociation stimulator-like 2,6448,175,0.88 [0.68-1.15],0.3479917564760637
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMA,Repulsive guidance molecule A,7641,209,1.54 [1.06-2.25],0.0236209547896178
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGMB,RGM domain family member B,7641,209,1.13 [0.73-1.72],0.5875998433074259
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS10,Regulator of G-protein signaling 10,6571,175,0.96 [0.74-1.23],0.726673444126777
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RGS8,Regulator of G-protein signaling 8,7455,203,0.97 [0.79-1.18],0.7522114800933909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RHOC,Rho-related GTP-binding protein RhoC,7462,207,0.95 [0.86-1.06],0.3894837833798735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RICTOR,Rapamycin-insensitive companion of mTOR,6368,169,0.88 [0.61-1.25],0.4672514088717306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIDA,2-iminobutanoate/2-iminopropanoate deaminase,6435,173,0.83 [0.61-1.14],0.2477307041210339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILP,Rab-interacting lysosomal protein,7636,207,0.78 [0.63-0.96],0.0215663681855017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RILPL2,RILP-like protein 2,6580,177,1.03 [0.88-1.19],0.7357816986675089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RIPK4,Receptor-interacting serine/threonine-protein kinase 4,6354,169,0.98 [0.78-1.23],0.8774012975883908
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN1,Prorelaxin H1,6571,175,1.10 [0.83-1.47],0.5118771445902354
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RLN2,Prorelaxin H2,6427,173,0.49 [0.36-0.68],1.3625738410380944e-05
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE1,Ribonuclease pancreatic,6592,177,1.49 [0.91-2.45],0.1169121169472703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE10,Inactive ribonuclease-like protein 10,6393,171,0.94 [0.68-1.29],0.6984334658456115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE3,Eosinophil cationic protein,7539,206,1.08 [0.97-1.20],0.1564866559381653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE4,Ribonuclease 4,6372,170,1.22 [0.73-2.04],0.4419587290602447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASE6,Ribonuclease K6,6547,177,1.28 [0.88-1.87],0.1909127911966607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASEH2A,Ribonuclease H2 subunit A,6571,175,1.15 [0.88-1.49],0.3072538769741201
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNASET2,Ribonuclease T2,7648,210,1.42 [0.91-2.23],0.1249475990173158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF149,E3 ubiquitin-protein ligase RNF149,6393,171,1.35 [0.85-2.15],0.2004193916104171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF168,E3 ubiquitin-protein ligase RNF168,6368,169,0.74 [0.48-1.13],0.1618551301918935
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF31,E3 ubiquitin-protein ligase RNF31,6368,169,0.89 [0.57-1.39],0.6066632728767087
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF4,E3 ubiquitin-protein ligase RNF4,6448,175,1.02 [0.82-1.26],0.861568054852328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF41,E3 ubiquitin-protein ligase NRDP1,7437,205,0.96 [0.78-1.16],0.6486887769387455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF43,E3 ubiquitin-protein ligase RNF43,6448,175,1.00 [0.78-1.29],0.9878276127894888
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RNF5,E3 ubiquitin-protein ligase RNF5,6393,171,0.86 [0.71-1.05],0.1488226876047463
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO1,Roundabout homolog 1,7584,207,1.56 [0.96-2.56],0.0745445594176735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO2,Roundabout homolog 2,7641,209,1.81 [1.10-2.98],0.0202201992371122
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROBO4,Roundabout homolog 4,6393,171,2.01 [0.87-4.65],0.1020718307607586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,7572,207,1.42 [0.97-2.08],0.0715294935267289
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RP2,Protein XRP2,7543,206,0.92 [0.68-1.24],0.5772943344012815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPA2,Replication protein A 32 kDa subunit,6368,169,1.01 [0.62-1.64],0.9718401529375688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPE,Ribulose-phosphate 3-epimerase,6448,175,0.86 [0.69-1.07],0.1863450918307301
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPGR,X-linked retinitis pigmentosa GTPase regulator,6413,172,0.85 [0.57-1.27],0.4309995403820985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPL14,60S ribosomal protein L14,6393,171,1.00 [0.68-1.48],0.9973529105414288
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RPS10,40S ribosomal protein S10,6354,169,1.11 [0.78-1.57],0.5700881085103484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRAS,Ras-related protein R-Ras,6413,172,0.97 [0.87-1.10],0.6663328012923628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2,Ribonucleoside-diphosphate reductase subunit M2,7437,205,1.27 [1.02-1.58],0.0333982090714927
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,7437,205,0.96 [0.79-1.16],0.6449967253640468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RRP15,RRP15-like protein,6400,169,1.10 [0.93-1.29],0.2531778426993555
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO1,R-spondin-1,7503,207,0.76 [0.52-1.10],0.1430620625303534
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RSPO3,R-spondin-3,7659,207,1.24 [0.82-1.89],0.3139819605745486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTBDN,Retbindin,7543,206,0.86 [0.56-1.33],0.5006118387561795
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTKN2,Rhotekin-2,6354,169,1.22 [0.93-1.59],0.1443152875076076
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",6571,175,1.03 [0.88-1.21],0.7041961452136702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RTN4R,Reticulon-4 receptor,7659,207,1.62 [1.15-2.28],0.005483030822189
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RUVBL1,RuvB-like 1,7437,205,0.97 [0.85-1.10],0.6490339511359873
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RWDD1,RWD domain-containing protein 1,7641,209,0.88 [0.72-1.07],0.206538877533824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",RYR1,Ryanodine receptor 1,6354,169,1.11 [0.76-1.62],0.5793084880774124
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A11,Protein S100-A11,7523,206,1.11 [0.87-1.43],0.3999685772528563
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A12,Protein S100-A12,7477,202,1.04 [0.88-1.24],0.6366434108437702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A13,Protein S100-A13,6368,169,0.81 [0.52-1.27],0.3551280062913633
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A14,Protein S100-A14,6571,175,1.17 [0.89-1.53],0.2621257270125267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A16,Protein S100-A16,7410,204,1.04 [0.85-1.27],0.7333769708207175
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A3,Protein S100-A3,6554,173,1.04 [0.76-1.42],0.8272774288909317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100A4,Protein S100-A4,7608,208,0.80 [0.64-1.00],0.04868829799626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100G,Protein S100-G,6571,175,0.95 [0.71-1.28],0.7471921683320548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",S100P,Protein S100-P,7455,202,1.10 [0.88-1.36],0.3987404378906055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAA4,Serum amyloid A-4 protein,6589,178,0.67 [0.33-1.40],0.2881220649787509
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAFB2,Scaffold attachment factor B2,6571,175,1.09 [0.65-1.81],0.7430837883030209
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAG,S-arrestin,6400,169,1.19 [0.92-1.55],0.188548116839357
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAMD9L,Sterile alpha motif domain-containing protein 9-like,7573,209,0.94 [0.79-1.12],0.4817343224606125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAP18,Histone deacetylase complex subunit SAP18,6448,175,0.85 [0.68-1.07],0.1670329528131104
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SARG,Specifically androgen-regulated gene protein,6557,176,0.96 [0.84-1.10],0.5903266532304152
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SART1,U4/U6.U5 tri-snRNP-associated protein 1,6354,169,1.23 [0.85-1.78],0.2632593972983102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT1,Diamine acetyltransferase 1,6354,169,1.10 [0.83-1.47],0.4917821793806368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SAT2,Thialysine N-epsilon-acetyltransferase,6448,175,0.78 [0.60-1.01],0.0574155583500212
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SATB1,DNA-binding protein SATB1,6571,175,1.24 [0.82-1.89],0.3044966882954263
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SBSN,Suprabasin,6557,174,0.93 [0.62-1.40],0.7278830144221153
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCAMP3,Secretory carrier-associated membrane protein 3,7543,206,1.00 [0.86-1.16],0.9995586072492711
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARA5,Scavenger receptor class A member 5,7641,209,1.30 [0.88-1.93],0.1859017301363559
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB1,Scavenger receptor class B member 1,7422,204,1.09 [0.89-1.34],0.4148614423028099
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARB2,Lysosome membrane protein 2,7364,204,1.26 [0.88-1.81],0.2095234855203477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF1,Scavenger receptor class F member 1,7681,210,0.99 [0.74-1.33],0.96543105489435
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCARF2,Scavenger receptor class F member 2,7641,209,1.29 [0.86-1.95],0.2197708194096591
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG2,Secretogranin-2,7617,206,1.20 [0.83-1.73],0.3304945007603109
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCG3,Secretogranin-3,7584,207,1.44 [1.00-2.07],0.0479351140784033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB1A1,Uteroglobin,7582,206,0.92 [0.73-1.16],0.4793221724831213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB2A2,Mammaglobin-A,6354,169,1.02 [0.62-1.69],0.93265925701601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A1,Secretoglobin family 3A member 1,6435,173,0.90 [0.52-1.54],0.6998323098142799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGB3A2,Secretoglobin family 3A member 2,7598,207,0.97 [0.83-1.13],0.6821570724519626
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCGN,Secretagogin,7455,203,1.18 [0.89-1.57],0.2400114569207101
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCIN,Adseverin,6400,169,1.02 [0.84-1.25],0.8318472632794783
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCLY,Selenocysteine lyase,7636,207,0.96 [0.73-1.26],0.7476237681328077
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2A,Sodium channel protein type 2 subunit alpha,6400,169,1.24 [0.95-1.61],0.1063156565143186
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN2B,Sodium channel subunit beta-2,6413,172,1.06 [0.61-1.84],0.8281545708934719
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3A,Sodium channel protein type 3 subunit alpha,6413,172,0.87 [0.56-1.35],0.5332458525853647
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN3B,Sodium channel subunit beta-3,6400,169,1.02 [0.74-1.39],0.9132228209050448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCN4B,Sodium channel subunit beta-4,6393,171,1.17 [0.82-1.65],0.3852963275400384
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCP2,Non-specific lipid-transfer protein,7437,205,0.98 [0.82-1.17],0.8037926435324005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCPEP1,Retinoid-inducible serine carboxypeptidase,6371,170,1.01 [0.74-1.37],0.9478342139763528
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRG1,Scrapie-responsive protein 1,6580,177,1.55 [0.99-2.44],0.0561072497942378
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRIB,Protein scribble homolog,6393,171,0.88 [0.73-1.07],0.1926503136161471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCRN1,Secernin-1,7573,209,0.92 [0.73-1.16],0.4888192363390471
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SCT,Secretin,6413,172,1.21 [0.90-1.62],0.2094744924784687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC1,Syndecan-1,7572,207,1.06 [0.78-1.43],0.7256613637197558
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDC4,Syndecan-4,7572,207,1.07 [0.82-1.39],0.6354405148575537
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDCCAG8,Serologically defined colon cancer antigen 8,6554,173,0.93 [0.81-1.06],0.2855814826463971
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDHB,Succinate dehydrogenase,6553,176,1.04 [0.82-1.32],0.7627481264250755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SDK2,Protein sidekick-2,6435,173,1.38 [0.97-1.97],0.0768555098500541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEC31A,Protein transport protein Sec31A,6393,171,1.01 [0.84-1.23],0.8844489874499998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEL1L,Protein sel-1 homolog 1,6393,171,0.99 [0.59-1.65],0.9725523903651182
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELE,E-selectin,7681,210,1.21 [0.94-1.54],0.1374613888543963
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELENOP,Selenoprotein P,6589,178,0.95 [0.50-1.79],0.8632756840314952
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELL,L-selectin,6589,178,1.52 [0.79-2.96],0.2125144971413436
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELP,P-selectin,7623,207,1.13 [0.91-1.41],0.2813158921768481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SELPLG,P-selectin glycoprotein ligand 1,7573,209,0.63 [0.42-0.94],0.0238168401687948
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3F,Semaphorin-3F,7572,207,1.87 [1.19-2.95],0.0065989213294382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA3G,Semaphorin-3G,6435,173,1.03 [0.75-1.41],0.8539140809215782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4C,Semaphorin-4C,7543,206,0.97 [0.62-1.51],0.898712619079586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA4D,Semaphorin-4D,7641,209,1.15 [0.76-1.74],0.4939113891300097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA6C,Semaphorin-6C,6368,169,0.96 [0.53-1.75],0.8947663603456079
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEMA7A,Semaphorin-7A,7661,210,0.87 [0.56-1.36],0.5472805933691985
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN3,Neuronal-specific septin-3,6571,175,0.91 [0.74-1.10],0.3204022186933547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN7,Septin-7,6448,175,1.23 [1.00-1.52],0.0515456838168102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN8,Septin-8,6555,172,0.90 [0.57-1.43],0.6691008096686084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEPTIN9,Septin-9,7543,206,1.30 [0.87-1.94],0.2033511352918415
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA1,Alpha-1-antitrypsin,6450,174,0.45 [0.07-2.95],0.4069114662611491
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA11,Serpin A11,7681,210,1.55 [1.14-2.09],0.0048255478028877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA12,Serpin A12,7361,201,1.01 [0.89-1.15],0.8348376626614605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA3,Alpha-1-antichymotrypsin,6571,178,2.89 [1.38-6.07],0.0049457067069431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA4,Kallistatin,6453,172,1.64 [0.88-3.05],0.1197895958283057
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA5,Plasma serine protease inhibitor,6479,176,1.71 [1.12-2.60],0.0133179299312734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA6,Corticosteroid-binding globulin,6589,178,3.03 [1.22-7.54],0.016977380901727
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA7,Thyroxine-binding globulin,6589,178,1.80 [0.83-3.89],0.1351847750216769
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,7507,206,0.99 [0.83-1.17],0.8686424852192081
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB1,Leukocyte elastase inhibitor,7571,208,0.98 [0.86-1.13],0.8332980645948368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB5,Serpin B5,7455,202,1.48 [1.14-1.93],0.0031822127370299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB6,Serpin B6,7614,209,0.97 [0.78-1.21],0.7971422245493803
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB8,Serpin B8,7660,209,1.10 [0.91-1.33],0.3416823282299734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINB9,Serpin B9,7503,207,0.94 [0.64-1.38],0.7550607864913427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINC1,Antithrombin-III,6579,178,4.79 [1.92-11.94],0.0007928122765419
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPIND1,Heparin cofactor 2,6579,178,2.02 [1.22-3.36],0.0065057360595412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE1,Plasminogen activator inhibitor 1,7681,210,0.99 [0.83-1.20],0.9497811851362408
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINE2,Glia-derived nexin,6580,177,1.15 [0.92-1.44],0.2199740616459107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF1,Pigment epithelium-derived factor,6482,174,2.19 [1.30-3.68],0.0031324140470448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINF2,Alpha-2-antiplasmin,6449,174,5.88 [2.10-16.46],0.0007323226973468
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPING1,Plasma protease C1 inhibitor,6579,178,2.34 [1.08-5.07],0.0309154352340675
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINH1,Serpin H1,6448,175,0.95 [0.84-1.06],0.3511991266355264
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI1,Neuroserpin,6425,173,1.22 [0.74-2.04],0.4359324890262379
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SERPINI2,Serpin I2,6553,176,1.00 [0.77-1.31],0.9752834928902464
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SESTD1,SEC14 domain and spectrin repeat-containing protein 1,7422,204,0.98 [0.81-1.20],0.8551095829386447
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SETMAR,Histone-lysine N-methyltransferase SETMAR,7475,205,1.32 [0.89-1.96],0.1711312459064748
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6,Seizure protein 6 homolog,6413,172,1.29 [0.82-2.03],0.2735474427256698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L,Seizure 6-like protein,7608,208,1.39 [0.90-2.13],0.1341966995914074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SEZ6L2,Seizure 6-like protein 2,7543,206,1.82 [1.14-2.92],0.0125849128042981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SF3B4,Splicing factor 3B subunit 4,7543,206,0.96 [0.81-1.14],0.6703496369734296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP1,Secreted frizzled-related protein 1,7475,206,1.09 [0.82-1.45],0.5469228079777113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFRP4,Secreted frizzled-related protein 4,6435,173,1.04 [0.72-1.51],0.839347103022129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA1,Pulmonary surfactant-associated protein A1,7437,205,1.07 [0.85-1.33],0.5660964983814389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPA2,Pulmonary surfactant-associated protein A2,7437,205,1.23 [0.99-1.53],0.0654462834814794
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SFTPD,Pulmonary surfactant-associated protein D,7572,207,0.89 [0.74-1.07],0.2167394630876729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SGSH,N-sulphoglucosamine sulphohydrolase,6475,175,1.20 [0.93-1.55],0.170301102444653
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2B3,SH2B adapter protein 3,7437,205,0.91 [0.80-1.03],0.1501105905100543
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH2D1A,SH2 domain-containing protein 1A,7573,209,0.89 [0.71-1.12],0.3069671895398457
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,6400,169,0.89 [0.68-1.16],0.3833118329013547
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3BP1,SH3 domain-binding protein 1,6553,176,0.96 [0.71-1.30],0.8063117212839984
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GL3,Endophilin-A3,6420,175,0.98 [0.82-1.17],0.828140547418944
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SH3GLB2,Endophilin-B2,6567,172,0.84 [0.68-1.05],0.1369143457226623
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHBG,Sex hormone-binding globulin,6592,177,0.82 [0.60-1.13],0.2327135592128317
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHC1,SHC-transforming protein 1,6350,168,0.93 [0.81-1.07],0.3058674637322129
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHD,SH2 domain-containing adapter protein D,6340,168,0.90 [0.74-1.11],0.3271340641296352
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHH,Sonic hedgehog protein,6368,169,0.77 [0.53-1.12],0.1687689811341808
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHISA5,Protein shisa-5,6573,174,1.37 [0.82-2.30],0.2301315612047959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHMT1,"Serine hydroxymethyltransferase, cytosolic",7598,207,1.00 [0.86-1.16],0.9794209322833268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SHPK,Sedoheptulokinase,6448,175,1.06 [0.75-1.51],0.7386593514866442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIAE,Sialate O-acetylesterase,7599,208,0.99 [0.75-1.30],0.9489542357298196
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC1,Sialoadhesin,7605,207,1.45 [1.09-1.94],0.010815509390455
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,7573,209,1.56 [1.09-2.23],0.0140086301624388
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC15,Sialic acid-binding Ig-like lectin 15,7422,204,1.20 [1.04-1.38],0.0126906456972359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC5,Sialic acid-binding Ig-like lectin 5,7592,208,1.06 [0.94-1.18],0.3456565022387291
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,7659,207,1.21 [0.84-1.76],0.3086027337488095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC7,Sialic acid-binding Ig-like lectin 7,7572,207,1.17 [0.75-1.81],0.492213395600106
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC8,Sialic acid-binding Ig-like lectin 8,6393,171,1.32 [0.95-1.82],0.0947223700163589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIGLEC9,Sialic acid-binding Ig-like lectin 9,7648,207,1.34 [0.88-2.04],0.1663260630386805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIL1,Nucleotide exchange factor SIL1,6393,171,0.87 [0.52-1.45],0.586638518957086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,7610,208,1.03 [0.83-1.28],0.7762646718972328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRPB1,Signal-regulatory protein beta-1,7562,207,1.22 [0.94-1.57],0.1324904278933616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT1,NAD-dependent protein deacetylase sirtuin-1,6368,169,0.88 [0.71-1.08],0.2237776908083211
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT2,NAD-dependent protein deacetylase sirtuin-2,7543,206,0.90 [0.77-1.04],0.1410780943982694
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",7422,204,1.04 [0.82-1.32],0.7416182248845768
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SIT1,Signaling threshold-regulating transmembrane adapter 1,7455,203,0.92 [0.73-1.16],0.4771347503983019
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP1,Src kinase-associated phosphoprotein 1,7493,207,0.91 [0.76-1.08],0.2835016327905394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKAP2,Src kinase-associated phosphoprotein 2,7605,207,1.02 [0.90-1.15],0.7564562718559504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SKIV2L,Helicase SKI2W,6354,169,0.79 [0.51-1.22],0.2852388973433206
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLA2,Src-like-adapter 2,6571,175,0.99 [0.86-1.14],0.9129829688296658
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF1,Signaling lymphocytic activation molecule,7455,203,1.06 [0.86-1.31],0.5604826974405832
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,7437,205,1.27 [0.91-1.78],0.1551672222664156
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF7,SLAM family member 7,7573,209,1.04 [0.85-1.29],0.6870835556657318
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLAMF8,SLAM family member 8,7437,205,0.92 [0.73-1.16],0.4925598158813845
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC12A2,Solute carrier family 12 member 2,6354,169,1.39 [0.85-2.26],0.1873229520130857
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC13A1,Solute carrier family 13 member 1,6554,173,1.11 [0.89-1.38],0.353341923693086
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC16A1,Monocarboxylate transporter 1,7422,204,0.96 [0.76-1.22],0.731347434654517
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC1A4,Neutral amino acid transporter A,6413,172,1.07 [0.80-1.42],0.6589420377994228
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC27A4,Long-chain fatty acid transport protein 4,7422,204,0.95 [0.78-1.16],0.620413852069931
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC28A1,Sodium/nucleoside cotransporter 1,6350,168,0.88 [0.66-1.16],0.3560385245918001
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC34A3,Sodium-dependent phosphate transport protein 2C,6350,168,0.79 [0.55-1.14],0.2074795700301197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A14,Zinc transporter ZIP14,7422,204,0.94 [0.65-1.36],0.7409383010839734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC39A5,Zinc transporter ZIP5,7573,209,1.04 [0.81-1.33],0.7584076736720393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC44A4,Choline transporter-like protein 4,6413,172,1.04 [0.83-1.29],0.7464301998231745
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC4A1,Band 3 anion transport protein,6573,174,0.74 [0.54-1.01],0.0549131383617495
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC51B,Organic solute transporter subunit beta,6354,169,1.13 [0.93-1.38],0.2157366136445508
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,6435,173,1.03 [0.86-1.22],0.7720144167809959
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,6553,176,1.04 [0.79-1.37],0.8013078985155193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",6350,168,0.85 [0.63-1.14],0.2776131240232879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLIT2,Slit homolog 2 protein,7422,204,1.01 [0.79-1.27],0.9644539534639978
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK1,SLIT and NTRK-like protein 1,6368,169,1.01 [0.64-1.60],0.9532747844502698
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK2,SLIT and NTRK-like protein 2,7659,207,1.37 [1.02-1.85],0.0359313844544336
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLITRK6,SLIT and NTRK-like protein 6,7455,202,1.65 [1.18-2.30],0.0031384386387572
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLK,STE20-like serine/threonine-protein kinase,6448,175,1.03 [0.86-1.23],0.7410116167058387
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLMAP,Sarcolemmal membrane-associated protein,6553,176,0.90 [0.75-1.08],0.2654338091422041
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SLURP1,Secreted Ly-6/uPAR-related protein 1,6520,172,0.89 [0.58-1.35],0.5794489767371014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD1,Mothers against decapentaplegic homolog 1,7437,205,0.99 [0.85-1.15],0.8922370103073082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD2,Mothers against decapentaplegic homolog 2,6554,173,0.92 [0.74-1.14],0.4286914377343082
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD3,Mothers against decapentaplegic homolog 3,6554,173,0.84 [0.63-1.12],0.2354363313477687
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMAD5,Mothers against decapentaplegic homolog 5,7543,206,1.52 [0.79-2.94],0.2074135305667896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMARCA2,Probable global transcription activator SNF2L2,7422,204,1.04 [0.87-1.23],0.6858684805740083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMC3,Structural maintenance of chromosomes protein 3,6350,168,0.99 [0.74-1.33],0.94610865899274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMNDC1,Survival of motor neuron-related-splicing factor 30,6553,176,0.95 [0.74-1.22],0.6808287940819976
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC1,SPARC-related modular calcium-binding protein 1,7659,207,1.40 [0.97-2.02],0.071203318156197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMOC2,SPARC-related modular calcium-binding protein 2,7605,207,1.22 [0.90-1.65],0.2067540529028213
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD1,Sphingomyelin phosphodiesterase,7601,209,0.98 [0.77-1.24],0.843926837573224
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPD3,Sphingomyelin phosphodiesterase 3,6368,169,0.84 [0.61-1.16],0.2880370254233139
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,7594,207,0.94 [0.78-1.13],0.5241859978170442
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,6554,173,1.07 [0.89-1.28],0.4617749090489094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMS,Spermine synthase,6400,169,1.12 [0.90-1.39],0.3218123000225998
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SMTN,Smoothelin,6554,170,0.95 [0.80-1.13],0.5538107882306856
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP23,Synaptosomal-associated protein 23,7572,207,0.93 [0.81-1.07],0.3115290219438273
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP25,Synaptosomal-associated protein 25,6400,169,1.07 [0.79-1.46],0.6534343675812024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAP29,Synaptosomal-associated protein 29,7608,208,0.99 [0.87-1.14],0.9128755313729916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNAPIN,SNARE-associated protein Snapin,6571,175,0.86 [0.66-1.11],0.2378828465027055
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCA,Alpha-synuclein,6435,173,1.00 [0.88-1.14],0.9607846338775116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNCG,Gamma-synuclein,7503,207,1.04 [0.86-1.25],0.6934732354339865
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",6393,171,1.45 [0.95-2.21],0.0839995939100482
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNRPB2,U2 small nuclear ribonucleoprotein B'',6567,172,1.13 [0.86-1.49],0.36800455221605
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNU13,NHP2-like protein 1,6354,169,0.99 [0.77-1.27],0.9393252796730116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX15,Sorting nexin-15,6435,173,0.83 [0.63-1.11],0.2069948704771836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX18,Sorting nexin-18,6553,176,0.59 [0.39-0.89],0.0127522392888818
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX2,Sorting nexin-2,6554,173,1.04 [0.88-1.22],0.6326739340009062
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX5,Sorting nexin-5,6393,171,1.13 [0.68-1.87],0.633463881691638
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SNX9,Sorting nexin-9,7572,207,0.89 [0.74-1.08],0.2570432984900406
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD1,Superoxide dismutase [Cu-Zn],7450,203,0.85 [0.65-1.12],0.2474687384389486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD2,"Superoxide dismutase [Mn], mitochondrial",7592,208,1.01 [0.73-1.41],0.9295820035876556
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOD3,Extracellular superoxide dismutase,6592,177,0.98 [0.77-1.26],0.8856163743321804
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORBS1,Sorbin and SH3 domain-containing protein 1,6571,175,0.71 [0.46-1.11],0.137825110289764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORCS2,VPS10 domain-containing receptor SorCS2,7437,205,1.35 [0.96-1.91],0.0816984707729525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORD,Sorbitol dehydrogenase,7623,207,0.76 [0.64-0.91],0.0022923723014172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SORT1,Sortilin,7561,206,1.11 [0.80-1.55],0.5214912630466539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOST,Sclerostin,7561,206,1.07 [0.78-1.48],0.66095252649394
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,6413,172,0.87 [0.62-1.22],0.4180100038815229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX2,Transcription factor SOX-2,6555,175,1.43 [0.84-2.43],0.1891107033751515
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SOX9,Transcription factor SOX-9,6413,172,1.28 [0.73-2.21],0.386842174800143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPACA5_SPACA5B,Sperm acrosome-associated protein 5,6571,175,0.91 [0.55-1.52],0.7293673465404961
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPAG1,Sperm-associated antigen 1,6571,175,1.02 [0.79-1.31],0.9004387199048535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARC,SPARC,7608,208,1.00 [0.84-1.19],0.9955392193069283
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPARCL1,SPARC-like protein 1,7598,207,1.44 [0.97-2.14],0.0669114057490116
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPART,Spartin,6435,173,0.90 [0.74-1.10],0.3065990329537298
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPESP1,Sperm equatorial segment protein 1,6580,177,1.12 [0.74-1.69],0.597069874696705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK1,Serine protease inhibitor Kazal-type 1,7592,208,1.17 [0.89-1.56],0.260689819639025
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK2,Serine protease inhibitor Kazal-type 2,6435,173,0.69 [0.45-1.07],0.0971874565502744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK4,Serine protease inhibitor Kazal-type 4,7573,209,0.99 [0.82-1.19],0.8936402641088343
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK5,Serine protease inhibitor Kazal-type 5,7592,208,0.89 [0.63-1.27],0.5168492339244245
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK6,Serine protease inhibitor Kazal-type 6,7659,207,1.05 [0.83-1.33],0.6812768876942359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINK8,Serine protease inhibitor Kazal-type 8,6354,169,1.24 [0.83-1.85],0.2885544249990486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT1,Kunitz-type protease inhibitor 1,7569,208,1.16 [0.73-1.84],0.5398587475490855
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT2,Kunitz-type protease inhibitor 2,7605,207,0.91 [0.66-1.25],0.5571546931718864
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPINT3,Kunitz-type protease inhibitor 3,6553,176,0.76 [0.70-0.82],2.68091378098248e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPOCK1,Testican-1,7503,207,0.60 [0.37-0.96],0.0332896740725937
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON1,Spondin-1,7584,207,1.43 [1.00-2.05],0.048795765636826
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPON2,Spondin-2,7542,206,1.18 [0.83-1.66],0.3571534247090754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPP1,Osteopontin,7669,209,1.29 [0.99-1.69],0.0591373716767539
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",6368,169,0.98 [0.68-1.40],0.8904070594885098
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRING1,SREBP regulating gene protein,6350,168,0.93 [0.72-1.20],0.5893597368611548
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR1B,Cornifin-B,6448,175,0.95 [0.79-1.14],0.594160854404885
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRR3,Small proline-rich protein 3,6567,172,1.02 [0.81-1.29],0.8491230922339146
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPRY2,Protein sprouty homolog 2,7455,203,1.00 [0.87-1.15],0.9842309250947044
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTBN2,"Spectrin beta chain, non-erythrocytic 2",6400,169,0.89 [0.55-1.44],0.6319376339049185
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SPTLC1,Serine palmitoyltransferase 1,6567,172,1.21 [0.87-1.67],0.2540224501325171
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRC,Proto-oncogene tyrosine-protein kinase Src,7596,208,0.99 [0.89-1.09],0.8060945536117252
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRP14,Signal recognition particle 14 kDa protein,7543,206,1.02 [0.82-1.26],0.8906446973070125
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPK2,SRSF protein kinase 2,7573,209,0.92 [0.79-1.07],0.2846347504711339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SRPX,Sushi repeat-containing protein SRPX,6580,177,0.99 [0.69-1.41],0.9524144387861736
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSB,Lupus La protein,7422,204,0.93 [0.75-1.17],0.5384453590438671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSBP1,"Single-stranded DNA-binding protein, mitochondrial",6368,169,0.98 [0.62-1.54],0.932476955755466
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,7561,206,1.05 [0.95-1.16],0.3734823591811586
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,7623,207,1.59 [1.18-2.12],0.0020439324067314
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSH3,Protein phosphatase Slingshot homolog 3,6350,168,0.65 [0.37-1.14],0.1312777827847693
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SSNA1,Sjoegren syndrome nuclear autoantigen 1,6553,176,0.88 [0.66-1.18],0.4031396503823566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST13,Hsc70-interacting protein,6435,173,0.84 [0.64-1.10],0.2043733491281588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",7543,206,1.12 [0.85-1.49],0.4156017297059703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",7681,210,1.65 [1.18-2.30],0.0033051209076909
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",6368,169,0.94 [0.69-1.28],0.6899428506422011
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAB2,Stabilin-2,6573,174,1.55 [0.91-2.64],0.1102166236987382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAM,Signal transducing adapter molecule 1,6554,173,0.71 [0.46-1.12],0.1434304858142523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAMBP,STAM-binding protein,7493,207,0.84 [0.69-1.03],0.09868843941193
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT2,Signal transducer and activator of transcription 2,6368,169,0.92 [0.75-1.13],0.4130592977400145
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAT5B,Signal transducer and activator of transcription 5B,7543,206,0.95 [0.87-1.04],0.2844181630176332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STAU1,Double-stranded RNA-binding protein Staufen homolog 1,6350,168,0.93 [0.73-1.18],0.5442210078125476
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC1,Stanniocalcin-1,7641,209,1.05 [0.80-1.37],0.7338866286384426
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STC2,Stanniocalcin-2,7582,205,1.46 [0.86-2.48],0.1568221925455799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STEAP4,Metalloreductase STEAP4,6400,169,1.06 [0.87-1.29],0.5860457159347143
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STIP1,Stress-induced-phosphoprotein 1,7579,208,0.87 [0.71-1.06],0.1676740945730921
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK11,Serine/threonine-protein kinase STK11,7455,202,0.96 [0.80-1.15],0.6585977873113757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK24,Serine/threonine-protein kinase 24,7422,204,0.97 [0.79-1.20],0.8070167429083439
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STK4,Serine/threonine-protein kinase 4,7572,207,1.00 [0.86-1.15],0.982217272179546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STOML2,"Stomatin-like protein 2, mitochondrial",6350,168,1.01 [0.86-1.19],0.8772596743391912
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX16,Syntaxin-16,7437,205,0.90 [0.71-1.14],0.3691894017186876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX1B,Syntaxin-1B,6413,172,1.10 [0.76-1.58],0.6146356215678097
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX3,Syntaxin-3,6567,172,0.98 [0.67-1.44],0.9250382571498782
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX4,Syntaxin-4,7543,206,0.94 [0.76-1.17],0.580790363797395
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX5,Syntaxin-5,6368,169,1.06 [0.74-1.52],0.7611129526635084
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX6,Syntaxin-6,7437,205,0.92 [0.75-1.13],0.4175438714553151
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX7,Syntaxin-7,6368,169,0.91 [0.67-1.24],0.5492364971020507
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STX8,Syntaxin-8,7573,209,1.09 [0.84-1.41],0.5282599225452578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP1,Syntaxin-binding protein 1,6571,175,1.00 [0.82-1.20],0.9595504727934746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",STXBP3,Syntaxin-binding protein 3,7437,205,1.10 [0.83-1.46],0.5191325629558602
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGP1,SURP and G-patch domain-containing protein 1,6553,176,0.66 [0.44-0.99],0.0468470523362049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUGT1,Protein SGT1 homolog,7437,205,0.91 [0.78-1.07],0.2635660429543877
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT1A1,Sulfotransferase 1A1,7641,209,0.96 [0.88-1.06],0.4640618997251997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SULT2A1,Bile salt sulfotransferase,7573,209,0.83 [0.66-1.05],0.1283453821349095
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF1,Formylglycine-generating enzyme,6368,169,0.99 [0.77-1.26],0.928734356231628
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,7641,209,1.01 [0.79-1.28],0.9623892071533164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUOX,"Sulfite oxidase, mitochondrial",6571,175,0.89 [0.70-1.14],0.3607892653450334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD1,Sushi domain-containing protein 1,7455,202,0.89 [0.69-1.16],0.3928107394114815
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD2,Sushi domain-containing protein 2,7592,208,1.33 [0.88-2.04],0.1802553235863042
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD4,Sushi domain-containing protein 4,6554,173,1.18 [0.84-1.66],0.3412847733014672
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SUSD5,Sushi domain-containing protein 5,6406,173,1.24 [0.81-1.90],0.327215693294977
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SV2A,Synaptic vesicle glycoprotein 2A,6413,172,1.12 [0.90-1.40],0.2989703148256523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SWAP70,Switch-associated protein 70,6553,176,0.96 [0.64-1.46],0.8590837071816941
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYAP1,Synapse-associated protein 1,6435,173,1.06 [0.82-1.37],0.6457984609729823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,6400,169,1.14 [0.90-1.45],0.2777152599247083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYT1,Synaptotagmin-1,6567,172,1.00 [0.71-1.42],0.9798588837764112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",SYTL4,Synaptotagmin-like protein 4,6580,177,1.09 [0.89-1.32],0.4012514610159113
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,6448,175,0.90 [0.78-1.04],0.1515835798293913
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACC3,Transforming acidic coiled-coil-containing protein 3,7543,206,0.94 [0.85-1.05],0.2648788691190874
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TACSTD2,Tumor-associated calcium signal transducer 2,6697,182,0.68 [0.43-1.07],0.0965587765666067
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TADA3,Transcriptional adapter 3,6554,173,0.96 [0.66-1.39],0.8286360634126823
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAFA5,Chemokine-like protein TAFA-5,7543,206,1.21 [0.88-1.68],0.2362792893292514
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAGLN3,Transgelin-3,6350,168,0.90 [0.69-1.17],0.4357058091919519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TALDO1,Transaldolase,6554,174,0.90 [0.64-1.27],0.5544075221156599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TANK,TRAF family member-associated NF-kappa-B activator,7455,203,0.91 [0.76-1.10],0.348082058299757
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAP1,Antigen peptide transporter 1,6448,175,0.98 [0.75-1.28],0.8739934166089107
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARBP2,RISC-loading complex subunit TARBP2,7422,204,0.96 [0.82-1.13],0.6412015077382893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",6413,172,1.08 [0.90-1.30],0.3910260416037634
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TARS1,"Threonine--tRNA ligase 1, cytoplasmic",6554,173,0.85 [0.57-1.27],0.4325145820613005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TAX1BP1,Tax1-binding protein 1,6567,172,0.88 [0.69-1.14],0.337161318921063
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D17,TBC1 domain family member 17,7422,204,0.63 [0.46-0.87],0.0047618527118299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D23,TBC1 domain family member 23,7543,206,0.98 [0.85-1.12],0.7298949533566708
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBC1D5,TBC1 domain family member 5,7573,209,1.04 [0.89-1.22],0.5926856506296214
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCA,Tubulin-specific chaperone A,6435,173,0.92 [0.77-1.11],0.4015936087312824
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCB,Tubulin-folding cofactor B,7503,207,0.95 [0.84-1.07],0.3894831751260691
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBCC,Tubulin-specific chaperone C,7503,207,0.92 [0.79-1.08],0.3097936667180012
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBL1X,F-box-like/WD repeat-containing protein TBL1X,7437,205,0.97 [0.84-1.13],0.7313551796532751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TBR1,T-box brain protein 1,6413,172,0.91 [0.65-1.27],0.577088831834762
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1A,T-cell leukemia/lymphoma protein 1A,7497,206,0.96 [0.85-1.08],0.4807380805511456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCL1B,T-cell leukemia/lymphoma protein 1B,7455,202,1.08 [0.93-1.25],0.3026471029083396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN1,Transcobalamin-1,6458,175,1.22 [0.82-1.83],0.3203971932502744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCN2,Transcobalamin-2,7669,209,1.17 [0.80-1.70],0.4271365001886434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCOF1,Treacle protein,6580,177,1.48 [0.99-2.21],0.0538170224694278
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCP11,T-complex protein 11 homolog,6448,175,0.96 [0.73-1.27],0.7840711782971731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TCTN3,Tectonic-3,6580,177,1.56 [0.96-2.51],0.0709003776859266
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDGF1,Teratocarcinoma-derived growth factor 1,7422,204,1.08 [1.00-1.18],0.0611023117623049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDO2,"Tryptophan 2,3-dioxygenase",6413,172,1.07 [0.72-1.59],0.7292280253728034
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDP1,Tyrosyl-DNA phosphodiesterase 1,6554,173,1.04 [0.85-1.26],0.729815151020754
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TDRKH,Tudor and KH domain-containing protein,7422,204,0.91 [0.78-1.07],0.2462754577441614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEF,Thyrotroph embryonic factor,6354,169,1.25 [0.92-1.70],0.161747651241241
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEK,Angiopoietin-1 receptor,7608,208,1.45 [0.84-2.51],0.1872717166522274
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TERF1,Telomeric repeat-binding factor 1,6368,169,1.52 [0.93-2.48],0.097766326798666
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TET2,Methylcytosine dioxygenase TET2,6432,175,1.08 [0.95-1.22],0.2431775150607749
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX101,Testis-expressed protein 101,6413,172,0.64 [0.50-0.81],0.00027638684123
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TEX33,Testis-expressed protein 33,6448,175,0.85 [0.54-1.33],0.4802702828590229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TF,Serotransferrin,6589,178,1.65 [0.86-3.20],0.1341193580872504
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFAP2A,Transcription factor AP-2-alpha,6400,169,0.99 [0.78-1.26],0.9510182129729722
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF1,Trefoil factor 1,7559,207,1.12 [0.97-1.30],0.1213315759040564
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF2,Trefoil factor 2,7598,207,1.13 [0.92-1.38],0.255298926048486
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFF3,Trefoil factor 3,7585,207,1.38 [1.03-1.84],0.0307059925649981
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI,Tissue factor pathway inhibitor,7578,204,1.70 [1.25-2.32],0.0008289673319244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFPI2,Tissue factor pathway inhibitor 2,7587,208,1.47 [1.16-1.86],0.0013458957482906
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TFRC,Transferrin receptor protein 1,7618,207,1.48 [1.09-2.02],0.0114034396491679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TG,Thyroglobulin,6554,173,1.23 [1.08-1.39],0.0017228859828571
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFA,Protransforming growth factor alpha,7573,209,1.16 [0.89-1.52],0.2678292472030296
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB1,Transforming growth factor beta-1 proprotein,7648,209,0.97 [0.70-1.33],0.8355142583233999
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFB2,Transforming growth factor beta-2 proprotein,6554,173,1.01 [0.76-1.32],0.9714612949670576
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBI,Transforming growth factor-beta-induced protein ig-h3,7558,203,1.12 [0.71-1.78],0.62369829639923
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR1,TGF-beta receptor type-1,6368,169,1.05 [0.53-2.10],0.8831137047971684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR2,TGF-beta receptor type-2,7608,208,1.82 [1.34-2.47],0.0001279889187983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGFBR3,Transforming growth factor beta receptor type 3,7681,210,1.09 [0.73-1.63],0.669022777077162
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGM2,Protein-glutamine gamma-glutamyltransferase 2,7562,207,0.81 [0.69-0.96],0.0135219334605368
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TGOLN2,Trans-Golgi network integral membrane protein 2,6592,177,1.38 [0.82-2.34],0.2233683722928523
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THAP12,52 kDa repressor of the inhibitor of the protein kinase,6343,168,1.03 [0.86-1.23],0.7726382840950932
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBD,Thrombomodulin,7572,207,1.50 [1.03-2.19],0.0342863442926103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS2,Thrombospondin-2,7592,208,1.10 [0.80-1.49],0.5605930856825089
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THBS4,Thrombospondin-4,7598,204,1.18 [0.90-1.54],0.2407663965464678
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THOP1,Thimet oligopeptidase,7537,206,0.79 [0.54-1.16],0.2326441996805268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THPO,Thrombopoietin,7455,202,1.20 [0.87-1.66],0.2595618330884334
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THRAP3,Thyroid hormone receptor-associated protein 3,6354,169,1.10 [0.97-1.24],0.136246374387573
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THSD1,Thrombospondin type-1 domain-containing protein 1,6317,168,0.82 [0.51-1.31],0.4011841853678275
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THTPA,Thiamine-triphosphatase,6540,173,0.90 [0.76-1.07],0.2318914887102493
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",THY1,Thy-1 membrane glycoprotein,7641,209,1.43 [0.95-2.14],0.0848757209139964
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIA1,Nucleolysin TIA-1 isoform p40,7376,202,0.98 [0.89-1.09],0.7699261858193642
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIE1,Tyrosine-protein kinase receptor Tie-1,7681,210,1.21 [0.88-1.67],0.2335256255173475
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGAR,"Fructose-2,6-bisphosphatase TIGAR",7412,204,1.05 [0.80-1.38],0.7032629319273733
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,6448,175,1.00 [0.68-1.47],0.9896146982509876
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,7623,207,1.69 [1.27-2.23],0.000263141460575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,6580,177,1.20 [0.84-1.71],0.3243885290547262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,6567,172,0.92 [0.78-1.10],0.3823948201132849
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP1,Metalloproteinase inhibitor 1,7517,204,1.36 [0.90-2.06],0.1413455543488349
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP2,Metalloproteinase inhibitor 2,6580,177,1.01 [0.61-1.66],0.9729635891742668
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP3,Metalloproteinase inhibitor 3,7605,207,0.99 [0.90-1.09],0.8030925842169496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TIMP4,Metalloproteinase inhibitor 4,7592,208,0.99 [0.73-1.35],0.9720704285481164
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TINAGL1,Tubulointerstitial nephritis antigen-like,7551,206,1.64 [0.94-2.87],0.0837769153461246
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJAP1,Tight junction-associated protein 1,7608,208,0.92 [0.79-1.07],0.296063645311056
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TJP3,Tight junction protein ZO-3,6400,169,1.28 [0.95-1.74],0.108320562228809
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TK1,"Thymidine kinase, cytosolic",6448,175,0.82 [0.57-1.17],0.2716580020146991
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR1,Toll-like receptor 1,6368,169,1.10 [0.62-1.94],0.742218367467702
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR2,Toll-like receptor 2,6448,175,1.56 [0.83-2.94],0.1647626633777017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR3,Toll-like receptor 3,7660,209,0.88 [0.72-1.07],0.1854990703107867
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TLR4,Toll-like receptor 4,6368,169,1.67 [1.01-2.79],0.0471014215808492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,6413,172,1.13 [0.88-1.46],0.3392425699581829
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED1,Transmembrane emp24 domain-containing protein 1,6448,175,1.07 [0.84-1.38],0.5718569787347021
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED10,Transmembrane emp24 domain-containing protein 10,6354,169,1.23 [0.97-1.57],0.0868154088735522
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED4,Transmembrane emp24 domain-containing protein 4,6354,169,0.90 [0.68-1.21],0.4941930314962535
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMED8,Protein TMED8,6553,176,0.95 [0.82-1.09],0.4539417167833892
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM106A,Transmembrane protein 106A,6554,173,1.05 [0.85-1.29],0.6480796941220016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM132A,Transmembrane protein 132A,6393,171,0.99 [0.78-1.26],0.9143282882588726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMEM25,Transmembrane protein 25,6571,175,1.19 [0.90-1.58],0.225068406175726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMOD4,Tropomodulin-4,6350,168,0.82 [0.55-1.22],0.3346055824528094
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11B,Transmembrane protease serine 11B,6400,169,0.99 [0.81-1.21],0.9086846623299778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS11D,Transmembrane protease serine 11D,6555,172,0.92 [0.63-1.34],0.661137410660344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS15,Enteropeptidase,7543,206,0.99 [0.86-1.14],0.8953177056343744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMPRSS5,Transmembrane protease serine 5,7469,205,1.14 [0.83-1.59],0.4175622955151492
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TMSB10,Thymosin beta-10,7592,208,1.03 [0.87-1.22],0.6912920159484792
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNC,Tenascin,7623,207,1.08 [0.84-1.40],0.5552521502802036
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,7451,202,1.28 [0.95-1.72],0.1031694031247373
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP2,Tumor necrosis factor alpha-induced protein 2,6553,176,0.90 [0.65-1.23],0.5050684895596904
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8,Tumor necrosis factor alpha-induced protein 8,7455,203,0.95 [0.67-1.34],0.7713012889634177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,6435,173,1.10 [0.87-1.39],0.4317943332413481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,7503,207,1.14 [0.79-1.64],0.4870283191976483
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,7503,207,1.14 [0.89-1.45],0.3017736045061049
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,7605,208,1.29 [0.99-1.67],0.0626519216702519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,7660,209,1.06 [0.78-1.43],0.702419087506448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,7573,207,1.33 [0.88-2.01],0.1730649889452797
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,7608,208,1.17 [0.84-1.64],0.3490121272310498
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,7584,207,1.35 [0.96-1.91],0.0842186709295778
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,7455,203,1.02 [0.74-1.39],0.9206396803950746
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF14,Tumor necrosis factor receptor superfamily member 14,7584,207,1.46 [1.00-2.13],0.0479287870823587
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF17,Tumor necrosis factor receptor superfamily member 17,6435,173,1.17 [0.83-1.67],0.3708621791283115
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF19,Tumor necrosis factor receptor superfamily member 19,7659,207,1.24 [0.88-1.76],0.2143443797085916
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,7592,208,1.54 [1.08-2.21],0.0183697891619819
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,7592,208,1.35 [1.03-1.76],0.0284516626074732
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF21,Tumor necrosis factor receptor superfamily member 21,7641,209,1.77 [1.17-2.67],0.0069383807558744
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,7648,209,1.44 [1.07-1.95],0.0167845572879773
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,7503,207,1.21 [0.98-1.48],0.0764187126394636
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,7641,209,1.25 [0.96-1.63],0.1018682913621208
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,7503,207,1.57 [1.20-2.06],0.0011376522999022
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF10,Tumor necrosis factor ligand superfamily member 10,7660,209,1.93 [1.19-3.14],0.0082248871694997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF11,Tumor necrosis factor ligand superfamily member 11,7573,209,1.19 [0.96-1.46],0.1057511508314496
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF12,Tumor necrosis factor ligand superfamily member 12,7660,209,0.87 [0.56-1.36],0.5373752705482204
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13,Tumor necrosis factor ligand superfamily member 13,7605,207,1.01 [0.64-1.60],0.9556520380415724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,7670,210,1.95 [1.32-2.88],0.0007435045181148
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF14,Tumor necrosis factor ligand superfamily member 14,7503,207,0.95 [0.76-1.18],0.653642187929601
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,6573,174,1.10 [0.75-1.64],0.6210290457653983
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNIP1,TNFAIP3-interacting protein 1,6567,172,0.96 [0.81-1.14],0.6369155383561527
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNN,Tenascin-N,6573,174,1.04 [0.75-1.46],0.8001087165183614
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNNI3,"Troponin I, cardiac muscle",7455,202,0.99 [0.85-1.15],0.8510539254878567
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNPO1,Transportin-1,6448,175,1.30 [0.86-1.97],0.2091296445547511
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNR,Tenascin-R,7503,207,1.47 [1.11-1.94],0.0076795678132484
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TNXB,Tenascin-X,7592,208,1.37 [0.85-2.19],0.1948449356836232
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOMM20,Mitochondrial import receptor subunit TOM20 homolog,6580,177,1.04 [0.86-1.26],0.6749062017765619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1,DNA topoisomerase 1,6553,176,1.05 [0.93-1.19],0.4244761784919875
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP1MT,"DNA topoisomerase I, mitochondrial",6350,168,0.75 [0.52-1.07],0.1076829173680434
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOP2B,DNA topoisomerase 2-beta,6368,169,0.96 [0.79-1.17],0.70616628909811
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TOR1AIP1,Torsin-1A-interacting protein 1,6393,171,1.11 [0.85-1.46],0.4510098419522997
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53,Cellular tumor antigen p53,7437,205,1.02 [0.76-1.37],0.8752597043847751
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53BP1,TP53-binding protein 1,6368,169,0.94 [0.78-1.12],0.4785438893958627
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53I3,Quinone oxidoreductase PIG3,6287,168,0.89 [0.66-1.19],0.424049777892016
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP53INP1,Tumor protein p53-inducible nuclear protein 1,7455,202,1.31 [0.90-1.89],0.1577795040088416
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TP73,Tumor protein p73,6413,172,1.09 [0.70-1.69],0.7146200270801726
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPBGL,Trophoblast glycoprotein-like,6413,172,1.06 [0.76-1.49],0.7197720003660344
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPD52L2,Tumor protein D54,6435,173,1.04 [0.90-1.19],0.5888682057041603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPK1,Thiamin pyrophosphokinase 1,6580,177,1.14 [0.67-1.93],0.6268997137553578
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPM3,Tropomyosin alpha-3 chain,6354,169,0.92 [0.66-1.29],0.6298637716035389
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPMT,Thiopurine S-methyltransferase,7437,205,0.94 [0.79-1.13],0.5132918232436374
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPP1,Tripeptidyl-peptidase 1,7526,205,1.01 [0.77-1.32],0.9373766529077032
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP2,Tubulin polymerization-promoting protein family member 2,6448,175,1.05 [0.88-1.25],0.6103796651916975
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPPP3,Tubulin polymerization-promoting protein family member 3,7422,204,1.01 [0.73-1.39],0.9625527167780764
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPR,Nucleoprotein TPR,6354,169,0.95 [0.69-1.31],0.7485622146468074
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPRKB,EKC/KEOPS complex subunit TPRKB,6350,168,1.05 [0.85-1.30],0.6376090848239584
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSAB1,Tryptase alpha/beta-1,7650,209,0.94 [0.74-1.20],0.6319587085391731
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSD1,Tryptase delta,6571,175,0.91 [0.61-1.36],0.635423072230519
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPSG1,Tryptase gamma,6368,169,0.90 [0.50-1.62],0.7305648148216114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TPT1,Translationally-controlled tumor protein,7455,203,0.89 [0.72-1.11],0.3042391640501279
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF2,TNF receptor-associated factor 2,7573,209,0.76 [0.63-0.92],0.0051597717168705
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3,"TNF receptor-associated factor 3, Isoform 2",6368,169,0.90 [0.60-1.36],0.6234030628349237
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,6354,169,1.11 [0.83-1.48],0.4687447417820681
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,6448,175,1.16 [1.00-1.35],0.0541208161285112
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREH,Trehalase,6573,174,1.10 [0.90-1.35],0.3649245090095024
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREM2,Triggering receptor expressed on myeloid cells 2,7573,207,1.42 [1.14-1.77],0.0017357050157607
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML1,Trem-like transcript 1 protein,6592,177,0.96 [0.72-1.27],0.7643975217598933
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TREML2,Trem-like transcript 2 protein,7592,208,1.25 [0.88-1.79],0.217257039705091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIAP1,TP53-regulated inhibitor of apoptosis 1,7659,207,0.99 [0.81-1.22],0.9284704353862414
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM21,E3 ubiquitin-protein ligase TRIM21,7573,209,0.84 [0.71-0.99],0.0398475096193755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM24,Transcription intermediary factor 1-alpha,6441,175,0.89 [0.70-1.12],0.3186214297562403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,6553,176,0.91 [0.79-1.05],0.1896114212887302
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM26,Tripartite motif-containing protein 26,6350,168,0.88 [0.65-1.18],0.3904077285458789
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM40,E3 ubiquitin ligase TRIM40,6413,172,1.04 [0.85-1.28],0.7015345504135091
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM5,Tripartite motif-containing protein 5,7573,209,0.92 [0.80-1.07],0.2716466765397102
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRIM58,E3 ubiquitin-protein ligase TRIM58,6554,173,0.93 [0.78-1.10],0.3863120118773828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TRPV3,Transient receptor potential cation channel subfamily V member 3,6354,169,0.96 [0.70-1.32],0.8077995016624299
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC1,Hamartin,6368,169,0.85 [0.67-1.08],0.183323586320599
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSC22D1,TSC22 domain family protein 1,6571,175,0.94 [0.75-1.19],0.6215708502791546
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSHB,Thyrotropin subunit beta,7572,207,0.95 [0.80-1.14],0.6020244134389023
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSLP,Thymic stromal lymphopoietin,7455,202,1.01 [0.82-1.26],0.9032629625603456
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSNAX,Translin-associated protein X,6354,169,0.74 [0.50-1.10],0.1350165354280033
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN1,Tetraspanin-1,7455,202,0.43 [0.34-0.54],2.4592684074071368e-12
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN15,Tetraspanin-15,6354,169,0.95 [0.70-1.28],0.7356013049603398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN7,Tetraspanin-7,6400,169,0.97 [0.83-1.14],0.7188313906608114
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPAN8,Tetraspanin-8,6553,176,1.01 [0.87-1.18],0.8827639265990382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TSPYL1,Testis-specific Y-encoded-like protein 1,6368,169,1.06 [0.72-1.55],0.783606036792103
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TST,Thiosulfate sulfurtransferase,7408,204,1.01 [0.85-1.20],0.9127633256739398
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTF2,Transcription termination factor 2,6413,172,0.96 [0.70-1.30],0.782482152946655
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTN,Titin,6354,169,0.95 [0.76-1.20],0.6700200782362066
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TTR,Transthyretin,6521,176,1.21 [0.68-2.16],0.5218038264734575
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TUBB3,Tubulin beta-3 chain,6400,169,1.40 [0.87-2.26],0.1699977439070488
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TWF2,Twinfilin-2,6573,174,1.00 [0.83-1.19],0.9612050924068788
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXK,Tyrosine-protein kinase TXK,6448,175,1.03 [0.86-1.24],0.7317273439497659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXLNA,Alpha-taxilin,7503,207,0.95 [0.82-1.09],0.4626292727810821
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXN,Thioredoxin,6480,176,0.78 [0.54-1.13],0.1916789471945396
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC15,Thioredoxin domain-containing protein 15,7608,208,0.90 [0.57-1.40],0.629907445609448
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC5,Thioredoxin domain-containing protein 5,7641,209,1.07 [0.89-1.29],0.4507764481602603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNDC9,Thioredoxin domain-containing protein 9,6567,172,1.07 [0.81-1.41],0.6579839582387339
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNL1,Thioredoxin-like protein 1,6388,168,1.16 [1.02-1.31],0.0216216997189221
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TXNRD1,"Thioredoxin reductase 1, cytoplasmic",7592,208,0.93 [0.71-1.23],0.626525877805177
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYMP,Thymidine phosphorylase,7528,205,0.91 [0.75-1.10],0.3294392918552924
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRO3,Tyrosine-protein kinase receptor TYRO3,7572,207,1.68 [1.08-2.60],0.0204707318416674
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",6368,169,1.13 [0.89-1.44],0.3150126866070836
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBAC1,Ubiquitin-associated domain-containing protein 1,7543,206,0.64 [0.44-0.92],0.0178703067860268
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2B,Ubiquitin-conjugating enzyme E2 B,6554,173,0.70 [0.41-1.21],0.2039648561614677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,6580,177,1.02 [0.80-1.30],0.8898730095357955
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBE2Z,Ubiquitin-conjugating enzyme E2 Z,6368,169,0.91 [0.68-1.20],0.4934107424840533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBQLN3,Ubiquilin-3,6354,169,0.93 [0.71-1.21],0.5807959312586437
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UBXN1,UBX domain-containing protein 1,6435,173,0.84 [0.67-1.05],0.1282713593897734
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,6553,176,0.99 [0.89-1.10],0.8138637278052262
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UGDH,UDP-glucose 6-dehydrogenase,6354,169,1.05 [0.91-1.21],0.5392705070880393
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UHRF2,E3 ubiquitin-protein ligase UHRF2,6354,169,0.79 [0.48-1.28],0.3328087221238309
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ULBP2,UL16-binding protein 2,7503,207,1.50 [1.12-2.01],0.0060228020258786
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UMOD,Uromodulin,7659,208,1.03 [0.81-1.30],0.8093074207832323
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC5D,Netrin receptor UNC5D,6368,169,1.05 [0.58-1.88],0.8822498903954992
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNC79,Protein unc-79 homolog,6350,168,0.88 [0.66-1.17],0.3782898120062525
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UNG,Uracil-DNA glycosylase,6554,173,1.09 [0.72-1.64],0.6891604700469277
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPB1,Beta-ureidopropionase,6580,177,1.01 [0.86-1.20],0.8878965601194017
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3A,Uroplakin-3a,6400,169,1.26 [0.95-1.66],0.1077340854697105
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UPK3BL1,Uroplakin-3b-like protein 1,6432,175,1.18 [0.94-1.47],0.1561867501932828
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROD,Uroporphyrinogen decarboxylase,6435,173,0.81 [0.64-1.01],0.0618199234435619
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UROS,Uroporphyrinogen-III synthase,6413,172,0.77 [0.60-0.99],0.0415532118635529
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USO1,General vesicular transport factor p115,7543,206,0.96 [0.83-1.10],0.5649742029630425
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP25,Ubiquitin carboxyl-terminal hydrolase 25,6554,173,0.85 [0.69-1.05],0.1346078016204679
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP28,Ubiquitin carboxyl-terminal hydrolase 28,6567,172,1.41 [1.03-1.93],0.0329939544053713
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP47,Ubiquitin carboxyl-terminal hydrolase 47,6354,169,0.83 [0.68-1.02],0.0717756569671381
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",USP8,Ubiquitin carboxyl-terminal hydrolase 8,7455,202,0.95 [0.82-1.09],0.4420459920890297
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",UXS1,UDP-glucuronic acid decarboxylase 1,7437,205,1.02 [0.80-1.29],0.8814657246220879
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP5,Vesicle-associated membrane protein 5,7455,202,0.83 [0.63-1.09],0.1783227128849799
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAMP8,Vesicle-associated membrane protein 8,6368,169,0.94 [0.79-1.13],0.5236375345715816
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASH1,Tubulinyl-Tyr carboxypeptidase 1,7573,209,0.94 [0.81-1.10],0.467322458404494
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASN,Vasorin,7468,203,1.98 [1.26-3.11],0.0032513658201654
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VASP,Vasodilator-stimulated phosphoprotein,6592,177,1.02 [0.83-1.25],0.8454849085972158
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAT1,Synaptic vesicle membrane protein VAT-1 homolog,7543,206,1.69 [0.90-3.19],0.1034518863875377
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VAV3,Guanine nucleotide exchange factor VAV3,6400,169,1.01 [0.87-1.18],0.8618414285882325
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAM1,Vascular cell adhesion protein 1,7611,206,1.60 [1.03-2.49],0.0357022171766701
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCAN,Versican core protein,7641,209,1.18 [0.79-1.78],0.4199662948880014
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VCPKMT,Protein-lysine methyltransferase METTL21D,6350,168,1.19 [1.04-1.37],0.0119323390991771
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFA,Vascular endothelial growth factor A,7643,209,1.00 [0.80-1.24],0.9789587812958896
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFB,Vascular endothelial growth factor B,6368,169,1.10 [0.66-1.82],0.7189217185388677
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFC,Vascular endothelial growth factor C,7608,208,1.03 [0.82-1.28],0.8269086214574589
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VEGFD,Vascular endothelial growth factor D,7652,209,1.16 [0.85-1.60],0.3485197287054316
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VGF,Neurosecretory protein VGF,6571,175,1.25 [0.79-1.98],0.3361413393289649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIM,Vimentin,7455,202,0.99 [0.89-1.10],0.8623785176631649
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIPR1,Vasoactive intestinal polypeptide receptor 1,6393,171,0.98 [0.51-1.89],0.9549383054601134
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VIT,Vitrin,6580,177,0.95 [0.65-1.39],0.8021090982873382
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VMO1,Vitelline membrane outer layer protein 1 homolog,7543,206,1.12 [0.93-1.36],0.2363654797701551
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN1,Pantetheinase,6592,177,0.96 [0.79-1.18],0.71081137646359
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VNN2,Vascular non-inflammatory molecule 2,7543,206,1.03 [0.79-1.36],0.8111658380876454
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS28,Vacuolar protein sorting-associated protein 28 homolog,6448,175,0.83 [0.66-1.06],0.1327899762971477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS37A,Vacuolar protein sorting-associated protein 37A,7543,206,0.94 [0.80-1.11],0.4700896442681922
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS4B,Vacuolar protein sorting-associated protein 4B,6554,173,0.95 [0.81-1.12],0.5596591518153533
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VPS53,Vacuolar protein sorting-associated protein 53 homolog,7543,206,0.95 [0.81-1.12],0.5378006495591217
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10,V-set and immunoglobulin domain-containing protein 10,6554,173,1.14 [0.74-1.73],0.5529837565264735
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,6354,169,1.21 [0.80-1.85],0.3635845924941431
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG2,V-set and immunoglobulin domain-containing protein 2,6554,173,1.25 [1.03-1.52],0.0228632866017603
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIG4,V-set and immunoglobulin domain-containing protein 4,7582,205,1.28 [0.97-1.69],0.0859871596585244
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,7559,206,1.03 [0.84-1.26],0.7837379157575332
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSNL1,Visinin-like protein 1,6567,172,1.11 [0.76-1.64],0.5877282685367229
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM1,V-set and transmembrane domain-containing protein 1,7422,204,1.09 [0.86-1.39],0.4681584122472391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2B,V-set and transmembrane domain-containing protein 2B,6448,175,0.88 [0.60-1.29],0.5154150082845699
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,7455,202,1.21 [1.00-1.45],0.0443296505774893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,7641,209,1.04 [0.87-1.24],0.6425097718353481
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTCN1,V-set domain-containing T-cell activation inhibitor 1,7437,205,2.35 [1.66-3.34],1.656093249770596e-06
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,6435,173,0.97 [0.74-1.26],0.817695494322684
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA1,von Willebrand factor A domain-containing protein 1,7647,207,1.15 [0.85-1.56],0.3538357028292135
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWA5A,von Willebrand factor A domain-containing protein 5A,6350,168,0.77 [0.60-0.99],0.0423623236300776
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2,Brorin,7478,206,1.45 [1.08-1.96],0.0150251170564172
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWC2L,von Willebrand factor C domain-containing protein 2-like,6571,175,1.04 [0.76-1.42],0.8268675271693267
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",VWF,von Willebrand factor,7681,210,0.99 [0.83-1.17],0.874829984126893
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WARS,"Tryptophan--tRNA ligase, cytoplasmic",7592,208,0.87 [0.63-1.21],0.4050199090276306
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WAS,Wiskott-Aldrich syndrome protein,7455,203,1.11 [0.91-1.34],0.3011561373754424
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF1,Wiskott-Aldrich syndrome protein family member 1,7455,202,0.92 [0.80-1.05],0.2177712813753427
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASF3,Wiskott-Aldrich syndrome protein family member 3,7422,204,0.98 [0.84-1.14],0.7841593975101949
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASHC3,WASH complex subunit 3,6567,172,0.95 [0.78-1.16],0.6106045863649328
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WASL,Neural Wiskott-Aldrich syndrome protein,6368,169,0.95 [0.73-1.24],0.7226657193471755
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WDR46,WD repeat-containing protein 46,6554,173,0.98 [0.64-1.50],0.9285992145604512
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC1,WAP four-disulfide core domain protein 1,6419,170,1.24 [0.99-1.55],0.0650574049616953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC12,WAP four-disulfide core domain protein 12,7647,207,0.74 [0.60-0.90],0.0030551365083409
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFDC2,WAP four-disulfide core domain protein 2,7207,196,1.33 [1.01-1.75],0.0400184344359502
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",7475,205,1.34 [0.99-1.80],0.0568432387444695
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",7584,207,1.03 [0.71-1.49],0.8806067344122703
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WIF1,Wnt inhibitory factor 1,7659,207,1.11 [0.78-1.60],0.5575096416308257
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WNT9A,Protein Wnt-9a,7455,203,0.97 [0.63-1.48],0.8716207301190345
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,7503,207,0.90 [0.71-1.15],0.4030274179730729
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XCL1,Lymphotactin,7659,207,0.98 [0.78-1.24],0.886824824289688
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XG,Glycoprotein Xg,7649,210,1.03 [0.73-1.46],0.8521394484892588
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XIAP,E3 ubiquitin-protein ligase XIAP,6368,169,0.90 [0.69-1.19],0.4644806442611953
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XPNPEP2,Xaa-Pro aminopeptidase 2,7608,208,1.00 [0.89-1.12],0.984343949281048
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",XRCC4,DNA repair protein XRCC4,7422,204,1.17 [0.85-1.61],0.3292362934731566
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YAP1,Transcriptional coactivator YAP1,6567,172,1.14 [0.70-1.88],0.5980368516297412
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YARS1,"Tyrosine--tRNA ligase, cytoplasmic",6553,176,0.98 [0.88-1.08],0.6686525857628083
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YES1,Tyrosine-protein kinase Yes,7543,206,0.96 [0.86-1.07],0.4431343670547477
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YJU2,Splicing factor YJU2,6554,173,0.83 [0.51-1.35],0.4613583185972718
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YOD1,Ubiquitin thioesterase OTU1,6354,169,0.71 [0.55-0.91],0.0065095831793005
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YTHDF3,YTH domain-containing family protein 3,7455,203,1.05 [0.90-1.22],0.5268617101514541
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YWHAQ,14-3-3 protein theta,6435,173,0.95 [0.77-1.17],0.6088422015846724
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",YY1,Transcriptional repressor protein YY1,6368,169,1.33 [0.78-2.27],0.2958062657434391
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBP1,Z-DNA-binding protein 1,6368,169,0.93 [0.61-1.41],0.7294278012127671
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB16,Zinc finger and BTB domain-containing protein 16,7437,205,0.87 [0.72-1.04],0.1241369721808659
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZBTB17,Zinc finger and BTB domain-containing protein 17,7455,202,1.26 [0.97-1.64],0.0824196159403583
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZCCHC8,Zinc finger CCHC domain-containing protein 8,6354,169,1.06 [0.83-1.35],0.6350031365256616
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZFYVE19,Abscission/NoCut checkpoint regulator,6553,176,0.95 [0.81-1.12],0.5592465751362474
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZHX2,Zinc fingers and homeoboxes protein 2,6567,172,1.15 [0.77-1.71],0.5032782834620585
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF174,Zinc finger protein 174,6368,169,0.93 [0.60-1.42],0.7292306683826805
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF75D,Zinc finger protein 75D,6448,175,0.81 [0.62-1.07],0.1368213628827988
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNF830,Zinc finger protein 830,6554,173,0.91 [0.73-1.12],0.3645434410690403
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRD2,Protein ZNRD2,6553,176,1.03 [0.84-1.27],0.7798707774674197
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZNRF4,E3 ubiquitin-protein ligase ZNRF4,6554,173,0.93 [0.71-1.23],0.6166389699909159
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP3,Zona pellucida sperm-binding protein 3,6393,171,1.01 [0.96-1.07],0.6814607988918
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZP4,Zona pellucida sperm-binding protein 4,6350,168,0.46 [0.24-0.86],0.0149416411249255
Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",ZPR1,Zinc finger protein ZPR1,6400,169,0.96 [0.82-1.13],0.6615223465844958
